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Chapter I 
INTRODUCTION 
Interest and need of the professional physical therapist in 
the field of cancer has been expanding at a tremendous rate. The 
r�aso�s for this interest are many: greater public awareness of the 
causes, effects, disabilities, and treatment of cancer; increased 
scie;ntific knowledge concerning the pathogenesis and natural his­
tory of varioup neoplastic processes; increased concern of national 
cancer organizations regarding disability due to cancer; better 
survival rates and longer durations of the disease are producing 
unique and challenging disabilities for the physical therapist. 
Also, since the overall incidence of cancer is increasing, now 
ranking second only to heart disease as a cause of death in the 
United States, more people will develop cancer, and greater num­
bers of patients that the physical therapist will be called upon 
to treat will have cancer or cancer- related disability. The 
extent of the problem and the need for the physical therapist to 
have sophisticated approaches at his disposal and resource in 
meeting the needs of cancer patients are obvious. 
There is a particular need for improvement in the type and 
kind of care given to the metastatic cancer patient. For this 
patient, the metastatic process spreads the disease beyond the 
limits of the area from which it has arisen. The problem presents 
a myriad of co�plex variables that need to be understood in order 
for the physical therapist to design appropriate physical therapy 
2 
proce dure s and programs.  All too often the phys ical the rapy pro­
grams that have bee n  writte n  by physical the rapi s ts or  othe r med ical 
profe s s ionals concentrate only on the acute and short te rm d isabili­
tie s ,  such as  loss  o f  range of  mot ion and swe l l ing of the ipsalat­
e ral arm fol lowing radical mas te ctomy (Beeby and Broe y , 19 7 0 ;  Die tz , 
19 6 9 ;  He ale y ,  1 9 7 1) . Also,  many of the se d i s abilit ie s are a re sult 
of the tre atment for the cance r ,  and not re ally due to  the d i se ase 
proce s s  i t se lf .  The que s tion conce rning de scrip t ion of spec ific 
d isab i l it ie s  encounte red in the me tas ta t ic bre a s t  cance r patient 
ha s not re ally bee n  s tud ie d in depth . The pre se nt re search ste ms 
out of  a s ince re de s i re to  improve the condi tions unde r which phys ­
ical the rapy e valuation and tre a tment of  the me tas tat ic bre ast  can­
cer patient is  approache d .  
In orde r to accomp li sh this ,  a cons iderat ion of the d i sease 
proce s s  and its  rel at ionship to funct ional disab il i ty is  ne ce s sary . 
The e xac t nature of this  re lat ionship i s  the targe t of s tudy of 
thi s  re se arch proje c t . 
DEFINITION OF THE PROBLEM 
The s igni ficance o f  bre as t  carc inoma in the human female 
lie s In the fact that it is the commone s t  c ance r in wome n . In  fac t , 
more women d ie of  bre as t  cance r than any othe r  form of  c ance r . Pre ­
sumably , there are 7 0 , 000  new case s and 40 , 000  dea ths from b re as t  
c ance r e ach ye ar  in the Unite d  S tate s (Kaufman , 19 7 3) . Seve nty- two 
new case s pe r 100 ,000  female s  a re d i agnosed annually, and the mor­
tal i ty rate is  2 7  pe r 100,000 . The often quoted figure is  that one 
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in 18 women will deve l op breas t cancer a t  some t ime in her life 
(Savl ov , 1973). Since the disease i s  s o  common, research regarding 
i t s  natural his tory and behavior con s titu tes a sound and wor thwhile 
under tak ing. 
A need for the s tudy of this t ype was felt chiefly due to 
the fact tha t physicia n s  are more commonly referring me tas t a tic 
p a tien t s  for physica l therap y treatmen t  in order to improve t he 
level of functional activi t y  in t hese p a tien t s , who are weakened 
b y  the effec t s  of the cancerou s proces s which has produced wide­
s pread, dis seminated d i sease. Me tas tases are u sually presen t in 
more than one organ or s y s tem, an d the s ymp t om s  tha t are produced 
may be either of a general or a s pecific nature. The disabilities 
that are encountered in these p a t ien t s  have never really been fully 
documen ted; all too often the therap i s t, on accoun t  of lack of 
acces s t o  wel l - def ined evalua tion parame ters , b eg i n s  trea tmen t  on 
a patien t who has not been p roperly evalua t ed for s pecific disabi l ­
it y . If the correla tion between ex ten t of disabili t y  a n d  amoun t of 
disease can be made , bet ter evalua t ion procedures can be employed 
and therefore more benef icial programs be devised for these pa tien ts. 
In effec t, for the proper care of t he me tas tatic cancer patient to 
be realized, the treatmen t mus t  become s pecific , a n d  move awa y  from 
the genera l realm i n  wh ich i t  i s  now firmly en t renched. 
General t reatmen t regimes are commonly employed for adva nced 
ca ncer p a tient s - modified whole bod y conditioning , func tional 
s trengthening, an d as sis ted ambula tion ac tivi ties . Specific 
approaches are lacking because the s ymp tom s  and disabili ties of 
met a s tatic cancer are not properly cat alogued , and they are oft en 
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different for different types of cancer. Other medical care and 
treatment for metastatic breast cancer depends on the localization 
of the metastases, the patientTs age and general condition, patterns 
bf hormone secretion, surgery, and the tolerance of the different 
patients for the various chemotherapeutic agents that are available 
(Viadana et al., 1 9 7 1) . If physical therapy is to play an integral 
role in the care of the metastatic cancer patient, more elaborate 
and detailed evaluation procedures as well as a firm foundation or 
rationale for treatment approaches are needed. 
The need can be further demonstrated if one examines the 
recent literature which has attempted to deal with the quality of 
survival in breast cancer. Craig, Comstock, and Geiser (19 7 3 ) 
studied 1 3 4  breast cancer patients and 2 60 controls. They claimed 
that the hindrance to many efforts was the lack of clarity and 
uniformity in defining and assessing quality of survival. In this 
particular study, physical functioning was measured by extent of 
disability and assessment of current health status, both being 
graded on a scale of zero to five. The goal of the study was to 
estimate the degree of disability and malfunctioning attributable 
to the cancer and its treatment, over and above that resulting from 
the age and socioeconomic condition of the subjects. They summa­
rized that the only important effects of breast cancer seemed to be 
a slight increase in overall physical disability by adding a small 
but measurable number of persons with surgery related disability. 
However, the disabilities were never categorized or described 
sufficiently to draw any conclusions as to the actual functional 
disability of these patients. In addition, the group was largely 
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composed of breast cancer patients who were in the early stages of 
the disease, and many of them did not exhibit distant metastases. 
An additional drawback was the fact that the assessment of current 
health status was made by the patient herself, thus adding to the 
subjectivity of this parameter. 
Another article stated that of a number of women under age 
65  at the time of mastectomy, fully 8 4  percent had resumed their 
preoperative responsibilities; this study did not document specific 
disabilities or dysfunctions, and did not state the percentage of 
patients that had distant metastases (Schottenfield and Robbins, 
1 9 7 0 ) . These two endeavors to outline the quality of survival in 
terms of physical dysfunction demonstrate all too clearly the need 
for more specific documentation. 
Although theoretically any type of human cancer can metasta­
size, effect serious symptomatology, and therefore lead to varying 
degrees of physical dysfunction, breast carcinoma in its many patho­
logical ,forms was chosen as the target for this study for many 
reasons: 
1. Breast cancer is the most common form of cancer in the 
human female, and is responsible for the greatest number of new 
cases and deaths annually. 
2. With increased and improved methods of surgery, chemo­
therapy, and radiotherapy, more patients will be living longer with 
recurrent or metastatic disease and morbidity. This will mean an 
increased number of patients with probable increased dependency and 
disability, necessitating the procurement of physical therapy ser­
vices to assist in bringing the patient to the highest level of 
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func tioning p o s s ible ln the l ight o f  the progre s s ive d ise ase . 
3. S ince in i t s  late r s tage s bre as t  cance r spre ad s  by both 
the lymphatic  and hemat ogenous route s ,  its  behav ior might we ll 
repre sent characte r i s t ic me tas tatic s ymp tomatology , that  i s , symp ­
toms that wil l  be more or le s s  spe c i fic for de s igna te d organs or  
systems . Also s ince both route s are portals of  inva s ion , me tas tase s 
can be e xpe c te d  to be more w ide spre ad t han i f  only one form of  d i s ­
semination we re common . The particular me tas tat ic trends of  this  
d i se ase will  be  out l ine d in the colle c t i on o f  data , and the se 
re late d to disab i l i ty . 
4 .  S ince an increa se d numbe r o f  patients  with d i sseminated 
bre ast  c arcinoma will c ome to the phys ical the rap i s t  for tre atment , 
there i s  a gre at nee d  to spe c ifically document the patte rns and 
type s of disab i l itie s that will be encounte re d . This  can only be 
done by a c l inic ian who is skille d and pe rceptive in evaluating the 
p roble ms that the me tas ta t ic cance r patient will p re sent . To do 
this  a thorough knowle dge of  the e x te n t  and s ymptomatology of  the 
me tastatic deposits  from the d i se ase is  ne ce s s ary . 
S TATEMENT OF HYPOTHESES 
This  s tudy will  a t temp t  to gathe r data that will  e i the r 
support or  re fute the following hypothe se s : 
1 .  HOl . The re wi ll be no or a ne gative s tatis tical  corre ­
lation be tween the e x te n t  o f  disease , as  me asured by the e x te n t  o f  
me tastase s i n  the bre as t  cance r pat ie nt de sc ribe d on an ope rat ional 
mode l (Mode l A) and the leve l of disab i l ity  and physical dys funct ion 
manife sted c l inically and me asured by pe rfo rmance on a te s t  con-
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structed to a>lSeSl"S-'tfl1!e ftln�ticn8l1 impairment of the patient in 
i-e'llsls of mGt"il ty :ancit J.f.\ulctional activities. (Model B).  
hatwooD the, ex1i:em \Of di:se'asEt 8.9 measuI'-E!'Q on Model A and the level 
of disability and physical dysfunction manifested clinically as 
measured by Model B .  
3. H02. For all persons in the' sample demonstrating a 
$.pEc-ified $,ite '-of metastasis, i.e. lung, there will be no or a nega-
� ,-,e c�rrelati@n between the ext-ent of disease, as measured by the 
e ant of mstas.t!atic disease operational model (Model A) and the 
level of disability and physical dysfunction as measured on Model B .  
fueFe will be $:everal correlation ecoefficients representing groups 
ha�� a certain type of m�tastasis. 
l1-. Ha2. For all persons in the sample demonstrating a 
slPseified s.i'te of metastasis, there will be a pasi tive statistical 
OOI'1:tslation between the scores obtained for that group on Model A 
wi t:Jl. Mo clE21 B .  
s. Ho3• Those patients over age 60 and those patients 
li�in� the �ongest (greater than 3.3 years) with disseminated 
di.s�a'Be will not exhibit: any greater amounts of disability, as 
rEdf leoted by higher scores obtained on Model B - level of disabil-
i�y:'and physical dysJUnction. 
6 .  Ha3. Those patients over age 60  and the patients liv­
ing -the longeSft with diss-eminated disease as defined above will 
e�lt �e g�eate9t amounts of disability, reflected by higher 
scores attained on Modei B ' - level of disability and physical dys-
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' I  7 .  The number of patients with various types of metastases 
will be distributed evenly over a six category functional classifi­
cation that describes the performance status regarding functional 
disability of women with metastatic breast cancer. 
SIGNIFICANCE: SCOPE AND LIMITATIONS 
The author desired in this study to document clinical dys­
function and disabilities in the metastatic breast cancer patient 
wbj.ch were a result of the disease and its ensuing dissemination. 
Xhese disabilities were expected to be a function of the number, 
site, size, and gross histological, radiological, and pathological 
characteristics of the cancer metastases in question. Since clini­
cians are constantly re- evaluating methods of description and clas­
sification of human diseases, and seeking alternate, more sophisti­
cated or more practical ways of outlining these characteristics, a 
documentation of this type will be significant in helping cancer 
clinici�ns to achieve this endeavor. 
In addition, the documentation will assist persons in 
quickly estimating the level and degree of involvement with metas­
tases in patients with disseminated breast cancer. A part of this 
research will include the construction of a validated descriptive 
m0del for use in interpreting the extent of metastatic disease in 
the patient. Included in this descriptive model would also be 
clinical signs d�e to chemotherapeutic, radiological, or surgical 
treatment of the disseminated disease. 
The lack of adequate and detailed documentation in meta­
static disease has been mentioned and will be further developed and 
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supporte d  in the revie w  o f  lite ra ture . The dilemma that the phyi­
c al the rapis t face s in choos ing prac t ical , rational and fe as ible 
me th0ds and tre atment  approache s is  large ly a result o f  the lack o f  
spec i fication in both the e x te n t  o f  disabilitie s  and me tastase s in 
the patient . Thus this re search wi ll hope fully be s ignificant in 
alleviating rhis  problem of t re atme nt  se le c tion 1n me tastatic bre as t  
carc inoma . 
The further significance of  thi s proj e c t  l ie s  in the fac t 
that the data will ass is t  in outl ining s ome o f  the fac tors that 
might inte rvene and modify the corre l ation be tween  the e x tent  o f  
disease pre sent  c l inically and the amount and kind o f  disab i li ty 
shown by the patien t .  I f  this is  demons trate d , it  i s  furthe r hoped 
that the spe c i fic factors and parame ters that might p o s s ibly be 
re spons ible for the dis abili t ie s  could be de l ine ate d . 
Finally , the approach that  is  deve loped might conce ivably 
be use d  for o the r type s of cance r ; with adj ustments  and appropriate 
de le tions of the mode l s , it  might be app lied to othe r type s o f  
me tastatic  c ance r ,  thus e nabling c l inic ians t o  docume nt more spe ­
c i fically the me tastatic proc e s s  1n disseminate d c ance r patie nt s . 
In addition to c ance r ,  the approach might also  be app l ie d  to o ther 
chronic disab ling d ise ase s , so  that the profe ss ional physical the ra­
p i s t  c an have acce s s  to a rationale for re lat ing dise a se entities  
to re s ul tant disabilitie s . 
The re sults 'o f  this s tudy a re limite d in that  the s ample 
is drawn from a population of bre as t  cance r patients  tre ated at 
Medical  College of  Virginia Hosp itals , thus the re sults are b iased 
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by .any charac teristics  and factors that might be particular to MeV 
jpal"iE!1l1ts . This perhaps iSi the gre ate s t  l imitat ion - that the 
�stl\Jtts are applicab le only to  thi s  s ample , and caution should be 
used in e x tending any conc lusions or inte rpre tat ions to populat ions 
outs ide o f  thi s ins titution . 
Anothe r l imitation is the vast  numbe r of  inte rvening var i ­
able s that could pos s ib le modi fy the corre lation be tween  the mode ls . 
Fao toFs such as patient mot ivation , l i fe s tyle , e x trane ous pre ssure , 
pest' or group p re ssure , and mult ip le psychological cons ide rations 
pe rhaps all play a part in a patien t T s  pe rfo rmance s tatus re garding 
funct ional ability in act iv i t ie s o f  daily living . The pre sent  
rese arch i s  not  de s igned to  asse s s  the significance o f  the se non­
medical parame te rs or the ir  role in functional  d isability in me ta­
s tatic c ance r patie nt s . The bas ic format of this  s tudy , which is 
Feported as a c orrelational s tudy , is not de s igned to imply a cause 
and e ffec t  sequence , but rathe r to de scribe the s tre ngth of the 
relationship be tween the me tas tase s and functional disab ility . 
Las tly , a numbe r of  non ne opl astic med ical  conditions may 
coe x i s t  with the b re as t  c ance r me tastase s .  Some o f  the se dise ase 
proce s se s  or syndrome s are common to populations of advance d  age , 
such as obe s ity , var ious arthri t ic cond itions , arte rioscle rotic 
he art d i se ase , and o the rs . The se might have a s ign i ficant be aring 
upon the leve l of func tional disability that many of the se patients 
will demonstrate . The e x tent  o f  me tastase s ope rational mode l will 
ide nt i fy cle a1i'ly those factors which are applicable to me tas tatic 
disease due to a pFimary b re as t  cance r . A s ince re e ffort  to dif­
fe rentiate the se factors from those due to othe r  me dical cond itions 
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will be  ope rative at all  time s  during data  c olle c t ion , and the 
assumption is made that the disabilitie s  that are e ncounte red are 
re lated to the met as tase s that are p re sent  unle s s  o the rwise docu­
mente d . 
DEFINITION OF TERMS 
1 .  Bre as t  c arc inoma : the re sult of  abnormal prolife rat ion 
and dis semination of epithe lial  ce lls  within the b re as t  t is sue . 
Seventy- five pe rcent of  bre a s t  c arc inomas are infiltrat ing duc tal 
c arcinomas , aris ing from the epithe lial lining of  a mammary duc t . 
2. Dis tant me tas tase s :  hematoge nous or  lymphatic spre ad 
of  the cance r be yond the confine s of the b re as t , ipsalate ral ax il­
lary or  inte rnal mammary lymphatic s . The following te rms are not 
e quivale nt to the te rm distant me tas tase s :  spre ad , e x te nsion , 
invol vement  or  me tastase s to ips alate ral submammary musculature 
�ec toralis  maj or  and minor) , ipsalate ral bre as t , homo late ral 
ax illary, or inte rnal mammary node s , or skin re curre nce within the 
suture l ine . 
3 .  C omplications due to tre atment : any adve rse s ide 
e ffe c t s , s ymptoms , or othe r c omplicating sequalae that are dire c tly 
o r  indire c tly  a re s ult  of the surgic al , radiological , or  chemo ­
the rapeutic or hormonal tre atment of  me tastatic b re as t  c ance r . 
4 .  Funotional act iv i tie s : for this s tudy , those  eve nts 
di�e c tly or indire c tly re lated to e ating , pe rsonal hygiene , loco­
motion , and daily rout ine chore s c arrie d  out by the patient . 
5 .  Me tastase s :  a growth of  a c ance r tha t is  separate and 
distinc t from its  primary s ource . A me tas tas is can originate from 
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any part o f  the primary tumor (one s tep)  or from an alre ady e x is t ­
ing me tastas is (" cascade " ) , and dis seminate v i a  the lymphatic o r  
hematoge nous route . 
6. Ope rational Mode l A:  Extent  of Dise ase : a val idate d  
soaled mode l devised t o  de scribe and give patients  a score base d on 
the characte ristics  of me tastatic dise ase in patients with dissemi­
nate d b re as t  c ance r .  
7 .  Ope rational Mode l B Leve l of  Func tional Disability :  a 
val idate d  and scale d mode l c onstruc ted and de s igned for the purpose 
o f  a s sign ing pat ients  in the s tudy a mathematical score based on 
per formance s tatus in func tional act iv i tie s . The score is a me a­
sure o f  the disability the patient e xhibits  in  the pe rformance of  
the se func tional ac t ivi tie s . 
8. Phys ical the rapy e valuat ion proce dure s : for this s tudy , 
those p rocedure s use d  to as se s s  type , leve l , e x tent  and e ffe cts  o f  
disability or dys funct ion manife s te d  i n  func t ional ac tivitie s . 
9 .  Se le c tive affini ty hypothe s i s : one of  two curre nt  
maj or the orie s  o f  the me chanism of  me tastatic growth of  tumors in  
the body , conte nding that  the deve lopme nt of  me tastase s is  a dire c t  
funct ion of  the s i te of  lodgeme nt ; local charac te ristics  o f  the 
organ in que s t ion will gove rn whe the r a me tas tasis grows ln that 
loc ation or not . Als o  calle d the soil hypothe sis . 
10 . Me chanical hypothe sis : the othe r maj or the ory of  the 
me tastatic mechanism o f  tumor growth and dis semination , conte nd ing 
that the location o f  me tas tatic growths is a dire c t  func tion of the 
numbe r of ce lls  p as s ing into the gene ral or re gional c irculation . 
Also  c alled the c irculating emboli  hypothe s is . 
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11. Palliation : the mi tigation and alle viation of  dise a se 
and its  e ffe cts  by various tre a tme nt re gime s although a cure is  not 
poss ible . The goal is  to  make the patient  more comfortable and 
e ase s ympt oms ; phys ical the rapy may be used as a palliat ive pro­
ce dure . 
ORGAN IZATION OF THE REMAINING CHAPTERS 
Because the fie ld o f  cance r me tas tase s ,  in particular 
b re as t  c ance r me tas tase� is  one that is remarkably vas t , the lit­
e rature review o f  this s tudy has  a t temp te d  to  demons t rate a more 
conc ise uni ficat ion of many s c ientific obse rvations that have bee n  
made and repor te d  throughout biological  and me d ical  j ournals and 
scatte re d  ove r the pas t de c ade s . The chapte r  attempts  to combine 
the various writings into a more c omple te whole . In the p roce s s  
the s truc tural framework for the cons truc tion o f  the ope rational 
mode l which forms the b ase for the data colle c tion of this the si s , 
was re alize d . This  task was made e as ie r  by e xce l lent  bibliography 
and c ross  re fe re nce s that we re found for e ach topic . Concentration 
in the se cond chapte r  is  on the maj or  s ites  o f  me tas tatic spre ad , 
although proper a ttention is  given to the le s s  c ommon although 
e qually inte re s ting minor s i te s  of spre ad . 
Chap te r three contains the me thods of  data colle c t ion and 
data analys i s ; he re also the te x t  de scribe s the c ons truc tion of the 
ope rational mode l s  for d ata co lle c t ion . The mode l s  the mse lve s  are 
p roperly place d in the append ice s bec ause o f  the ir  undue length . 
The procedure for mode l approval is  outline d , as we ll as  p re c i se 
plans for the inte rpre tation of  data that was obtaine d . The e x ac t  
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proced�re s use d  in  data colle c t ion a re de scribe d in  full , comple t ing 
this  chapte r .  
In chapte r four , table s de scribe the re sults o f  this  s tudy , 
and chap ter five comple te s and reviews the s tudy . Some impl ications 
for future re search are give n , in p articular the proj e c ted  use of 
the mode l to  o the r forms of c ance r . 
In  surrunary , be fore we c an de c ide - with certainty what kind 
and le ve l of  phys ical the rapy treatment i s  nece s sary , the dys func ­
tions of  the patient  should be accurate ly , thoroughly , and com­
p le te ly unde rstood . This also appl ie s  to dys func tions that are a 
re sult o f  me tastatic , disseminate d cance r - the dise ase proce s s  
chosen for the topic of  this  s tudy . 
This re se arch proj e c t  hope fully will fac ili tate evaluation 
and tre atment of  the me tas tat ic b re as t  cance r patient in l ight of  
this unde rstanding . 
I 
. ' 
Chapte r 2 
REVIEW OF LITERATURE 
THE NEED FOR CLASSIFICATI ON SF DISTANT METASTASES 
Attempts  t o  clas s ify bre as t carc inoma for both academic 
and prognos t ic intere s t  have bee n common in the l i te rature . One 
s ys tem which was used quite e x tensive ly emp loye d  four groups 
de s ignate d by roman nume rals (S iche r and Wate rhouse ,  1 9 7 3 ) . This 
system grouped patients accord ing to the s t age of  the dise ase 
which progre s se d  from the les ion be ing c on fined to  the bre as t  to 
the patient having wide spre ad ,  dis seminate d disease . Haage nsen 
(19 7 1) has  employe d  a four st age system based on fac tors such as  
numbe r and locat ion of  involve d lymph node s , size of primary tumor , 
de gree o f  skin involveme nt , and othe r local characte ristics . 
During this  century , c l inic ians discove re d that although 
de tailed loc al ization o f  the p rimary tumor within the bre as t  
, 
appe are d  t o  have l it t le influe nce on prognos is , a supplementary 
c lass ification of node involvement  p rove d to be a valuable adj unct 
to  a s se s sment  of  l ike ly survival . Thus the TNM s ys te m  of c lass ifi-
cat ion was  conce ive d . In this s ys tem  the le tte r  T rep re s e nts  
characte ristics  o f  the p rimary tumo r , the le t te r  N the s tate of 
the re gional lymphatics , and the le tte r M the p re sence or absence 
of distant me tast ase s outs ide the de fine d zone of re gional lym-
phatic drainage . Separate de sc riptions we re s e t  up by  the Inte r-
nat ional Union Against Cance r (UICC) and the Ame rican Joint Com-
mittee for Cance r S taging (AJCC)  for the c l inical c la s s ificat ion 
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of bre as t cance r .  In the se sys tems a treme ndous amount of  de tail 
and attention is  paid to  local characte r is tics of the le s ion , such 
as the primary tumor , ipsalateral ax illary node status , and skin 
condition overlying the tumor . 
Howe ve r ,  in all discuss ions pe rtaining to c la s s i ficat ion , 
the M divis ion is only grade d Ml or Mo , that  is , if  dis seminate d 
dise ase is  pre se nt or not . The re are no' prov is ions in the clas s ifi­
cat ion system for the numbe r ,  s ite , type , and growth of  the dis tant 
metastase s . In addi tion , no de finitions as  to e xac tly what  const i ­
tu�e s a dis tan t  me tastas is we re offere d .  
Philips (19 7 3) reporte d  the re sults of  a prospe ctive five 
ye ar c l inical trial o f  the TNM system  o f  c las s i fication as proposed 
by the UICC . Fifty-nine out o f  a total of  1 , 5 1 7  case s had dis tant 
me tastase s when first e x amine d . This demons trate d a c le ar nee d  for 
furthe r bre akdown o f  the M c ate gory . It  is  illogical to as sume 
that primary tumor and nodal involveme nt e xe rt the main influe nce s 
on like ly survival when it  is  dis tant  me tas tase s or the ir compli­
cations that mos t  ofte n kill  the patie nt . Distan t  me tastase s can 
c once ivably be pre sent but dormant in a cons ide rab le se gme nt of 
the populat ion c oming for initial treatme nt for the ir breast  tumor 
(Siche r and Wate rhouse , 19 7 3 ) . 
Re cently , a group o f  inve stigators have attemp ted to  c las ­
s ify patients with dis seminate d bre ast  carcinoma . Cutle r ,  S idne y ,  
As ire , and Taylor (19 69 )  c onte nded that the time inte rval be tween  
initial diagnosis  of  the pr imary dise ase and the numbe r and type s 
of  organ s ite s involved influenced the survival time . The authors 
indicate d that the more obvious advantage s of a class ification 
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'iCh inc luded such parame te rs would fac ilitate e valuation o f  
the rapeutic results and als o he lp phys ic ians sele c t  the tre atme nt 
fOF individual patients (Cutle r e t  al . ,  1 9 6 9 ) . 
Slack , B lume nson , and Bro s s  (19 69)  formulated a mathmatical 
mode l which might characte rize the course of bre as t carc inoma . One 
of the purpose s o f  the mode l was to  de ve lop a formal me thod of te s t ­
ing a two dise ase hypothe s i s  - Type A be ing the more malignant , 
fas te r growing tumors and type B le s s  malignant or slowe r growing 
tumors . Include d  we re parame te rs me asuring or e s timat ing the tumor 
doub l ing time , nodal involvement , de lay t ime , and chance of  distant 
me tastase s .  E ffe c ts of tre atme nt we re cons ide re d important  in s ig­
nificantly influenc ing the c linical p ic ture of  the patient . 
As in othe r s imilar s tudie s ,  the re was reason to  que s tion 
the accuracy of the numbe r of pos itive node s de tec te d . Also , the 
mode l by S l ack and his colle ague s profe s se d  the growth rate of  the 
primary tumor and the me t astatic le sions t o  be the s ame , but the 
se le c tive affinity hypothe s is o f  me tas tatic c ance r - whe re the s i te 
of  me tastasis  is  the s tronge r de te rminant of  growth o f  the tumor -
may not fully support this . The conclus ion was that the data did 
support a two dise ase hypothe s is , but more s ignifican tly , prope r 
attention was beginning to be paid toward the dis tant me tas tatic 
aspect of  bre ast carc inoma and its impact on the natural his tory 
of  the dise ase . 
Reventos (19 69 )  wrote c oncerning the current  status of  
c l inical c las s ification o f  bre as t  cance r .  He sugge s te d  that  dis ­
tant me tastatic involvement  be asse s se d  and incorporate d into the 
schema by the addition o f  a checkl i s t  for s i te s  of dis tan t  spre ad ;  
tni s  could be used as  an addendum to the alre ady e s tablished TNM 
sys, em . Although his c oncepts  nee de d  furthe r development and 
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d' �ine ation , the impoptance of  di stant me tas tase s and the ir  me ans 
<oil de tedtion was give n fur the r support . 
Cutle r (19 7 0) outl ine d s ome parame ters of prognos t ic fac ­
tors in bre as t  cancer .  He s tre ssed  abs t ract ing pe r tine nt informa­
tion from the medical record o f  the patient , including dis tant 
me tastase s s tatus . No attemp t  was made t o  furthe r divide the d i s ­
tant me t as tatic fac tor , de spite the admitted fac t that le s s  than 
half o f  b re as t  cancers  diagnose d we re con fined to the bre as t . 
Cutle r (19 7 0) did find that re lationships be tween  the clinical 
characte ristics  o f  e ach group , the pe rcentage hav ing pathologically 
involve d node s, and p rogno sis  sugge s te d  that this information may 
be u se ful in dec iding on individual tre atme n t  plans . His mathe ­
matical three digit mode l ,  whe re tumor s ize , fixation and e dema , 
and axillary node s ta tus we re graded re spe c t ive ly , ne gle cte d d i s ­
tan t  me tastas e s  entire ly .  The author did re i te rate the nee d  for a 
more complex and comprehe ns ive che ckl i s t  for dis tant me tastase s in 
e ach patient (Cutle r ,  1 9 7 0 ; Cutle r and Mye rs ,  1 9 67 ) . 
As e arly as 1 9 67 , the latte r authors s tudie d a se rie s of  
2 , 0 34  c ase s in an  empirical s tati s t ical approach to classification . 
S taging recomme ndations base d on Ame rican and inte rnational com­
mitte s  we re compared .  The y found that the s ame e valuation and 
t re atment  plan was not appropri ate for all patients falling into 
the s ame p rognos tic c lass , due pre c ise ly to variations in clinical 
charac te ristics . Because s cheme s did not p rovide homoge nous groups , 
a fairly de taile d  and inclus ive che cklist  of  re levant charac ter i s -
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t;i,cs including distant  me tastatic s ite s , was p rovide d to he lp 
fW.ysic ians in asse ssment  o f  the dise ase . Galasko (19 7 4) s tated 
that " although TNM c lass ification is  we ll de scribe d in the lite ra­
ture and in the maj ority of te x tbooks , ve ry few men tion modern 
me thods  of de termining d i s tan t  me tas tase s ,  e ven though ultimate ly 
the prognosis  depends on the de gree of  dis semination" . 
The e xtrapolation of  the pre ceding paragraphs is  that 
phys ical therap is ts as  we ll  as phys ic i ans nee d  a spe c i fic clas s i fi ­
c at ion of disseminate d b re as t  c arc inoma for e valuat ion and treat­
ment proce dure s to  be  corre c t  and appropriate . Howe ve r ,  admi tte dly 
c linic ians could antic ipate much d i sagreement  if  dis tant me tas tase s 
we re incorporate d into the e x is ting class i fication sys tems ; s ince 
many diffe ren t  s i te s can be e ffe c te d  in a varie ty of ways , the 
added pe rmutat ions and comb inations could be truly comp licating . 
Be cause not only the p re sence or  absence of  dis tant spread , 
but also  the location , numbe r ,  symptomatology , and charac te ris tic 
nature oj the me tas tase s e ffe c t  prognos is and morb id i ty , the nee d 
for furthe r c lass ificat ion of  dis seminate d b re as t  carc inoma has 
been demons trate d . 
INTRODUCTION TO PATHOLOGICAL CONS IDERATIONS 
The p atho logy of e arly and late carc inoma of the bre as t  is 
a funct ion of  the numbe r of  type s of neoplas t ic d isorde rs that c an 
a ffe c t  the bre as t .  Excluding the rare sarcomas , Haagensen (19 7 1) 
offe red at le as t e ight d is t inc t forms . The se  are dis tinguishable 
mainly and princ ipally according to anatomical l ocation wi thin the 
mammary tissue , ce ll s ize and type , and p atte rns of growth . The 
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so  calle d  infiltrating ductal carc inoma comprise s 75  pe rcent of all  
bre ast  cance r ,  so  it will be  de scribed in  more de tai l .  
The e arlie s t  morphologically recognizable s te p  in the tran-
s itfon from normal to ne oplasti� his tology is  the multip lication of 
the epithe lial' duc t lining ce lls in number s  gre ate r than are 
require d for normal home os tasis . In duc tal c arc inoma , once the 
actual transformation has take n  p lace , the proce s s  was irre ve rs -
ible and progre s se d  ine x orably and o ften rapidly to involve are as  
of  the epithe lium and to invade adj acent  b re as t  tissue ; the origin 
was c ons ide red to be multifocal by many authors . Gallaghe r and 
Martin (19 7 0 )  propose d the mode l de scribe d in Figure 1 ,  e xplaining 
b re as t  c arcinoma in te rms of a transition from normal epithe lial 
lining to an invas ive carc inoma . 
normal 
epithe lium 
Figure 1 
initiat ing fac tor 
� 
persistant 
hype rp lasia 
�Onma lignant 
le s ions 
(pap i lloma , 
othe rs)  
Repre sentat ive Trans ition from Normal 
Tis sue to Carc inomatous Change 
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Ductal carcinoma of  the infiltrating type may actually 
a�ise outs ide of a duct , and so diste nd a lobule that the carcinoma 
app@ ars to be a true ductal carc inoma . Othe r carc inomas c ommonly 
ar · se from e pithe l ial ce lls of the lobule s themse lve s ,  the large r  
ducts , and from intralobul ar tissue (We l l ings and Jensen ,  1 9 7 3 ) . 
A variety of  histological  appe arance s c an p re se nt . The re ade r is  
re fe rred to Haagense n T s  tre atise for a detaile d  discuss ion o f  the 
microscopic pathology o f  bre ast carc inoma . 
B re ast c ance r commonly spre ads by  both the lymphatic and 
hematogenous route s . As a rule , but by no me ans unde r all  c i rcum­
stance s ,  hematogenous dissemination follows l ymphatic spre ad by 
s ome months or ye ars . Howe ve r ,  blood borne me tas tase s without 
lymphatic spre ad c an occur , and may be pre sent when the patient 
c ome s for primary tre atment o f  he r bre ast tumor . Curre nt thinking 
stre sse s the re lationship betwe e n  the two route s . 
Metastase s we re most c ommon in the lungs , l ive r ,  bone s , 
brain , apd kidne ys - organs which have e xtens ive pare nchyma , and 
we re highly vascul ar we re more p rone to deve lop metas tatic growths 
(Coman , De Long , and Cutche on , 1951) . A p re l iminary step to me tas ­
tasi s  was invas ion of the primary tumor , gove rned by  the rate o f  
growth , motility of the c ance r ce lls , and loss  o f  c ohe s ive ne s s  o f  
the malignant cells . E laboration o f  lytic subs tance s ,  such a s  
e nzyme s and prote ins , also p robably p layed a p art in the ability 
o f  the tumor to invade contiguous structure s (Te rry , 1 9 7 4) . 
C oman et  al . ,  ( 1951) studie d the mechanic al hypothe s is 
us ing the Brown Pe ace Rabbit tumor , and obse rve d that embolitic 
tumor cells  we re more like ly to e stabl ish themse lve s and form new 
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tumors  i f  the y lodge d  i n  the capillarie s than i f  the y arre s te d  in 
the arte riole s .  This s tudy had some imp lications  for bre as t  carc i ­
noma - pe rhaps the s ite s of  spre ad we re de te rmine d b y  how many 
e mboli  re ache d the c ap i llary be d ;  the soil  hypothe s is could support 
this , as the ske le tal , ne rvous , and pulmonary systems we re all 
r ichly e ndowed with an e x tens ive capillary ne twork (Coman e t  al . ,  
1 9 5 1) . S till unre s o lve d , both the orie s have the ir  p ropone nts - i t  
is  l ike ly that tumor embol i are commonly de s troye d by immune me cha­
nisms in organs whe re me tas tases  are rare , such as muscle , fibrou s , 
and cartilaginous t i s sue . 
Med ical profe s s ionals today re cognize that d i s seminate d  
b re as t  c ance r has a n  e x treme ly  wide variab i l ity in its natural 
behav ior ; e ve ry c a se is truly indiv idual istic . The re is no pre c ise  
way of  de te rmin ing change s in  the ne oplas tic  ce l l  population quan­
t itative ly  at  fre quen t  inte rval s , so  re lating tumor charac te ristics  
to the c l inical pre sentat ion i s  d i fficult and at  be s t  only app rox ­
imate . In add ition , the de s c r ip t ion of  an ind ividual bre as t  carc i ­
noma acc ord ing t o  any of  the accep ted  parame te rs i s  not final , 
bec ause p rogre ss ion o f  the d isease  allows a change in the tumor 
ce l l  population towards  new c l in ical  s tate s ove r time (Bre nnan , 
1 9 67 ) . Thus , c l inic ians are e ncourage d to view bre as t  carcinoma 
me tas tas e s as fluid , dynamic tran s i tional s ta te s , upon which a 
multitude of fac tors c an ac t .  
The his tory o f  bre as t  cance r could be e as ily div ided into 
two phase s :  the invis ible or pre c l inical pe riod of growth , and a 
v i s ible or c l inical phase (MacDonald , 19 6 6) . He proposed that 
fully three - fourths of  the l i fe cycle of a mammary c arc inoma 
pasBE!d be fore cl,inical diagnos i s  was poss.ible . The biological 
ba�ance be tween t�e hDs t  and ne oplasm could be come e s tablishe d 
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l ong be fore the c l inici an could e xe rt any influence on the proce s s . 
Implications for me tas tase s and the ir c linical p re sentat ion we re 
��ally c le ar :  the me tas tatic growths we re e s tablishe d  and deve l-
oped a s ignifican t  b iological balance with the i r  hos t  so that when 
they became c l inically de tec table , the relat ionship had probably 
re ached an irre ve rs ible course (MacDonald , 1 9 6 6) . 
If  dis tant spre ad we re the re sult of dissemination o f  tumor 
ce lls  remaining in the tre ate d  are a , one would think that local 
re currence s and mani fe s tations might be come e vi dent  long be fore 
the dis t ant me tastase s had de clare d  the ir pre sence c linically , but 
accord ing to one s tudy , this was no t the c ase (Bruce , Carte r , and 
Frase r ,  1 9 7 0) . Conce rning d i s tant spre ad to  bone without local 
re currence , it was ve ry conce ivab le that  whe n a physici an pe rformed 
a radical  mas te c tomy and thre e ye ars late r the bone me tas tase s 
appe are d , the ne oplastic  entity was pre sent  in the bone or se rum 
during that time and somehow late r  re ac t i vate d  to produce c l in i -
cally e vident  me tas tase s (Bruce e t  al . ,  1 9 7 0) . Thi s  gathe re d fur-
the r s ign ificance c onside ring the fac t that in 25 pe rce nt of e arly 
patie nts coming for primary tre atme nt , the re we re alre ady bone 
me tas tase s present tha t  did  not show up radiographically . 
The fac t  that lymphat ic me tastase s could appear in dis tan t  
rathe r than proximal lymph node s was a fac t frequently ignore d by 
surge ons for a long t ime (Fi she r ,  1 9 69) . This  author also indicate d  
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that  the re was a c loser  re lationship be tween hematogenous and lym-
phatic spre ad of tumor ce l ls than was currently be lieve d . For 
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e x amp le , tumor c e l l s  th a t  we re p r i ma r i l y  grow i n g  ln l ymph n o de s 
c ou l d  e x te nd t o  the v a s c u l a r  s y s te m  and d i s se m i na te , and the o re t ­
i c a l l y  b l ood b o rne me t a s t a se s c o ul d  fi n d  a w a y  i n t o  the tho rac i c  
o r  o the r l a r ge l y mph duc t a n d  d i s se m i n a te l ympha t i c a l l y . The l a t te r  
wa s p robab l y  much le s s  l ike l y , c on s i d e r i ng the re ve r s e  p r e s s u re 
grad ie n t  tha t  e x i s t s  from l ymph t o  b l o o d  p o rt a l s , a nd the fa c t  tha t 
t um o r  c e l l s  we re n o t  l i ke l y  t o  t r ave l a ga i n s t  the n a t u ra l  f l ow o f  
l ymph wh i c h  i s  t owa rd the l a r ge l ymph d uc t s . 
Tha t  t i s s ue s  whi ch we re d amage d phys i c a l l y  o r  c he m i c a l l y  
m i gh t  p r o v i de fe r t i le s o i l  fo r the de ve lopme n t o f  me t a s t a se s was a 
de f i n i te p o s s i b i l i ty ;  th i s  mi gh t  be one o f  the fac t or s  whi ch c o n ­
t r o l le d  the t rap p i n g  o f  the c i rc u l a t i n g  t umo r c e l l s a nd i n flue nce d 
the i r  s ub s e que n t  g r o w th . Fo r e x amp l e ; the ve r t e b r ae , pe l v i s , a n d  
uppe r fe mur wh i c h  a re c o n s t an t l y  sub j e c te d  t o  the phy s i c a l s t r a i n s  
o f  be a r i n g  the we i gh t  o f  the b o d y  i n  l o c o mo t i o n , we re b y  f a r  the 
mo s t  c ommo n  s i te s  o f  b o n y  me t a s t a se s . L i ke w i se , the l un g s  wh i c h 
we re p o s s i b l y  re pe a te d l y  t r a uma t i ze d  b y  t ob a c c o  smoke a nd/o r o the r  
i r r i t a n t s , we re a c ommo n  s i te o f  d i s t a n t  s p re a d . 
Be fore d i s c us s i n g  s ymp t om s  and c l i n i c a l man i fe s t a t i o n s  o f  
me t a s t a t i c d i se ase i n  b re a s t  c a rc i n oma , a b r ie f  e x p o s i t i o n  o f  the 
imp o r t an c e  o f  l oc a t i on o f  the me t a s t a s e s i s  ne c e s s a r y . 
Pa t t e r n s  o f  D i s s e m ina t i o n  
V i o l a  (19 7 1) o ffe re d s o me d i agn o s t i c  c l ue s t o  d i ffe re n t  
t yp e s o f  me t a s t a s e s , and ou t l i ne d  s o me o f  the s i te s  th a t  c ou l d  g ive 
r i se t o  t re a t ab le c omp l i c a t i o n s . Among c ommo n  s i te s  we re b ra i n , 
lung a nd b o ne me t a s t a s e s ,  a nd ob s t ruc t i on o f  abdom i n a l  o r  me d i a -
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s t in�l lymph uode s . Fre id and Goldbe rg (1943 )  emphas ize d skin , 
ske le tal , pulmonary , p leural , cerebral , hepatic , and intraabdominal 
me tas tase s as be ing s igni ficant s ite s . Ske le tal involvement  
occurre d  in  we l l  over one -half , l ive r involvement in at le as t one ­
hal f ,  and pulmonary spre ad in approx imate ly one - third or more o f  
patie nts  (Fre id and Goldbe rg , 1 9 43 ) . 
Rece ntly a group o f  re se arche rs carrie d out an autopsy 
s tudy of route s o f  d i ssemination o f  c ance r o f  the breast  (Viadana , 
Bross , and Pickre n , 1 9 7 3) . The ir  notable summary reporte d  647  
primary bre a s t  carc inoma case s , and explaine d  the one s tep  proce s s  
o f  the disseminat ion o f  c ance r , whe reby a l l  c ance r ce lls  we re 
der ived dire c tly from the primary tumor and spre ad to me tas tatic 
s ite s throughout the body , compare d  to the much more plaus ible 
mult i s te p  or TT Cascade TT proce s s  whe re secondary me tas tase s them­
se lve s give rise to o the r  me tastase s . Pathologically , i t  i s  no t 
poss ible to de te rmine with ce rtainty whe the r a growth in que s tion 
is indeed  from the primary tumor or a secondary me tas tase s .  
The y reporte d  that at autopsy , 6 6  pe rcent  o f  patients had 
lung involvement , 61 pe rcent  l ive r involvement , and 7 0  pe rcent had 
osseous me tastase s . These three maj or are as we re cons ide re d to be 
potential sources  of  furthe r me tastatic d i sseminat ion be cause the y 
were the most  common s ite s and locations o f  dis tan t  me tastase s in 
bre as t  c ance r (Vi adana e t  al . ,  1 9 7 3) . The re se arche rs found a low 
frequency of  me tas tase s in various minor s i te s  whe n the three maj or 
s i te s  (lung , bone and l iver) we re not affe c te d  or seede d . Con­
ve rse ly , if one or more o f  the three maj or  sites were involve d in 
the me tastatic proce ss , a highe r  inc idence o f  me tastase s to various 
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v s i te s  was obse rve d . A p artial l i s t  o f  e ffe c t s  of the three 
maj or  s i te s  is shown in Table 1 .  As an illustrative example , the 
f · rs t  line s igni fies that 6 6  percent o f  tumors me tas tatic to the 
p i tui tary also me tas tas ized  to bone ; and 15 pe rce nt also  me tas ta-
s ized to the lung . 
Table 1 
Bre ast C ance r Me tast ase s - Effe c t s  of  
Three Maj or S i te s  on  Seven  Minor 
S ites of Involvement  
S ITE GREATEST EFFECT SECOND GREATES T  EFFECT 
Hi tui tary 6 6% to bone 15% to lung 
CNS 61% to  lung 2 1% to  live r  x bone 
Stomach e rrat ic patte rn 
Pancre as 48% to l ive r 2 9% to lung 
Kidney 41% to lung 25% to live r  
Ute rus 7 7% to  bone 1 3% to lungs x bone 
Thyroid 5 2% to lung 2 2% to bone 
I t  appe ared that the lungs might tend to re le ase me tas tase s 
into the c irculation and the reby e s tab lish me tas tase s in the CNS , 
p ancre as ,  p i tuitary and thyroid  (mul t i s tep , hematogenous) .  Any 
s ingle e ffe c t  could s imply have been  a me asure o f  the s trength of  
the assoc iation be tween the two organs , and not nece s sarily an 
ac tual disseminat ion of me tas tase s from one of the three maj or 
s ite s to one of the minor one s (Vi adna e t  al . ,  1 9 7 3) . 
One s tudy c las s ified me tas t at ic cance r patients with bre as t  
primarie s into the following five groups : bone , che s t , and soft 
t i ssue , brain , and v isce ral (McCorkle , 1 9 7 3 ) . Othe r source s have 
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grouped all  che s t  and medias t inal spre ad unde r the he ading thorac ic . 
Shie lds and Withan (19 3 3 )  outlined the distribution o f  
me tastase s from bre as t  c arc inoma , s ta t ing that few mali gn an t  tumors 
me tas tas ize as wide ly .  The s tudy was base d  on 1 62 autop s ie s , and 
reporte d the following s ite s o f  me tas tase s in orde r o f  de c re as ing 
fre �uency :  dis tant lymph node s , lungs , l ive r , bone , skin , pleura , 
and adre nals . 
The authors  agreed  that in hematoge nous d isseminat ion 
me tastase s we re usually  p re se n t  ln the lungs and disseminate d from 
that organ - the y e xplained bone me tastase s without demons trable 
lung involvement as minute v i able tumor emboli be ing able to bypass 
the pulmonary c irculation (Shie lds and Withan , 1 9 3 3) . 
Cutle r ,  As i re , and Taylor (1 9 69 )  indicated that much more 
c omple te information was nee de d  conce rning the his tory and c l in i ­
c al course of  me tastatic bre as t  c ance r . The ir  mode l , which p ro­
v ide d one of  the groundworks for the mode l used  in  the pre sent  
s tudy , outline d  four s i te s  of  me tastase s as  as soc i ate d with a high 
mortal i ty : live r ,  brain , pe ritoneum , and sp inal cord . Two maj or 
points evolved from thi s  s tudy : (1)  If the high mortali ty s i te s  
we re e xclude d , s pe c i fic s i te s  of  me tas tase s we re n o t  corre late d 
with variat ion in survival t ime , but that the numbe r of s i te s  
invo lve d was s igni ficant , and (2)  the longe r the free inte rval , 
that  is , the longe r  the inte rval be tween primary tre a tment  and the 
diagno s i s  o f  re currence of  d i st ant me tas t ase s , the longe r was the 
surv ival t ime afte r that diagnos i s  (Cutle r e t  al . ,  19 69) . Both 
the more common s i te s  of  me tas tase s (bone and lung) and those that  
t yp ic ally c arry a high mortal ity are among those include d in  the 
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�$crip t ive mode l .  
The re fore , ce rtain me tastat ic s i te s , among them the more 
C OJmI1Qn are as of spre ad (l-ung , bone ) although s ignificant , might 
�nly longer  surv ival time s  than those of other me tas tatic s ite s 
(brain , l ive r) . This fac t might be he lpful in  asse s s ing morb id i ty 
and in choos ing tre a tme nt app roache s in p a t ie nts with dissemina ted 
�jsease . Likewise , patie nts wi th l ong free i nterval s could be 
expe c ted  to have fairly long survival t ime s . 
Role of the Ve rtebral Venous Sys tem in Me tas tatic Bre ast  Cance r 
Be fore de s cribing the various s i te s  of  me tas tase s from 
bre as t  c ance r ,  a ve ry importan t  re lated phenome non de se rve s spe c ial 
atte ntion ; the ve rtebral ve nous sys te m  and its re lation to tumor 
spre ad .  Many authors have outl ined  the charac ter i s tics  o f  this  
type o f  spre ad (Batson , 1 9 4 2 ; Haagensen , 1 9 7 1 ;  Henrique s , 19 62) . 
At one time , it  was thought that a l l  hematogenous dissemi ­
nation of  bre a s t  cance r occurred and originate d from pre -e x is ting 
me tastase s in the lung . Tumor e mbol i  we re thought to lodge in the 
firs t vascular bed that  the y e ncounte red (Henrique s ,  1 9 62 ) . How­
e ve r ,  care ful autopsy  s tudie s reve ale d that many bre as t  c ance r 
patie nts harbore d  distant me tas tase s , particularly in bone , without 
demonstrating pulmonary spre ad . 
Anatomically , i t  i s  poss ib le for the tumor ce lls  to  re ach 
Q�s tant s ite s without passing through the lung . The ve rtebral 
ve ins for� intricate p le xuse s  inside and outs ide the ve rtebral 
can al ; the se basal ve rtebral ve ins form wide channe ls within the 
vertebral  bodie s , emptying into the ve rtebral plexuse s ,  which in 
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1mIm oummunicate a t  e ach costal se gmen t  with the inte rcostal ve ins . 
The int'e reostaJ. ve ins d rain p ortions o f  the bre as t , as we ll  as  the 
tiho�a�ic  are a o f  e ach segment . Furthe r inves tigation (B�tson , 1 9 4 2 ; 
He�rtriqu&� , 1 9 &2) showed that the sys te m  also  c onnec te d  wi th the 
pel. ic gird le , uppe r ends  of  the femur and hume rus , shoulde r girdle , 
a d?  skul l . The se are as, are the commone s t  s ite s o f  me tas tase s o f  
bony involvement from me tastat ic bre ast c arc inoma . 
Henrique s (19 62 )  also conte nde d that the ve tebral system 
lay outs id€ the body c avity � se and the re fore was  not  subje cted 
to  the s ame pre s sure change s . The re was radio logical evide nce that  
demons trated re flux shunting o f  blood c ould occur into the ve rtebral 
ve ins at all leve l s  of  the sp ine during such activ itie s  as coughing , 
s training , pe rforming a valsalva maneuve r ,  or l i fting . 
Add i tional fac tors which supporte d the ve rtebral ve nous 
system were the fac t that it was found to be for the mos t  part with­
out valve s and had a l ow venous pre s sure , thus re trograde flow was 
c ommon . Even without phys iological nee d ,  the re was much more b lood 
pre sent  in the ve rtebral ve s s e l s  than was prac tically or me taboli­
cally  nee de d  (Haage nse n , 1 9 7 1) . This  alte rnate me rited furthe r 
d iscuss ion above be c ause (1) bone me tas tase s are the most  common 
distant me tastase s in bre as t  c arc inom� and (2)  bone me tas tase s 
c ar�y a s igni ficant morb idity and potential disabil ity . 
Summary 
The pre ce ding sec tion has pre sented mate rial and concep t s  
concerning the gene ral patho logy of  bre ast  carc inoma with p artic­
ular re fe rence on dis seminate d dise ase . The te x t  alluded to the 
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anatomical d i ffe rentiation be tween d i s t ant and re giona l spre ad 
offere d in chapte r one , and the two main route s o f  d i ssemination 
we re comp a re d . Consensus of  the l i te rature was that s ign ificant  
inte rplay be tween  lymphat ic and hematogenous dissemination occurre d ; 
support for both the s o i l  and the me chanical the ory of me tas tatic 
growth , and the rationale for separation of  maj o r  and minor s i te s  
of  me tas tase s we re out l ined . The ve rtebral ve nous system and its  
alle ge d  role in the dis tant spre ad of  b re as t  cance r was explaine d 
in the light o f  increased bony me tastase s to a re a s  suppl ied by thi s  
syste m .  
A de taile d  outline of  each maj or me tas ta t ic s ite , diagnos is , 
c l inical  charac te ri s t ic s , and tre atme nt will comprise the re mainde r 
of  chap te r two . In the following o rde r ,  pulmonary , p leural , bone , 
l ive r , central ne rvous system , spinal cord , and distant lymphatic  
me tas tase s will  be  de scribe d . 
PULMONARY METASTASES 
Pathology 
The re are three ways for carc inomatous emboli to re ach the 
lungs from the bre as t :  
1 .  Lymphatic sp re ad from the bre as t  c an re ach the central 
lymphatic te rminus  a t  e ithe r s ide of  the ne ck a t  its base , ne x t  
emptying into the innominate ve in , then to the vena c ava and in 
turn to the pulmonary c i rcula tion . 
2 .  Tumor emboli  that have e rode d cap illarie s or  venuole s 
re ached the inte rnal mammary or ax illary ve ins , in turn to the 
innominate ve in , and thus to the pulmonary c irculation . 
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3 .  Tumor cells  can embol ize in the inte rcostal ve ins , and 
e " the r trave l in a re trograde manne r to the ve rtebral  venous system 
as pF9viously de scribe d , and e ve n tually back to the lungs by  the 
s ys temic circulation ££ dire ctly emp ty into the azygous ve ins , and 
thus to the vena c ava and the pulmonary c irculat ion to se t up me ta­
s tatic growths . 
Whatever route i s  use d , the tumor ' emboli  had seve ral  alter­
nat ive s re garding the i r  his tory . S ome o f  them we re choked and 
de stroye d  by the fibro s i s  that deve lope d around them ; s ome grew 
into the pulmonary pare nchyma to be come true pulmonary me tas tase s ; 
or others may have bypassed the pulmonary cap i llarie s entire ly and 
re ached the syste mic  c irculation . 
An e arly s tudy de scribed the fate of  carc inoma emboli that  
re ached the l ungs (Saphir , 1 9 47 ) . Twelve l ungs we re s tudied which 
had histo logically d is c lose d tumor but no frank me tas tase s .  Whe n 
tumor cells  fai led  to pene trate the ve sse l wall and form me tas tase s , 
they cause� the formation o f  hyaline thromb i which grew adj acent to 
the tumor ce lls  and caused the latte r  to atrophy (Saphir , 1947 ) . 
The re are many fac tors which make the lung an ide al loca­
tion for sec ondary spre ad o f  tumors (vascularity , s ize , rich 
e p i the lial  l ining) . Howeve r ,  the ide al condi tions which are 
require d  for emboli  to attack the cap il l ary wal l , bre ak through , 
and se t up a d i s t inct growth which e ventually de ve lops i t s  own 
b lood supply de scribe a remarkable proce ss  or se tting that i s  not 
comple te ly unde rs tood . 
One re se arch report outline d  a c l inical - radiological s tudy 
o£ pulmonary me tas tase s on a group of 2 9 9  pat ients  with d iffuse 
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6aroi�oma tos is ; 7 7  o f  the se we re bre as t  primarie s (Minor ,  1950) . 
The author de scribed five diffe rent groups of pulmonary me tastase s 
aoc ording to radiographic appe arance . The y we re nodular , or round 
discre te we l l  c i rcumsc r ibe d le s ions within the lung p are nchyma ; 
amorphous , or infiltrative appe aring as diffuse shadows and thicken­
ings wi thin the p arenchyma ; lymphangit ic , comfine d mainly to the 
pulmonary lymphatics ; miliary ,  gre atly diffuse , spotty spre ad with 
much rep l aceme n t  of lung parenchyma ; and finally mass ive consolida­
tion with fre quent atale ctasis  (Minor , 1 9 5 0) . He s tate d  that ove r­
lapping of  c la s s i fication was the rule rathe r than the exception . 
Haagensen T s  de scrip tion only include d the b as i c  nodular and l ym­
phangitic types , the latte r  wil l  be  discus se d  in de tail in subse ­
quent tex t . 
Nodular le s ions in the lung may be notoriously  asymtomatic 
for long pe riods , an observat ion note d by many authors (Bate s , 
19 64 ;  C l age tt and Woolne r ,  1 9 64 ;  Haage nse n , 1 9 7 1 ; He itzman , 197 3 ;  
Minor , 1 95 0) . According to C l age tt and Woo lne r , (19 64) in report­
ing a se rie s of 1 65 pulmonary me tas tatic c ancers  ( 21  or 1 2 . 7  pe r­
cent  bre a s t  primarie s) , nodular le s ions we re much more o ften mult i ­
p l e  than s ingle o r  solitary . Be c ause the tumors we re usually 
locate d  in the lung parenchyma and the bronchi were not typ ically 
involve d  exte ns ive ly , symptoms we re few (Clage tt  and Woolne r ,  19 64) . 
The se same authors s tre s sed  that a s ingle lung shadow 
particularly in the hilum or ape x  o f  the lung , was much more like ly 
to be a primary lung tumor . Cahan and Cas tro (19 7 5 ) share d this 
s ame v iew . A solitary nodular lung shadow in a person wi th a known 
primary bre as t  c arc inoma was a ve ry amb iguous c linical pre sentation , 
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vequiring prompt c larification as to its histo logical nature so  
that proper tre atment could be  ins tituted . The authors maintained 
that the comb ination o f  lung and breast  primarie s would occur more 
o ften because (l) more female s are surviv ing the ir bre as t  cance rs , 
and (2)  the rate o f  lung c ance r in wome n  is  rising p re c ip i tous ly . 
Some nodular le sions did produce local problems , pe rhaps 
by rap id growth and pre s sure or e rupt ion into a cont iguous bronchus . 
Obs truction of  a main bronchus with re sultant ate lec tasis  occurre d  
ocoas ionally (Minor ,  1 9 5 0) . He also s tated that  carc inoma of  the 
bre as t  was the commones t  primary le s ion to me tas tas ize to the lun g ,  
and that  bre as t  c arc inoma me tas tase s produced the gre ate s t  de gree 
of  ple omorphism in the lungs , and furthe rmore was more prone to 
me tastas ize to the pleura and the me dias tinum than any othe r type 
of c ancer . 
S igns and Symptoms , De tec tion 
The symptomatology of  bre as t  carc inoma me tas tatic to the 
lung will depend a gre at deal  on the type o f  me tastase s .  Nodular 
growth may be come symptomatic as mentione d above if the depos its 
are large and obs truc ting . Symp toms for the various type s include d 
cough , dyspne a or tachypne a ,  sputum produc tion ; anorexia , feve r ,  and 
we ight loss we re the s ys temic manife s tations . Infe c t ions , with 
purulent drainage and hemoptys is  or bloody sputum could occur , but 
we re much le ss  common (Hause r and S tee r , 1 9 5 1 ; De Wys , 1 9 7 4) . 
Typic ally , re spiratory emb arrassment  and seve re pulmonary symptoms 
we re not seen unt il  l ate in the course o f  the dise ase . 
For that re ason , the mos t  common me thod o f  de te ction of  
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pulmonary metastase s was v i a  X- rays o r  tomograms , and the maj ority 
of oase s  we re d i agnose d and dis c overed incidentally by routine 
follow-up radiographs.. The miliary type of  spre ad or mass ive con­
solidation produced pulmonary symp toms such as  dyspne a and cough 
e arlie r in the ir  course than s imple nodular spre ad .  De cre ased 
v tal capac ity was a finding that depe nded on the amount of 
parenchymal tissue rep l aced or rende re d  insufficient for normal 
pulmonary physiology by obs truc tion , collapse , or de struction . 
Tumors could invade the pulmonary vasculature and cause hemmorhage 
wh · ch could be a se rious complication . Finally , lung me tas tase s 
might lead to p le ural spre ad from blood borne e mboli  in the pul­
monary arte rie s . Carc inoma ce l ls could also be shed  dire c tly into 
the p le ural cavity and e ffec t  a pleural e ffus ion (Haagensen , 1 9 7 1) . 
The concep t  of tumor doub l ing t ime (TDT) has enj oye d par­
ticular re levance in re lat ion to pulmonary spre ad . In a re cent 
se rie s rev iew , a group of  inve s tiga tors evaluate d 4S patients with 
pulmonary me tas tase s (Joseph , Morton , and Adkins , 1 9 7 1a) . TDT was 
e as ily  c alculate d  for lung me tast ase s if the y are discre te and 
c learly out line d  on che s t  radiographs . Thirty- seven  case s me t 
those crite ria and were c lass ifie d a s  rapid , inte rme diate , or s low 
according to the ir growth rate s . 
Some of the factors which poss ibly gove rned the TDT we re 
numbe r of  prolife rating ce l l s ; length of  cell  cycle ; e x tent  of ce ll 
los s  or  de ath due to ce ll  ne crosis ; embol ization ; de s truc tion of 
ce lls  by immune re sponse ; and the numbe r o f  non-prolife ra t ing ce lls . 
The s ame authors (Joseph , Morton , and Adkins , 1 9 7 1b) in a separate 
3 5  
puhl · cation , re le ased the re sul ts  o f  a s tudy o f  1 1 3  patie nts , nine 
o f  which we re b re as t  primarie s . Quite often b reast  carc inoma 
met as tase s did not mee t  the crite r ia nece ssary for the pre c ise 
de termination of  the TDT . 
The inve s t igators supporte d the ir previous re se arch : the 
shoFte r TDT T s  corre lated with a shorte r free inte rval from primary 
le s ion re section to onse t of pulmonary me tas tase s .  Also , (1) c on­
ve rse l y , longe r  TDT f s  had longe r free inte rvals  and longe r s urvival 
t ime s , an� (2) the use of the TDT as  a prognos t icator for survival 
was l imite d  as it only could be emp loye d  in bre as t  c ance r c ase s with 
a ce rtain type o f  lung me tastase s (Joseph e t  al . ,  1 9 7 1b) . The con­
c lus ion was that  the ope rab i l i ty , behavior of  the le s ion , and chance 
for survival appe are d to be more a func tion of the TDT than o the r 
c rite ria . 
Tre atme nt 
One of  the t re a tment me thods which was utilized more o ften 
ln the pas t , but is  s till  j us t i fie d in se le c te d  c ase s wa s surgical 
removal of the me tastatic tumors . Moe rsch and C lage tt (19 61)  pub ­
l ishe d a report on 1 3 4  case s , 2 1  or 1 2 . 5  percent of  which we re 
b re as t  p rimary . The y po inte d out that the nature and origin o f  
the primary le s ion was only o f  some p rognos tic import i n  individual 
c ase s for surge ry , as  all type s could have long term surv ival . 
Many authors have advoca te d  surgical removal of  me tastatic pulmonary 
tumors (Choks i ,  Tahita , and Vince nt , 1 9 7 2 ; Mountain , 1 9 7 0 ; Smith , 
1 9 6 3 )  and one source s tate d that re se c tion o f  me tas tatic le s ions 
from the kidne y ,  ute rus or large bowe l was followe d by the gre ate s t  
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degree o f  surgical succe s s , but that  bre as t , e ndocrine o r  me lanoma 
primarie s gave more discouraging re sults (Smith , 1 9 63) . Accepting 
thi s  opinion , surge ons could only se le c t  re lative ly few for this  
form o f  the rapy . 
Choks i e t  al . ,  ( 197 2)  be l ieve d  that s ave for organs drained 
by  the portal venous s ys te m ,  the pulmonary vascular be d forme d the 
first  e ffec tive filte r for tumor embol i ;  thus he emphas ize d  the 
importance and incre as ing incide nce of pulmonary growths . The y 
also note d that bronchoscopy prior to surgery for diagnos t ic pur­
pos e s  was often ne gat ive be c ause the me tas tase s we re mainly pe riph­
e ral , only infreque ntly involving the bronchus . 
Clage tt and Woolne r (19 64) claime d that surgical re sec tion 
of solitary nodular depos its  might be undertaken only if the re we re 
no othe r evidence of  re current  or  me tas tat ic d i se ase . The survival 
rate , howe ve r ,  was a dep re s s ing 3 0  pe rcent . 
Mount ain (19 7 0) outline d the cri te ria of  ope rab ility  for 
patie nts with pulmonary me tas t ase s :  ab ility to tole rate the surgi ­
cal procedure , abse nce o f  d ise ase at the p rimary s i te , and absence 
of e x trapulmonary me tas tase s . S ince 15  to 25  pe rce nt o f  patie nts  
have lung involveme nt as  the ir only s ite of  dis tant  spre ad ,  surgi­
c al conside ration could be  given some we i ght in  s e le c te d  case s . 
Howe ve r ,  bre as t c ancer me tas ta t ic to lung had a re lative ly poor 
pos t surgical  tumor free inte rval , p robably be c ause the re was a 
high inc idence of co-exis ting me dias tinal node involveme nt in the se 
patie nts (60 pe rcen t) . Choks i and his c olle ague s (19 7 2) concluded 
that TT a solitary me t as tasis , i f  not remove d , will  continue to  grow 
and le ad to a de c re ase d re se c tabil ity rate , and the pos s ibil ity of  
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deve lopme nt of te rt iary me tas tase s " . Me tasta t ic lung tumors are 
not c ommonly irradiate d  be cause of the low tole rance (re lat ive ly) 
of pulmonary t i ssue to ionizing radiation ; in addi t ion , a trouble ­
some fibros is is  a typ ical sequalae , and c an e ffe c t  pulmonary 
func tion i f  large are as are affe c te d . Chemothe rapy in comb ina­
t ions om drugs has produce d re gre s s ion of  pulmonary le s ions in 
many patients , but the re sponse is  difficult to asse s s  s ince nod ­
ule s may remain quie scent for long pe riods , and may re gre ss or  
incre ase in s i ze in re sponse to concomitant  fac tors othe r tha n 
chemothe rapy e ffe c ts , most  of  the se are unknown . 
In summary o f  non - lymphangitic pulmonary me tas tase s ,  the 
depos its  in the lungs produce d only such change s in pulmonary 
function as  we re cont ingent and consequent  upon rep lacement of 
alve olar t is sue by the s o l id tumors , Surgical tre atme n t  has wane d 
in light of chemothe rapy and radiat ion , but the use of  b oth of the 
latte r is  l imite d  in me tas tatic bre as t  carc inoma with pulmonary 
manife s tat�ons . 
Lymphangit ic Pulmonary Me tas tase s 
In contrast to  the above , in lymphangitic carc inoma of the 
lung , an e ntity o f  which the pathology me rits  more de tailed e xpla­
nation ; loss  of pulmonary comp liance and seve re s ymptomatology were 
early fe ature s (Bate s and Chris tie , 1 9 6 4) . Seve re dyspne a ,  the 
mos t  prominent symp tom , ante date d  the radiological change s in many 
case s . 
In lymphangitic me tas tase s ,  tumor ce lls  we re carrie d to the 
lungs by  the bloodstre am ,  and afte r ex travasating from the b lood 
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ve sse ls  to the inte rs titium , re ache d the pulmonary lympha t ic s . The 
inte rs titium be c ame thicke ne d  due to dis tention of  the channe ls  
immediate ly behind the central lymphat ic tumor embo l i , due to  tumor 
cells  in the inte rstitium itse l f ,  or due to the pulmonary e dema 
(Re itzman , 1 97 3 ; 3 3 0 - 3 3 2) . This  inte rs titial pulmonary e de ma was 
thought to be a common cause o f  ple ural e ffus ion be cause of  accu­
mulated fluid . 
A comprehens ive s tudy by Goldsmith , Baile y , C allahan and 
Be attie (19 67 )  reported that 8 7/3 65 or 2 4  pe rcent of  bre as t  c ance r 
patients  coming to autops y  had lymphangitic me tas tase s .  According 
to this report , the progre s s ive pulmonary lymphat ic involvement  wi th 
tumor c ause d the reduction in the ab ili ty o f  the parenchyma to move 
in accordance with p re ssure change s in the p le ural cavity (de c re ased 
pulmonary comp li ance ) , and pathologically p re sente d  as  de cre ased 
tidal volume , vital c ap ac i ty , inspiratory capac ity and de c re ased 
e xp iratory re se rve volume , all  accompanying the e x tre me dyspne a or 
t achypne a .  This s ame re se arch found a highe r  inc idence of p le ural 
e ffus ion (6 3 pe rcent) in lymphangitic me tas tase s as opposed to non­
lymphangitic pulmonary me tas tase s (41 pe rce nt) . 
Fischera and Hage rstrand (19 65) discussed the pathology o f  
thi s  of ten unre cognized phenome non . The y deb ated whe the r thrombo­
s is of  the blood ve s se ls should have bee n  ascribe d to  carc inomatous 
growth �n the pe ri -vascular lymphatics or  to tumor fragments  tran s ­
porte d  i n  the actual b lood ve s s e ls . Of inte re s t  �n the s tudy was 
the fact that out of 97 case s , 20 , approx imate ly 20  percent , we re 
bre as t  c ance r primary , and tumor growths we re found in the pul-
ml,Onary lympha.tics in 9 7/17 4 c ase s with all type s o f  pulmonary 
me tas tase s .  
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A typ ic al s ymptom comple x was dyspne a , cough , cyano s i s , 
pleuri t ic pain , and general phys ical de te rioration (Hause r  and 
Stee r , 1 9 5 1) . The se we re mos t  like ly c aused  by the pulmonary 
e de ma , fibros is , decre ased pulmonary compl i ance , and obl i te ra t ive 
arte ri t i s  which we re found (He itzman , 1 9 7 3) . Mue lle r and Sniffen 
(1945)  thought that the pre se nce of  masse s o f  tumor ce lls  in the 
dilate d  lymphatics  was re spons ible for the pe culiar radiographic 
picture and patte rn - a ne twork of inc re ase d lung density  radiating 
from e nlarge d  hilar lymph node s and spre ad ing through the lung 
fie lds , inte rspe rse d with nume rous fine nodule s .  
More curre nt thinking in lymphangi tic carcinomatos i s  of  the 
lungs was disp layed by Janowe r and Ble nne rha s se tt  (19 7 1) and 
Trapnel l  (19 6 4) . The y d iv ided the che s t  radiographs o f  2 3  case s 
(13 o f  them b re as t  primarie s)  into three groups - mixe d , lymphan­
git ic , and no rmal . Autop s ie s  demon s t ra te d  that in lymphangi tic  
me tastase s one -half of  the bulk o f  the incre ase d t i s sue was due to  
tumor ce lls , and the othe r hal f  to  re ac t i ve fibro s i s  and inflam­
matory t is sue . Othe r re se arch s c ie nt i s ts have emphas i ze d  that 
pare nchymal nodular and lymphangi tic pulmonary me tas tase s qui te 
often e x i s t  toge the r  in the s ame individual . De te c tion o f  this 
c ondi t ion i s  not d ifficult  owing to the symp tomatology and char­
ac te ri s t i c  radiograph p ic ture . Howe ve r ,  if  the patient i s  in the 
e arly stage s , and i s  asymptomatic , the radiologis t  mus t  rule out 
se ve ral  othe r d i se ase proce s se s  that c an mimic lymphangitic  me tas ­
tase s radiographically . The re are fe w s tudie s conce rning the 
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appr0priate clinical management of  this  cond ition , and once inte r­
s titial b lockage and dyspne a be come progre s s ive ly seve re , treatme nt 
is  s ymptomatic . 
Summary 
In summary , pulmonary me tas tase s a re a re sult o f  tumor 
emboli becoming lodge d  in the lung cap i ll.arie s ,  and bre aking 
through into the lung p arenchyma or lymphatic ve s s e l s . The re are 
v ar ious charac te ri s t ic radiographic pic ture s o f  pulmonary me tas-
tase s , and a wide varie ty of s ymp toms may ensue , particularly in 
the lymphangitic type . All forms of  se condary lung tumors are 
potentially le thal be cause the y c an replace normal lung tissue , 
collapse are as , and in so  doing upse t the normal phys iological 
func tion of pulmonary tissue . 
PLEURAL EFFUS I ONS 
Malignant pleural e ffus ion is anothe r re lative ly common 
complication o f  disseminate d  bre as t  carc inoma (De Wys , 1 9 7 4) . 
Fracchia , Knappa ,  C are y ,  and Furrow (19 7 0) e s t imate d that approx i-
mate ly one hal f  of  patie nts with s ys temic bre ast carcinoma deve l -
oped pleural e ffus ions , and that bre as t  carc inoma was the tumor 
mos t  frequently re spons ible for the c ompl ication . Effus ions 
occurred more fre quently in patients with p re -e x is ting lung me tas -
tase s , e spe c ially of the lymphangitic type (Goldste in e t  al . ,  1 9 6 7 ) . 
- -
Pathology 
Pathologically , e ffus ions o f  a malignant nature could be 
divided into three type s : 
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(1) those due to irri tation of se rous 
membrane s from solid tumor implants , with e xfoliation of the tumor 
ce l l s  into the fluid ; (2) obs truc tion of the small ple ural ve s se ls 
or  l ymphatics assoc iated with large solid tumor masse s , a type 
u$ual ly ace llular ; and (3)  nodules  of carc inoma be ne ath the visce ral 
p le ura b re aking through a te ar  in the p leura , pe rmitting c arc inoma 
ce lls  to e sc ape into the c av ity (Haagense n , 1 9 7 1) . 
Symptoms 
The cardinal s ymptoms we re dyspne a ,  pain and cough 
(Haagense n ,  1 9 7 1) . Porte r  (19 65) reported that out of  7 6  c ase s in 
a se rie s , 49  we re ipsalate ral , 41  contralate ral to the b re as t  pri­
mary , and 2 3  we re bilate ral . Both authors conte nde d that malignant 
pleural e ffus ions we re due to lymphatic pe rme ation through the 
che s t  wall , bec ause e ffus ions ari sing from hematoge nous spre ad 
should the ore tically have arisen e qually o fte n  on e ither s ide . 
Tre atme n t  
Pleural e ffus ions are usually treate d , if se ve re e nough to 
be res olve d by  me thods  o the r than s ys temic chemothe rapy , by 
thoracente s is with or without ins tillation o f  tumorc idal age nts . 
Radiation or surgic al re sec tion are only rare ly emp loye d . 
Le ninge r ,  Barke r ,  and Langs ton (19 69 )  remarked that the 
pathology behind p leural e ffus ions was not we ll unde r s tood and that  
whe the r tumor ce lls  � � exude d fluid or whe the r an exudat ive 
response was secondary to the tumor imp lant produc ing fric tion 
agains t th€ opposing p le ura , was not cle ar . The y re comme nded 
lntercos tal c a the te r drainage followe d  by  the administration of  
intrapleural chemothe rapeutic agents  and appropriate analge s ics  
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and antieme tics . They gave the following rational for the e fficacy 
of  chemothe rapy : " the finding of tumor implants on bo th the vis­
ce ral or parie tal p le ura at  autopsy sugge s ts that  chemo the rapy not  
s o  much de s troys tumor ce lls , but  rathe r cause s a chemical p leuri­
tis  that bonds the pleura toge the r afte r the fluid has been with­
drawn by a che s t  tube " (Leninge r  e t  al . ,  1 9 69 ) . Howe ve r ,  this  
bond may not  be  advantage ous ; some c l inic ians p re fe r chemothe rapy 
that de s troys cells  ye t p revents thi s  chemical p le uritis . l Te tra­
cyc line is  tumorc idal ye t doe s not c ause this bonding . 
Summary 
Ple ural e ffus ions , then are c ommon ln dis seminate d bre as t  
c arcinoma ; the ave rage survival pe r iod in untrea ted  patie nts is 
app roximate ly seven months ; chemotherapy or radioac tive iso tope s 
introduced intrapleurally can do much to relieve the s igni ficant  
s ymptoms and morbidity that this comp l ication can produce . 
BONE METASTASES 
Extent of the Problem 
The s tory of the dissemination of b re a s t  carc inoma c an be 
told v irtually in te rms o f  me tas t ase s to the ske le tal sys te m .  
Osseous involveme n t  i s  the mos t  common se qualae o f  bre as t  dance r 
Inr . Sus an Me lle t te , pe rsonal communication . 
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dissemination , mos t  fre quently pre sents as  the first  s ign of dis tant 
spre ad ,  and probably cause s the mos t  distre s s ing symp tomato logy and 
comp l ic ations of  all forms of  me tastase s .  In female s ,  the gre at 
maj ority of ske le tal me tas tase s were cause d by breast  cance r 
(Zimskund and Surve r ,  1 9 5 8 ) . In  care ful autopsy s tud ie s , ske le tal 
le s ions are found in approximate ly 85  pe rce nt of  women dying from 
bre as t  c arc inoma (Galasko , 197 2) . The pre sent day oncologist  can 
e xpe c t  osseous me tas tase s to be come c linical ly ev ident in from 50 
to 60 pe rcent of  pat ients with bre a s t  cance r - the se s ignificant 
figure s see k to introduce the se riousne s s  of  the prob lem . 
The fre que ncy o f  involve ment of  the diffe rent bone s is  
qui te variable , be ing a func t ion o f  the me thods of thoroughne s s  of 
de te c tion in a give n se rie s  (S tale y ,  1 9 5 6) . Galasko (19 7 2) 
reporte d the following bone s and pe rce ntage s  o f  patie nts having 
me tas tase s :  dorsal sp ine , 7 2  pe rcent ; lumbar sp ine , 68 pe rcent ; 
pe lvis , 6 6  pe rcent ; ribs , 62  pe rcent ; prox imal femur , 44 pe rcent ; 
skul l ,  44 pe rcent ; and ce rv ical sp ine , 2 6  pe rce nt . Hos kins (19 7 1) 
reporte d  on the re cords of 1 5 0  c ase s of  dis seminated bre ast  car­
c inoma , with ske le tal spread oc curring in 53  pe rce nt of  this total . 
Ful ly 3 0  pe rce nt of the se appe are d  wi thin the firs t ye ar of  prl­
mary surge ry - an obse rvation part icularly common in post­
menopausal women . Howe ve r ,  o s se ous me tas tase s could pre sent five 
and e ven ten ye ars afte r tre a tment of  the primary bre a s t  tumor . 
Long fre e inte rvals obse rve d in some patients we re prob ­
ably due to the fac t that a pe rce ntage of  ce lls  fai le d  to survive 
whe re the y lodge d , or the y could remain quie scent in nove l loca-
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tions for ye ars be fore e rupting into c l in ical me tastase s .  Re cently , 
the re has bee n  evidence that sugge s ted  that bone me tas tase s we re 
more l ike ly to occur in pat ie nts  who de ve lope d the i r  dise ase at  a 
re lative ly e arlie r age , compare d  to more e lde rly individuals 
(S tale y ,  1 9 5 6) . 
Las t ly , the fac t that re cent se rie s  o f  s imp le mas te c tomie s 
had surv ival rate s comparable to serie s of  radical mas te c tomie s 
sugge s te d  that  dis t ant bone me ta s tase s might have alre ady occurred 
in many patie n ts at  the t ime of  diagnos i s  and ini ti al t re atme n t  
(Sklaroff and Charke s , 1 9 68) . 
Pathology 
Whe the r radiographs re ve ale d  bone me tas tases  depende d 
conside rable upon the manne r in which the d i se ase grows in bone . 
Haage nsen  (19 7 1) de scribe d three type s o f  me tas ta se s : the inte r­
trabe cular t ype le ft the trabe cul ae ne arly intact but fil le d  the 
marrow space s in be tween them wi th carc inoma . In the oste o lytic 
type , the bone trabe culae we re de s troye d  by the c arc inoma , rad io­
graphically le s i ons appe are d  as i rre gular are as o f  de c re ased 
dens i ty . In the o s te oblas tic type , the bone trabeculae we re 
thicke ne d ,  and coale sced forming osseous masse s . The y pre sente d  
on rad iographs as  abnormally dense are as o f  bone ; al though ve ry 
common in p ros ta t ic c ance r ,  only about ten p erce nt o f  me tastatic  
bre as t  cance r p re sente d  sole ly a s  this type (Haage nsen , 1 97 1) . 
Galasko (19 7 2 ) emphas i ze d  that o s te o lytic and o s te ob las t ic 
patte rns occurre d  more or le s s  s imul tane ous ly as ne t re sults  of  
bone formation and bone de s truc tion . He the or i ze d  that o s te o -
8 ),.erotic ce lls we re re spons ible for the bone de s truction , but 
afte r tumor surrounded the bone sp icule s , the os te oblas ts d i s ­
a��aare d  and the tumor ce l ls themse lve s de s troye d the osseous 
t�ssue . I f  the latter was the case , some prope rty o f  the me ta­
s �atic c ance r cel l s  was re spons ible ; what exac t  chemical was 
rele ased and the b iochemical trans format ions taking place at the 
tumor c� l l  bone inte rface we re not comple te ly unde rs tood . 
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Bone me tas tase s we re more common in re d marrow as oppose d 
to ye l low marrow (Hoskin s , 1 9 7 1 ; Haagense n , 1 9 7 1 ; Robb ins e t  al . ,  
1 9 7 2 ;  Z imskund and Surve r ,  1 9 58 ) . This  i s  anothe r re ason for the 
une qual  dis tribution o f  me tas tase s in the ske le ton . Unfortunate ly , 
e st imate s o f  the p roportional amount o f  bone me tas tase s e ffec te d  by  
the ve rtebral venous sys tem as  oppose d to  the amount by the systemic 
venous s ys tem  are l acking . Hicke y  (19 67 )  remarked that pain would 
not occur until  the pe rioste um was e ffe c te d , and that e arly in the 
course o f  me tas tatic dise ase in bone , c ancerous tissue could be 
p re sent  in the s oft t is sue o f  bone marrow without bone alte rati on . 
The pathological me chanism o f  me tas tatic bone spre ad was 
based on three cons iderat ions (Johnston , 1 9 7 0 ) . The firs t was that 
s ite s of bone me tastase s we re not de te rmined by blood flow alone -
tumor emboli  could re c i rculate and not localize to the first bone 
which the y re ache d . Secondly , the morphologic patte rns o f  ske le tal 
vasculature - cap i ll ar ie s in a rich s inuso idal patte rn within the 
red marrow - partially explained the high incidence of me tastase s 
to bone . Recall  that arte riolar walls  we re more re s is tant  to tumor 
invas ion than were the c ap i llarie s (Johns ton , 1 9 7 0 ) . Thirdly , othe r 
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fac tors we re important such as the de c re ased me tastati c rate in 
patients on anticoagulent the rapy , the purporte d  incre ased rate 
with c ortisone , nature o f  the primary tumor , and suppre s s ion o f  
the ce ll me d i ate d immunity , favoring acce lerated dis semination in 
the late r te rminal s t age s . 
Symptoms and De tec tion 
E arly in the ir  involvement , bone me tastase s are asymptomatic . 
Pain usuall y  he ralds pos itive radiographs ; i t  usually is  deep and 
worsene d  by act ivity , particularly we ight be aring . Pathological 
fracture , with pain , de formity , and loss  of func tion o f  the j oint , 
is  typically o f  late occurrence . Infre quently the patient pre ­
sents with s e ve re pain and no abnormali ty can be disce rne d by bone 
surve y or scan . 
Improveme n t  in the me thods o f  bone scanning has broadene d 
the role of  the te chnique s o  that pre sently e arlie r ,  smalle r ,  and 
ve ry ofte n  unsuspe c te d  le s ions are be ing routine ly localized  
(Ve rnon , Yano , and Ange r ,  1 9 7 1 ) . C linic ians have re adily agreed  
that the use  of  radionucl ide s demons trated osseous involveme nt  
frequently be fore radiographic change s occurre d (Galasko , 1 9 6 9 ; 
Lawre nce and Horse le y ,  1 97 4 ;  Scott  and Adams , 1 97 4 ;  Ve rdon e t  al . ,  
1 9 7 1) . 
The basic princ iple s unde rlying bone scanning have bee n  
outline d (Bl and , 1 9 7 1 ; Hoffman and Marty , 1 9 7 2) . Scans we re 
gene ral and not spe c i fic fo r cancer ,  the me thods be ing base d on 
uptake of the rad ioac tive t racers  in ac tive ly growing bone and no t 
on up take by the c ance r cells  pe r se e New bone was l aid down by 
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prolife rating o s te oblas t s ; wi thin the matrix hydroxy apatite crys -
tals forme d which inte rac ted with the trace rs . Be cause the prin­
c ip le s unde rlying trace r up take app lie d  e qually we ll to benign dis ­
orde rs and tumor me tastase s ,  the scan find ings should be cons ide re d 
in te rms of  an alteration in local bone me tabolism rathe r than a pos­
itive ind ication of the p re se nce or absence of me tas tatic cance r 
(Bland , 19 7 1 ; Hoffman and Marty , 1 9 7 2) . 
Bone b iopsy , by tre phining , de scribe d exce lle ntly by 
Haagensen (19 7 1) , is spe c i fic only if  the bone truly has me tas tase s 
and is  not commonly use d due to the fac t that scanning cove rs a 
gre ate r are a , and although more l ike ly to be e quivocal , carrie s a 
le s se r  like l ihood of  complications . 
Complications and Tre atment  
Pathological frac ture s e ventually occurred in  5 0  pe rce nt 
of  patients  with radiographic e vidence of osse ous me tas tase s 
(Schurman and Amstutz , 1 9 7 3) . Femoral frac ture s are the mos t  com­
mon and c arry the gre ate s t  amount of morbidity , chie fly be cause of  
the we ight be aring prope rtie s of  this bone . The ave rage time inte r­
val be tween initial diagno s i s  and onse t o f  ne oplas tic  frac ture s was 
5 8 . 6  months for the femur and 5 2 . 1  months for the hume rus ; thus the y 
are a late se qualae of  bre as t  cance r . Be als and Sne ll (19 63)  
reporte d  on  3 2  patients  with 60  femurs so involve d ; In  his  se rie s , 
the femoral me tas tase s occurre d wi thin two ye ars of  the diagnos i s  
o f  b re as t  cance r ,  but the fracture s somewhat late r .  Pe lvic le s ions 
ne arly always pre ce de d  femoral involvement , an ob se rvation no te d  by 
Schurman and Amstutz (19 7 3) , and Haagensen (19 7 1) . 
48 
Studying the rad iographs and c l inical picture , Be als and 
Sne ll s tate d  that the frac ture rate in me tas t atic femora was 40 
pe rcent , and impe nding bre aks could be pre dicted by checking the 
s ize of  the le s ion , its  pre c i se location , and the de gree of involve ­
ment of the corte x . Stale y  (195 6) reporte d pathologic al frac ture s 
in 8 0/1 66  patients for a rate of 48 pe rcent . 
TTA pathological fracture of  a maj�r long bone is  a dramatic , 
distre ss ing , and incapac itat ing manife s tat ion of dis seminate d 
bre as t  carc inomaTT (Coran , Banks , Aliapoulios and Wilson , 1 9 68 ) . 
Exc luding ve rtebral body col lap se , frac ture s of  the femur we re 
the most  common comp l ic a t ion . Accord ing to Galasko (19 7 2) , the 
me an surv ival afte r a pathological frac ture was ten months . 
Various c l inic ians have at temp ted to se arch for some 
cri te r ia that could pre sage the imminent frac ture s in femurs , so  
that prophylac t ic hip nail ing could be done (Sne ll and Be als , 1 9 64 ; 
Bouchard , 1 9 45 ) . The latte r conte nded that pathological frac ture s 
we re common in ,oste olytic me tas tase s whe re the re was marke d pain 
and more than 50  percent of  the corte x  de s troye d  1n any one area . 
He adde d tha t whe n me tas tase s deve lope d in re gions o f  the ske le tal 
system  whe re the natural body we ight , torsion , indire c t  force s ,  or 
muscular trac tion we re more pronounce d ,  pain was sharpe r and came 
on e ar l ie r , and pathological frac ture s we re a distinct pos s ibility . 
A de taile d  de scription of  the surgical management of patho­
logical frac ture s was publishe d by Koskine n and Niemine n , (19 7 3 ) . 
The y pointe d  out that frac ture s of  the d iaphys is  or  trochanter ic 
re gion we re the mos t  common . Three points we re s tre s se d : (1) i t  
was difficult t o  give a re liable progno s is , so  the patie nt should 
be given opt imal surgical cons ide rat ion , (2)  the bony union of a 
me tas tatic frac ture appe ared to be e sse ntially e ffe c te d  by the 
tumor type and re sponse to pall iation (bre ast  cance r appe are d  to 
49  
be a type conduc ive to good bony union) , and (3)  the frac ture frag­
ments should c ontain e nough appare ntly he althy bone in orde r to 
rende r a s table oste osynthe s is probab le (Koskine n and Nieme n , 19 7 3) . 
The type of  orthope dic proce dure s commonly used we re 
inte rnal fixation wi th a intrame dullary rod for sha ft frac ture s ; 
re sec t ion of the he ad and ne ck of the femur , a proce dure no t done 
as o ften as forme rly ; a Jewe tt  or othe r nail or plate for inte r­
trochante ric fracture s ;  and pro s the tic replacement  of the femoral 
he ad for trans or subcap ital frac ture s (Poigenfurs t ,  Marcove and 
Mille r ,  19 68) . The y asse ssed  succe s s  of  the ope ration on the 
patient T s  ab il ity to walk ; 60  out of  112 did ambulate pos t surge ry ,  
but the proce dure failed to re s tore ambulatory func tion in 40 . 
Long s tem  pro s the se s  we re favore d , be cause the y maintaine d s ta­
bil ity , re s to re d  func tion earlie r ,  and carrie d  the pos s ibility of 
s t ab il i z ing the femoral shaft at  the same time (Poingenfurs t e t  al . ,  
1 9 68 )  . 
Knut s on and Spratt  (19 7 0) reported survival pe riods for a 
surgical and non- surgical group , which was approx imate ly 1 3  months ; 
one -half of the forme r group improve d the ir ambulat ion s tatus post  
surge ry ,  while no  one in the lat te r group did so . 
The re are seve ral important and dis tinc t advantage s of  
inte rnal fixation of pathological frac ture s of  the femur due to  
me tastatic bre ast  carc inoma : 
1 .  re lie f o f  pain 
2 .  potential for ambulation enhance d 
3 .  radiothe rapy treatme nt is  fac i l itated  
4 .  exce llent  re duc t ion and fix ation wi thout splint ing 
5 .  fac ilitate s  nurs ing care 
6 .  complications o f  the be dridde n pat ient are avoided 
7 .  transportation and patient  handling made e as ie r  
8 .  inc idence o f  bony union i s  incre ased 
9 .  hospitalization s tay is shorte r 
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Whe re me tallic fixat ion dev ice s we re cons ide re d applicable , 
one had to have a s trong enough bone surrounding the frac ture to 
support it (Leach and Torge nson , 1 9 67 ) . The se same authors valued 
phys ical the rapy p roce dure s to expe d i te and a s s i s t  in the t reatment 
of  patients with osseous dise ase . 
In a re trospe c t ive s tudy of  9 6  patients , Parrish and Murray 
(19 7 0)  de scribe d 64 comple te frac ture s , three impend ing frac ture s , 
and 7 2  surgical proce dure s  performed . The y j udged the re sponse 
to trea tme nt of me tas tat ic ske le tal frac ture s by the o s te oblas tic  
react ion in  the le s ions and by re lie f of pain , and ins i s te d  that 
the bene fi ts o f  inte rnal fixat ion and ope n reduc tion far outwe ighe d 
e ffe cts  the procedure might  have had on growth or local  e x tension 
o f  the le s i on (Parrish and Murray , 1 9 7 0) . 
The re lat ive ly new concept  o f  prophylac t ic fix ation o f  
immine nt or  thre atening pathological frac ture s has p re se nted an 
exc i t ing challe nge to the orthoped ic surgeon . S ince one -hal f  o f  
patient s  with bone me tas tase s will e ventually de ve l op a frac ture , 
Be al s , Lawton , and Sne ll  (19 7 1) p rophylac t ically p inne d 9 4  case s , 
noting that the me tabol ic s tre s se s  of  e le c tive surge ry we re le s s  
than the combine d s tre s se s  o f  surge ry and frac ture . The y expe ri-
enced no  me chan ical fai lure s , and the re sults we re encouraging . 
The ope ration was cons ide red whe n a we l l - de fine d lyt ic type le s ion 
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o f  2 . 5  em . diame te r o r  gre ate r involve d  the c ortex . 
Prophylac tic intrame dullary nailing or pros the tic replace ­
ment  o ffe red the following advantage s : patient was in a re lative ly 
be tte r  c ondition ; the ope rat ive proce dure was of  le sse r magnitude 
and was le ss  shocking ; pain , displacement of fragme nts , and an 
eme rge ncy s i tuation c re ated by the fracture we re all  avoide d and 
p re vente d  (Coran e t  al . ,  1 9 68 ; Fidle r ,  1 9 7 3) . 
Non- surgical tre atment of  osseous me tas tase s inc lude d 
irFadiation , hormonal manipulation , and chemothe rapy . Eisen , 
Bosworth , and Gho s se in (19 7 3) s tated that fewe r patients would run 
the risk o f  de ve lopme n t  of collapse d ve r tebrae , cord compre s s ion , 
or painful me tastatic dise ase i f  the whole spine we re irradiated 
initially  with 3 , 000  to 4 , 000  rads . The rat ionale was that a high 
pe rcentage o f  patients  that we re ini tially tre ated for a s ingle 
me tas tat ic focus in the spine re quire d subsequent  tre atment to 
anothe r are a  for s ymp tomatic d ise ase (Eisen e t  al . , 197 3) . Bhalla 
(19 7 0) advise d radiothe rapy in combinat ion with hormonal the rapy 
for control of the me tas tatic deposits , if the re we re no neuro­
logical involvement . Collapsed ve rtebrae we re tre a te d  s ymptomati­
cally , s ome time s  with e x te rnal support of brac ing , al though the 
latte r we re tole rate d poorly by patients  with e x tens ive me tas ta tic 
dise ase . 
T TWhen osseous me tastase s are p re dominant ,  survivals are 
indire c tly thre a te ne d , e . g .  by comp l icating fac tors such as hyper­
c alcemia , pathological frac ture s , or  paraplegia or  quadriple giaTT 
(Me lle tte , 1 9 7 0) . In a report conce rning hormonal manageme nt of 
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bone me tas tase s ,  one o f  the maj or premise s was that e s troge nic 
hormone s administe re d  in gre ate r than phys iologic amounts  sup ­
pre s se d  tumor growth i n  3 0  pe rce nt o f  post-me nopausal female s . 
Androgens  worke d  be t te r  on wome n more than five ye ars or more pos t­
menopause . The s ide e ffec t s  o f  the latte r , howe ve r ,  we re common 
and d i s t re s s ing . For pre -me ns t rual wome n , oophore ctomy would 
e ffec t  bone tumor re gre s s ion in 30 to 35 pe rcent of patients , and 
finally the pos it ive obj e c t ive re sponse to adrenale c tomy in patients 
with osseous me tas tase s was about 37  pe rce n t . 
The se re sults we re e ncouraging , eve n  more so  i f  the hormonal 
man ipulation were comb ined with radiation . Unfortunate ly , chemo­
the rapy doe s not  control  or a ffe ct  re gre s sions in  bone me tastase s 
as we ll  as  i t  doe s for some s oft tis sue dissemination . 
Summary 
Bone me tas tase s may cause s igni ficant morbid ity due to 
pain , de cre ase d range of mot ion , immine nt or re sultant frac ture s ,  
and othe r comp l ications . Common s urgical p rocedu re s  we re out l ined 
for e ach fracture type , and re sul ts of tre atme nt o f  this  nature 
have bee n  promis ing . This  se c t ion has de scribe d the diagno s is , 
complications , use o f  radioisotope s , and summarized the basic  tre at­
ment  and managemen t  approache s to thi s  common s ite of  d i s semination 
in human b re as t  cance r .  
LIVER METASTASES 
Inc ide nce and Pathology 
Me tas tase s to the live r  from bre as t  carc inoma i s  one o f  the 
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three mos t  common s ite s o f  me tastase s o f  this d i se ase . C linic ians 
can e xpec t  the l ive r to be invo lved in bre as t carc inoma in approx i ­
mate ly 5 0  pe rcent  of  c ase s (Fre id and Goldberg , 19 43) . Abrams , 
Spiro , and Golds te in (1950)  reported a 61 pe rce nt me tas tatic rate 
to  the l ive r ; the rich vascular i ty and e x tent  o f  pare nchyma of  
thi s  organ , as  we l l  as  local  me chanica l and biochemical fac tors , 
probably all figure in caus ing the high rate of  me tas tase s .  In 
fac t , l ive r involvement  could be the s ole evide nce of  d i stant 
spre ad of  the bre a s t  c ancer (Obe rfe ld ,  Cady , Paz ianos and Salzman , 
1 9 7 2)  . 
The commone s t  pathogene s is was by  t rue me tastase s from the 
s ys temic c i rculation ; me tastase s via  the portal ve in we re also  a 
the ore tical pos s ib i li ty . Mic roscop ically , hepatic arte rial embol i ­
zation was d i fficul t  t o  identify be cause the rapid ly ensuing intra­
hepat ic me tas tase s comp l ic ate d the pic ture (She rlock , 1 9 68 ) . If 
the l iv e r  parenchyma we re grossly  rep laced or  de s troyed , the re 
could be dec re ase d phys iological func tion which could be me asured 
by l ive r function te s t s . 
Diagno s i s  and Symptoms 
The card inal symptoms of live r  spre ad we re fullne s s  afte r 
eating , anore x ia , nause a ,  eme s i s , and e arly tobacco and coffee 
intole rance ; hepatome galy , gene ral discomfort ,  asc ite s  and consti­
pation also  occurre d . Clinical j aundice of  the obs t ruc t ive type 
could occur i f  the me tas tatic growths impinge d upon or blocke d  
ducts . 
Diagno s i s  o f  l ive r me tas tase s c an be d i fficult . Although 
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dire c t  b iopsy was the most  re liable me thod , i t  was a maj or  pro­
cedure in a pat ient alre ady we akene d  by me tas tatic d i se ase (DeWys , 
1 9 7 4) . Nee dle aspiration biopsy was le s s  tax ing but failed  to 
de te c t  tumor in 30 to 40 pe rcent  of case s : the chance of obtainirg 
a pos i tive re sult incre ased wi th e x tent of  me tas tase s , s i ze of  
live r ,  and the pre sence o f  a palpab le mas s  in  the abdomen . 
Live r scanning with radioac t ive isotope s has be come an 
invaluable adjunct i ve d iagnos tic tool in me tas tatic bre as t  cance r . 
Unlike bone scanning , those hepatic are as with d isease will be 
poorly func t ioning and will the re fore take up le s s  o f  the isotope , 
and will  appe ar as an are a o f  le s s  dens ity or as a TYcold spot TY .  
Volpe e t  al . ,  (19 7 1) clas s ifie d live r  s c ans  into e ight cate gorie s 
for d iagnos tic  purpos e s . 
Covington (19 7 0) d i scussed the accuracy o f  pho toscans , 
emphas izing normal re adings ; and s tre ssed  that proof o f  accuracy 
of  a positive scan was always nee ded by b iopsy , ope ration , or  
autopsy which corroborate d the photoscan in  8 7 , 7 1 , and 72  pe rce nt 
of  sep arate serie s  re spe c tive ly for e ach me thod . The tre atment of 
live r  me tas tase s is  usually by hormonal therapy or chemothe rapy 
technique s . 
BRAIN METASTASES 
Introduc tion and Pathology 
Breast  c ance r is  the mos t  common ne op lasm in female s to 
me tas tas ize to the bra in (Furlow , 19 61) . Inc ide nce of  this compli­
cation varie s w i th many factors - the true inc idence i s  d i fficul t 
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to c alculate s ince the me tas tase s are often asymptomatic . Vie th 
and Odom (19 65 )  reporte d  that  from 1 5  to 3 7  pe rcent of  primary 
bre a s t  carc inomas e ventually me tastas i ze to the brain . Of all 
b rain  tumors , s ome 1 2  to 2 0  pe rcen t  were of me tastatic origin . 
Bre as t  c arc inoma accounte d  for 44/19 5  (22 . 6  pe rce nt - S imone scu , 
1 9 60) ; 2 2 2/5 60 (39  pe rcent  - Nisce , Hilaris and Chu , 1 9 7 1 ) ; 51/31 3  
(1 6 . 3  pe rcent  - Vie th and Odom , 1 9 65) ; and 15 . 8  pe rcent (Lang , 
19 67 )  o f  the me tas tatic  tumors in various se rie s . Bre as t  cance r 
tumor emboli can re ach the central ne rvous sys tem  by the pulmonary­
s ys temic or the ve rtebral ve nous c i rculation , the latte r  was dis ­
cus se d  in de tail  in the be ginning of  this  l i te rature re view . 
Pathoge ne s i s  
The location o f  the me tas tatic depos i t s  was parie tal , 
frontal , ce rebe l lar , temporal , and occipi tal are as in o rde r of 
de c re as ing fre quency (Haar and Patte rson , 1 9 7 2) . The predominant 
d is t r ibution o f  the s ingle or mult iple le s ions tende d to be in the 
a re a  o f  the b ra in supp l ied  by the middle ce rebral arte ry .  
Pathologically , CNS me tas tase s from bre as t  carc inoma demon­
s trate d  typ ical  characte ris t ic s : the y we re ve ry l ike ly to be mul­
t ip le rathe r than s ingle : in fac t  the le s i ons we re multiple in  
fully 8 0  pe rcent  o f  the case s ; the y we re usually we ll  demarcated 
from the surrounding b ra in parenchyma ; the y we re encapsulate d , and 
we re o fte n grayish in color . Le s ions varie d in s i ze from a few 
millime te rs to seve ral centime te rs (Fulle r e t  al . ,  1 9 7 0) . Wilson 
and Fewe r (1 9 7 1) e mpha s i ze d  marke d  ce rebra l e dema ; the re has bee n 
suffic ient evide nce that the re might be cons ide rable e x tens ive 
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oar�bral e dema wi th gross  ve ntricular displacement eve n  though the 
actual tumor nodule s we re small (Furlow , 19 61) . The ave rage inte r­
val be tween  b re as t  primary d iagnos i s  and onse t of  brain me tas tase s 
was 1 7  months , and only one -half  of  the se case s we re symp tomatic 
(Le s se and Ne tsky , 1 9 5 4) . 
Symptoms and De tec t ion 
The s ymptoms of me tastatic involveme nt depended primarily 
upon the loc ation of the le s i ons , and we re due not only to the 
expanding les ions but also to the incre ased intracranial p re ssure 
which accompanied the m . Pe rs is tant e arly headache usually pre ce de d  
nause a ,  eme s is , p s ychic change s ,  and localizing s igns such as 
Jacksonian se izure s , hemipare s i s , speech d isorde rs , v i sual fie ld 
defe c t s , and p arie tal lobe sensory change s (Fulle r e t  al . ,  1 9 7 0 ) . 
Nisce e t  al . ,  (19 7 1) reporte d motor de fic its  in 7 5  percent ; d i s ­
orientation , le the ragy , or coma in 41 pe rce nt ; he adache s i n  3 3  
pe rcent ; and sensory de fic its i n  28  pe rcent  o f  patients with brain 
me tas tase s .  Hype rre fle x ia can occur (incre ased DTR) e spe c ially in 
patients who e xpe rience d hemiplegia . As c linical symptoms we re the 
same as those in primary b rain tumor and othe r intracranial pro­
ces se s , a d i ffe rential d iagno s is was mandatory (Le sse  and Ne tsky , 
1 9 5 4) . 
With the discove ry and de ve lopment o f  scanning with radio­
active isotope s , the de te ction of  brain me tas tase s is  much more 
re liab le than forme rly . The mechanism o f  scanning paralle ls  
c lose ly that for bone me tastase s ;  that is , are as o f  suspe c te d  
m� tas tase s show as are as of  incre ased radioac t ive up take on the 
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s c an . B iopsy o f  a cereb ral  le s ion c arrie s s ignifican t  risk , and 
is  not commonly e mploye d  as  a d iagnos tic  p rocedure . 
Tre atme nt 
The t re a tment of  CNS me tas tase s was e ithe r by neurosurge ry , 
irradiation , or  s te ro id therapy - fre quently a comb ination o f  tre at ­
me nt approache s was emp loyed . Seve ral authors have supported surgi ­
c al p rocedure s for re moval of  a s ingle me tas tatic focus (Haar and 
Patte rson , 1 9 7 2 ;  Lang , 19 67 ; S imone scu , 1 9 60 ; Vie th and Odom , 19 65 ; 
and Wilson and Fewe r ,  1 9 7 1) . Surge ry might have bee n  indicate d  to 
e st abl is h the diagno s i s  in a patient  without e vidence of  a p r imary 
tumor (rare in b re as t  c arc inoma) ££ in a patient without evidence 
of d i s seminat ion e xcep t  for the solitary brain tumor (Haar and 
Pat te rson , 1 9 7 2) . Othe r indications for neurosurgery we re l imited 
to a se le c t  group - re se rved for rapid de te rioration in a solitary 
le s ion , obs truc tion to ce rebrospinal fluid flow , or re currence afte r 
a total course o f  radiat ion had bee n  given (Fulle r e t  al . ,  1 9 7 0) . 
C omb ining s te ro ids  and radiation with surgical proce dure s was 
recommende d .  
Lang (19 67 )  stated  TT Surge ry doe s increase longe v i ty in 
patients with brain me tastase s ,  but it may no t be long enough to 
make the procedure rewardingTT .  Othe r s urge ons are skeptical  about 
a procedure which only could be cons ide re d  in one - fifth of  a pop ­
ulation with CNS di s seminat ion . 
Recently , the t rend has bee n  toward wh� brain i rradiation , 
usually combined with s te roid admin i s tration . Ni sce e t  al . ,  (19 7 1) 
reporte d  improvement  in the functional s tatus of  one -half o f  the 
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��tients with brain me tas tase s ;  the ave rage duration o f  the remi s ­
s. ion was s ix months for bre as t  c arcinoma patie nts . 
One report conce rned the improvement  o f  the quality o f  
su�vival afte r irradiation for brain me tas tase s (Orde r ,  He llman , 
Von E s se n , and Klige rman , 1 9 68) . The se authors did propose a 
func tional c la s s i fication of  pat ients  with brain me tastase s ,  which 
was use d in the cons truc t ion o f  Mode l A - Extent  of  Me tastase s 
Ope rational Mode l ,  for the purpose o f  data colle c ti on in thi s  
the s i s . 
Of seven p rimary b re as t  tumor s  with CNS me tas tase s , four 
imp roved the ir funct ional s tatus for varying pe riods of t ime afte r 
radiation (Horton , Bax le , and Olson , 1 9 7 1) . The re commende d dose 
was 3 , 000  rads to the entire cranium in spl i t  dose s . S ince the 
intracranial pre ssure could ri se se condary to i rradiation , s te roids  
in s ufficient dose s we re rout ine ly given to  counte rattack this  com­
mon sequalae to tre atment . S ince mos t  c l inic ians have been  report­
ing supe rior re sults  with radiation and s te ro ids , the se procedure s 
are now p re fe rre d ove r surgical inte rvention in the maj ority  of  
c ase s . 
Summary 
In summary , d i s seminat ion of  bre as t  carc inoma to the CNS 
was one of the more common obse rvations in this d i se ase ; from 15  
to more than 3 0  percent of  women wi th b re as t  cance r will  e ventually 
suffe r brain me tas tase s .  The s ymptomatology that  was outline d  was 
he ighte ned by an aggre s s ive and c ons is tent rise in intracran ial 
p re ssure . Although b re as t  c arc inoma ce rebral me tas tase s we re 
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characte rist ically wel l  demarcate d and usually e nc apsulate d , the y 
were se ldom amenable to s urgical rese c tion , chie fly be cause of  
the ir' mul t ip l ic i ty . Once the neurological de fic its and other dis ­
tre ss ing symptoms appe ared ,  the oncologis t  could utilize s te roids 
and radiation to re l ie ve suffe ring and palliate the re sultant d isa­
b i l i t ie s . 
EPIDURAL SPINAL CORD COMPRESS ION 
Spinal cord compre s s ion due to e pidural me tas tase s was one 
o f  the c linical s yndrome s that had be come more commonly re cognized 
in re cent de cade s . Cons ide r ing the gre at fre quency with which 
breast  carcinoma me tas tas ize s to the ve rtebrae , it was surprising 
that thi s  comp l ication was not more common (Rubin , Maye r ,  and 
Poulte r ,  1 9 69) . 
Me tas tatic tumors almo s t  always compre s s e d  the cord from 
the epidural space - a re sult of ve rtebral body e x tens ion (Posne r ,  
Mye rs , Benua , and Lipton , 1 9 7 1) . Much le s s  commonly ,  the tumor 
me tas tas ize d to the epidural space without dire c tly involving the 
bone . True intraspinal me tas tase s within the tracts  and ne rve 
ganglia of the cord sub s tance we re e xtreme ly rare . As the tumor 
spre ads to the e p idural space in the mos t common manne r ,  the blood 
supply  was compromised  and a hemorrhagic infarc t ion deve loped le ad­
ing to a paraple gia or quadriple gia that was irreve rsible (Posne r  
e t  al . ,  19 7 1) . 
Symptoms and De tec t ion 
Prodromal p ain may be p re sent  for days or  weeks prior  to 
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the o the r s ymptoms : we akne s s , sensory los s , atax i a , motor los s and 
finally autonomic dysfunc tion . S ince compre s s ion could re sult in 
comple te motor and sensory loss  and loss  of sphinc te r  control , the 
s yndrome c ould contribute to s igni ficant d isabil ity in the me ta­
s tatic b re as t  c ance r patient . For this  re ason , c l inicians usually 
consi d€ red the condition to be a medical eme rge ncy (Rubin e t  al . ,  
1 9 69)  . 
The diagnos is o f  the epidural b lock was be s t  made by  mye lo­
grapby (Viola , 1 9 7 1 ; White , Patte rson , and Be rgland , 1 9 7 1) . The re 
has bee n cons ide rable controve rsy re garding the p rope r tre atment o f  
spinal cord compre s s ion - the physic ians mus t  think i n  te rms o f  
p reventing rathe r than attempting t o  re s tore or  reve rse the para­
p le gia . The l i te rature has emphas i ze d  a comb ined attack o f  surgl­
c al lamine ctomy and de compre s s ion , rad iation , and chemothe rapy 
(Fage r ,  1 9 67 ; Rubin e t  al . ,  1 9 69) . 
Tre atment  
Mos t  o f  the re se arch conce rning the p roper manage me nt o f  
spinal cord compre s sion has been pe r forme d  o n  mixed se rie s  of  
patie nts , which have included various primary tumors , mos t  o f  them 
o f  the lymphoma group . C aution is  advise d in ex trapolating re sults 
to c ord comp re s s ion due to me tas tatic bre ast carcinoma . Rubin and 
his  assoc iate s agre e d  that high daily dose radiothe rapy without the 
nee d  for l amine c tomy or  sys te mic chemothe rapy affe c ted  improve ment . 
The y recommended a re gime of  400 to 5 0 0  rads daily for three days , 
the n 100  to 200  rad s  daily unti l  improvement was max imal (Rubin 
e t al . ,  19  69)  . 
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The re were those  who be l ie ve d  radi at ion e dema he ighte ne d  
&nd aggravated neuro logical s ymptoms ; the re fore , the se c l inician s  
s�Ror�e d  surgical decompre s s ion and lamine c tomy wi th or wi thout 
radiation (Viola , 1 97 1 ; Whi te e t  al . ,  19 7 1) . I f  surge ry was 
e le c te d , the s p in� c ord mus t  be we l l  dec ompre s se d  and as much of  
the tumor removed as pos s ib le . Whi te and his colle ague s (19 7 1) 
reporting the re sults o f  de compre s s ion l aminec tomy in 2 2 6  patients 
(1 6 pe rcent were b re a.s t  primarie s ) , c onte nded that when s igns  of  
neurological dys func tion occurre d , surge ry was the primary form o f  
tre atment , unles s  the tumor was highly radiosens i ti ve . Due t o  the 
eme rge nc y  nature of  the s i tuation , the role o f  chemothe rapeutic 
agents  in the tre atment o f  sp inal cord compre s sion is l imite d . 
Summary 
Spinal cord compre s s ion from me tas tatic spread o f  the 
d ise ase into the epidural space has be come incre as ingly more re cog­
nize d  in d isseminate d bre a s t  carc inoma . The comp l ication usually 
pre sented as  a medical  eme rgency due to the tremendous potenti al 
d isab i lity  when the b lood supply to the cord be came compromise d . 
At the pre sent  time , although rad iation the rapy appe ars to be pre ­
fe rred ove r surge ry ,  the circums tance s in which sp inal cord com­
pre s s ion by me tastatic carc inoma can be tre ated s olely by  radiation 
the1:lapy remain tD be e st ab lishe d . 
D ISTANT LYMPHATICS 
One o f  the mos t common mode s of  d i s tant me tas tase s of 
breas t carc inoma was spre ad wi thin the lymphatic system to d i stant 
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node s (Sp ie l s  and Withan , 1 9 3 3 ) . By the de finition give n  in thi s  
th& s is , d i stant lymphatic  spre ad excluded me tas tase s t o  ips alate ral 
axilla ry and inte rnal lymph node s of  the mammary chain , but include d 
me tas tase s to the suprac lavicul ar or ce rvical lymph node s on e ithe r 
s ide , as  we l l  as any othe r dis tant lymph node s (Cutle r e t  al . ,  1 9 69) . 
Viadana e t  al . ,  (19 7 3) in the ir  s tudy o f  647  primary bre as t  
carcinomas , reporte d  the ce rvical lymph node s to be involved in 
2 3 3  (3 6 pe rcent) ; the thorac ic lymph node s in 3 5 9  (5 6 pe rce nt) ; the 
abdominal lymph node s in 250  (38 . 5  pe rcent) and the pe lvic  lymph 
node s in 1 0 7  (1 6 . 6  pe rcent) o f  case s . Cle arly the re was a gre ate r 
fre quency of  me tas tase s to the lymphatics  anatomically close r to 
the bre as t . 
The inte rre lationship be tween hematogenous and lymphatic  
di ssemination p layed an integral role ; e ithe r d i s tant lymph node 
spre ad could occur as a re sult  o f  d i re c t  re trograde growth through 
organ lymphatics  or  le s s  commonly , the me tas tase s could re ach the 
are a  through the hemato�e nous route , and subsequently p ie rce the 
e ndothe l ial and lymphatic  walls  and commence me tastatic growths in 
the c ontiguous lymphatics . 
Symptoms and De te c tion 
Involvement  of  the hilar or  pe r ibronchial lymphatics  could 
produce cough and dyspne a ; s igni ficant dysphagia could re sult i f  
the pe rie sophage al lymph node s we re involve d (Se ars , 19 68 ) . Eso­
phage al mani fe s tations typ ically occurre d at  the leve l o f  the 
carina , and tre atment was by radiation or  surge ry (Conklin , 19 6 4) . 
Spre ad to the lymph node s prox imal to the vena cava could cause 
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� vena c ava s yndrome , charac te rize d  by  face and neck e dema , 
venous d i s tention , and poss ible conge s tive he art failure (Se ars , 
1 9 68) . 
Involvement  of  the sc alene lymph node s , which anatomic ally 
are In  c lo se p roximity to the brachial plexus , e ffe c te d  on occas ion 
neurological s igns and s ymptoms re fe rrable to that ple xus . Symptoms 
we re also poss ible i f  the suprac lavicular lymph node s we re e xte n­
s ively invo lve d with me tastat ic tumor (Se ars , 1 9 68 ) . Brachial 
ple xus inv olvement  typ ically p roduce d pain , numbne s s  or  pare s the ­
s ias , and motor or sensory los s which varied from minimal to se ve re . 
Me tas tase s to the abdominal or me sente ric lymph node s p ro­
duced s ymptoms or  syndrome s large ly depe nde n t  on the numbe r ,  s ize 
of the me tastase s ,  and e x tent  o f  obs truc t ion or compre s s ion of the 
organs or  systems by the e nlarge d  lymphatic s . The pe lvic lymph 
node s we re involved in le s s  than 2 0  pe rce nt  o f  case s (Viadana 
e t  al . ,  1 9 7 3 ) and usually only as a late man i fe s tation . Symp toms 
o the r than p a in might �e lacking unt i l  the pe lv is  was filled wi th 
tumor ; gen itour inary complications , s uch as blocke d  ure te rs and 
e nsuing uremia , we re rare but could occur . 
De te c ti on of  d i s t an t  lymphatic involvement  will depend 
upon s ymptoms caused by the tumor fille d  lymphat ics . Supe rfic ial 
lymph node s c an be de tec te d  c l in ically by palpation , but the deepe r  
node s , i f  involve d , may e sc ape de te c t ion i f  the patient i s  asymp to­
matic . The ac tual e x tent  in  te rms o f  numbe r and amount of  tumor 
spre ad to d i s t ant  lymphatics  is  ge ne rally d i scove red as  an inc i ­
dental finding in  autop s y  s tudie s . Lymphangiography l S  o f  more 
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use In c ance rs having more pre dictab le route s of deep l ymphatic 
spre ad. ,  such as te s ti cular tumors . The tre atment  of  me tas tatic 
lymph node c arcinoma will  depend on location , s ize and e x tent of 
symptomatology . Radiothe rapy might be j udicious for some are as , 
while s ys temic or re gional che mo the rapy more prudent  in o the r 
s i te s . Rare l y  i s  surgery ind icate d . 
In s ummary , d i s tant lymph node spre ad was common , e spe -
c ially to the mediastinal lymphat ics . One would do wel l  to remem-
be r that most of the s o  calle d  v isce ral spre ad of b re as t  carc inoma 
was actually me tastase s to the contiguous lymph node s in the abdo-
men or thorax , producing organ s ymptoms by v irtue o f  pre s sure or 
obs truc tion . 
OTHER r:1ETASTATIC S ITES AND SYSTEMIC EFFECTS 
� 
Hype rcalcemia 
Elevated leve ls  of c alc ium in the blood se rum can have 
variable c auses  whe n found in the me tas tatic cance r wi th a bre as t  
primary . S te roid therapy , i f  long continue d , in high dose s , has 
been sugge s te d  as  be ing contributory . Long te rm e s troge n  or o the r 
hormonal the rapy could pre c ip i tate a hype rcalcemic e p i s ode . 
Although the gre at maj ority of women suffe ring thi s  potentially 
fatal complication also had ex tens i ve bone me tas tase s ,  hype rcal-
cemia c ould occur in patients  wi thout e vi dence of  o s se ous d issemi-
nation . 
Galasko (19 7 2) reported 2 4-/12 7  incidental (asymptomatic)  
hype rcalcemia and 18/1 27  acute hypercalcemic crise s  in one serie s . 
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The inc i de nce reported by Davis ,  Wise ly , Ramire z ,  and Ans fie ld 
(l9 7 3) was 7 . 2  pe rcent of  3 0 5  women wi th d i sseminate d  b re as t  carc i -
�oma ; Galasko and Burns (19 7 1) reporte d  a 14  pe rcent incide nce i n  
1 3 0  patients . In the s tudy o f  Davis e t  al . ,  (19 7 31 1 3  deve loped 
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the cond it ion spontane ously , and e ight d id so  following e s trogen 
or  androge n  admin i s tration . 
Pathologically , in o s te o lytic me tas tase s , the balance 
be tween calc ium depos i t ion in bone and calc ium mob i l i zati on from 
bone was upse t . As complex p roce s se s  de s troye d  the ac tual bone 
and the os seous ce l l s  unde rwent  ne c ros is , c alcium spille d  into the 
c irculation . Se ve ral me chan isms we re probably re spons ib le . I f  the 
e xce s s  calcium was excre te d  by the kidne y ,  c l inical hype rcalcemia 
d id not occur . 
Symptoms and De tec tion 
The s ymptoms according to the above authors we re ske le tal 
pain , gas tro inte s t inal symp toms s uch as anore x ia , nause a ,  eme s is , 
and we akne s s , le thargy , or s omno lence . The hype rc alcemic episode 
could be fatal in up to one - third of patie nts e xpe rienc ing the 
c omp l ication (Mannhe ime r ,  1 9 65) . 
Tre atme nt 
Tre a tme nt o f  hormone induce d hype rcalcemia re sponde d we ll  
to withdrawal of  the drug and d iure s i s , according to  Mannhe ime r 
(19 65) . Cort icos te roid the rapy was some t ime s  use d ,  but the d i s -
advantage s we re i t s  s lower ac tion , 20  t o  3 0  percent non re sponse 
rate , and s ide e ffe cts  such as peptic ulce r .  Mithramyc in , an 
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ant ibiotic use fu l  i n  ce rta in te s t icular ne opla sms , e ffe c te d  a 
lowe re d se rum calcium within a matte r  o f  hours (Lehnha rd , . 1 97 1 ;  
S layton , Schni de r ,  Elias , Morton , and Pe rlia , 1 9 7 1) . The symp toms , 
le thargy , bone pain , and G I  d i s turbance s ,  could be succe s s fully 
t re ate d by d ie t ,  d iure s is , mi thramycin , phophate s , or  s te roids . 
Othe r S i te s  
Accord ing to Viadana e t  al . ,  (19 7 3 ) me tastase s to the 
foliliowing organs we re e xpre sse d as a pe rcentage of 647  primary 
bre a s t  cance rs : s tomach , 10  pe rce nt ; pancre as , 12 pe rcent ; adre nals 
38  pe rcent ; and ovarie s 1 5  pe rcent . 
Advanced c ache x ia , often see n  as a te rminal s yndrome in 
many cance r patients , was not as common in bre a s t  cance r .  Brie fly , 
cahe x i a  was a syndrome manife sted by we akne s s , anore x ia , we ight 
los s , and prote in los s - charac te rize d  by was t ing and atrophy of 
the body t i s sue s in comb ination with hype rme tabol ism for the 
nutr i tional s tate of  the ind ividual . The orie s have propose d  that 
the c arcinoma caused the inappropriate ac t ivation and inac t ivat ion 
of e nzyme s without a nee d  or a plan , le ad ing to an incre ased e ne rgy 
e xpenditure and me tabol ic rate de spite semi - s tarvation . 
COMPLICATIONS DUE TO TREATMENT 
The re are four maj or  tre atme nt approache s of bre a s t  carc i ­
noma : surgical ,  radio logic , chemothe rape ut ic , and hormonal . S ince 
mos t  of the surgical comp l ications are re late d to radical mas te c ­
tomy for the primary tumor , the y will not be cons ide re d he re . 
Maj or surge ry ,  e xc luding ablative hormonal proce dure s ,  which will 
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be t re ated unde r hormonal approache s ,  and outs ide of  the removal 
of the rare solitary pulmonary or ce rebral le s ion , or prophylac tic 
and re const ruc tive orthope dic proce du re s , doe s  not play a large 
role in the tre atme nt o f  me tas tatic bre as t  carc inoma . 
Hormonal The rapy 
Re gime s based on hormonal manageme nt have varied with the 
age and me ns t rual s tatus of the patient , the dise ase free inte r­
val , and the s ite s o f  organ involvement (Kaufman ,  19 7 3 ; Me lle tte , 
1 9 7 0 , 1 9 7 5 ) . Preme nopausal patients we re subj e c te d  to surgical or 
radio logical cas trat ion ; recent te s ts that employ e s troge n  b inding 
pro te in s c reened those patients  who would bene fi t from the proce ­
dure (approximate ly 3 0  pe rcent) . Ke lle y  (19 7 1) s tate d  that  
patients re spond ing to oophore c tomy had a s igni ficantly be tte r  
chance o f  re sponding favorably t o  furthe r p all iative me asure s -
adrenalec t omy , hypophyse c tomy , o r  androgen adminis trat ion . S ide 
e ffe c t s  o f  ablative oophore c tomy we re onse t of the menopause with 
its  assoc iated s ymptoms ; the se we re not usually trouble some for 
the patients . 
Adrenale c tomy p roduce d obj e c t ive re sponse s in from 3 0  to 
4D pe rcent  of case s (Fracchia , Randall , and Farrow , 19 7 0 ; 
Me lle t te , 1 9 7 0) . They found that  patie nts with CNS me tas tase s ,  
re s tric tive pulmonary or  p le ural spre ad , o r  seve re l ive r involve ­
ment  did  not fare a s  we l l  as  patients  with s o ft t is sue or bone 
me tastase s .  Patients might deve lop hypoadre nal i sm and could 
re quire e xogenous adminis trat ion of the lacking adre nal hormone s .  
Comb ined adre nalec tomy and oophore c tomy was frequently pe rforme d ; 
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fluid and e le c trolyte imbalance s that occurre d re qui red  prompt and 
p�oper attention (Rat zkowski , Adle r ,  and Hochman , 1 9 7 3 ) . 
Hypophyse ctomy had many propone nts . In addi tion to hav ing 
a suppre sant e ffec t  on  e stroge n  produc t iv i ty , and thus upon the 
growth o f  the tumor , the p rocedure e l iminated growth hormone and 
p rolac tin , which probably also had an e ffe c t  on tumor growth . Com­
p l ications inc lude d fluid and e le c trolyte imbalance s and abnormali­
t ie s , which could be con trolle d by cortisone ; and occas ional dia­
be te s ins ipidus , t re ate d by s al t  re tain ing s te roids such as de xa­
me thasone , Thyroxin mus t also be supplante d . 
In pos t -menopaus al patient s , e i the r e s trogens o r  androge ns 
we re admin i s te re d . Pos s ible s ide e ffe c t s  o f  e s troge n  tre atment 
we re mild to seve re , and inc lude d fluid re ten t ion , ute rine b le e d ing , 
and possible hype rc alcemia . The chronic e ffe cts  of androge n  tre at ­
ment  we re fluid re ten tion and pos s ible hype rcalcemia , in addition 
masculinization c ould occur ; many patients  found thi s  d ifficult to 
tole rate . Addi t ive hormonal the rapy was popular not only for i t s  
e fficacy but a l s o  bec ause the agents  employe d did  no t cause bone 
marrow suppre s s i on (Hicke y , 19 6 7 ; Me lle t te , 1 97 0) . 
Chemothe rapy 
Although bre as t  c ance r did  no t re spond as  dramat ically as 
o the r c ance rs ( i . e . leukemi a , Hodgkin T s  Dise ase ) to chemo the rapy , 
s i gn i ficant palliation with remi s s ion las t ing months or ye ars could 
be obtaine d . The cho ice and se quence of  agents  was c ri tical , 
bec ause se ldom was i t  pos s ib le to try se quent i ally seve ral succe s ­
s ive the rapeut ic age nts i n  the tre atment  o f  one patie nt . The bone 
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marrow fre quently be came irreve rs ibly  dep le te d by  c ance r ,  chemi­
cals  use d , and associated  radiothe rapy (Eckle s ,  1 9 7 0) . Newe r and 
more e ffe ctive choices of tre atment seque nce s and comb inations 
were deve lope d .  As a rule , hormonal me asure s we re used and 
e xhaus ted be fore chemothe rapy was tried - the goal be ing the TTmo s t  
e ffe c tive re l ie f  i n  the shorte s t  time with the le as t morb id i  tyTT 
(Obe rfie ld e t  al . ,  1 9 7 2) . S ome o f  the more common chemothe rapeutic 
agents  and the ir  s ide e ffe c ts and comp l ications  are l i s te d  in 
Table 2 .  
Chemo the rapy charac te ris t ically has been cons ide re d e ffe c ­
t ive in induc ing re sponse s i n  those s i te s  with a re lative ly long 
survival t ime , inc luding bone , pulmonary nodular , s o ft t i ssue , 
pleural e ffus ions , and minor l ive r involvement  (Plotkin , Kagan , 
Nussbaum , and Reddi , 1 9 7 3) . S ie ve rs and Donavan (19 7 3 ) warned 
that ove r ze alous chemothe rapeutic  managemen t  might induce obj e c ­
t ive re gre s s ion , but fre quently sub s t i tute d  morb id i ty se condary to  
the the rapy e xcee d ing that which ex i s te d  as a re sult of  the disease . 
The much ce leb rate d  " C oope r re gime TT has been  used by many 
c l inic ians t re at ing d i sseminated bre as t  carcinoma afte r hormonal 
the rapy had been exhausted in the pat ien t . The app roach cons i s te d  
i n  c ombinat ions of  vincris tine , cytoxan , 5 FU , me thotre xate , and 
p rednisone . Ave rage re sponse rate s , even with two or three drug 
comb inations we re from 5 0  to 60 pe rcent ; the re are wide variations 
among individual authors  reporting re sul ts . The advantage s o f  
comb ination chemothe rapy - appropriate agent  s e lec tion and dosage 
aga inst  ce ll population - use fulne ss  when the cells  have be come 
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Table 2 
Common Chemothe rapeutic Agents Used in Advance d 
Bre as t  Cance r ;  Acute and De laye d  
S ide E ffe c ts and Complications 
Age nt 
I .  Alkylating 
Agents  
A .  Cyclopho s ­
phamide 
B .  Thiotepa 
C .  Me lphalan 
I I . Ant ime tabolite s  
A .  Me thotre xate 
B .  Flourourac i l  
( 5  FU) 
I I I . Natural Produc ts 
(Plant Alkaloids)  
A .  Vincri s tine 
Sulfate 
B .  Vinblastine 
Sulfate 
IV . Ant ib iotics  
A .  Adriamyc in 
Acute S ide 
Effe c ts 
nause a ,  
eme s is 
none 
none 
diarrhe a , 
hepatone cros i s  
and tox i c i ty 
nausea  
eme s is . 
locally 
irri tating 
locally 
irri tat ing 
nause a ,  
eme s is . 
locally 
irritating . 
nause a 
eme s is . 
De layed Tox ic ity 
bone marrow depre s s ion . 
alope c ia . hemorrhagic 
cys t i t i s . 
bone marrow de pre s s ion . 
bone marrow dep re ss ion . 
oral , GI  ulce ration . 
bone marrow depre ss ion . 
c irrhos is . 
oral and G I  ulce ration . 
s tomatitis , diarrhea . 
bone marrow depre ss ion . 
pigme ntat ion of skin . 
constipation , arre fle x ia 
i leus . pe riphe ral 
neuropathy . 
s ome bone marrow 
depre s s i on ,  alope c ia . 
s tomatitis , de cre ase d 
re flexe s .  
bone marrow depre s s ion . 
total alope c ia . s tomati­
t i s . c ardiomyopathy 
(EKG change s , usually 
in the T wave . )  
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re sis tant as a re s ul t  o f  repe t i t ive exposure to s ingle agents  -
we re we ighe d in light of appropriate ly lowe re d dose s to avoid  
intole rab le s ide e ffec ts (Plotkin et  al . , 1 9 7 3) . Me lle tte be lie ve d  
that the ore tically at  le as t ,  the s ide e ffe cts  might be more tole r­
able s t i l l  allowing for gre ate r  e ffe c t ive ne ss . 
C omp l ications due to the treatme nt could be conve niently 
divide d  into systems exhib i t ing s ide e ffe c ts ; many of the se we re 
also pe r t ine nt to radiation sequalae . Hemato logic comp lications 
we re by far the mos t c ommon (WBC and plate le t dep re s s ion , anemia) 
fol lowe d by gas t ro inte s tinal comp laints (nause a ,  eme s i s , diarrhe a , 
cons t ipation , ulce ration , anore x ia) . Othe r pos s ib i l i t ie s  we re 
ne urologic , hepatic , ge nitourinary (tubular ne cros is , nephritis , 
cyst itis , and re nal fa ilure ) and de rmatologic (alope c ia , pruri tus , 
hype rp igmentation , rashe s , and atrophy) . Infe c t ion , sep s is , fe ve r , 
and gene ral s ymp toms such as fatigue and we akne s s  we re common ; 
misce llane ous comp licat ions inc lude d pulmonary fibro s is , pneumonia , 
myopathie s ,  s terili t y , and c arcinogene s is . 
The comp l ications then due to hormonal and chemothe rapeutic 
tre a tment in advance d b re a s t  c arc inoma we re nume rous , and could be 
manife sted withe r gene ra lly o r  spe c i fically in seve ral somatic 
systems . Mos t  commonly , the hematological and gas trointe s t inal 
sys tems we re affe c ted . Those are as having the greate s t  turnove r 
of cells  we re mos t  often the s i te of se rious s ide e ffe c t s  of tre at­
ment . This concep t  seeme d  to  paralle l that of  radiation the rapy 
and its  comp l ications , whe re most  of the damage was to those are a s  
a1J.d organs having the mos t  rapidly d ivid ing ce lls ; i . e .  bone mar­
row , G I , gonads and skin . 
THE ROLE OF PHYS ICAL THERAPY IN THE 
METASTATIC CANCER PATIENT 
7 2  
Although many authors have written conce rning the manage -
ment o f  pos t surgical patients , inc luding pos t mas te c tomy patients , 
few have outlined programs for the me tastatic c ance r patient . Cur-
ren t  thought conc lude s that  the phys ical the rapy care adminis te re d  
t o  the advance d bre as t  c ance r patient  doe s not diffe r s ignificantly 
from the supportive care give n to othe r me tastatic patients . Unfor-
tunate ly , the rese arch in this are a is  almo s t  entire ly de script ive , 
and demons trate s programs appl icab le to all me ta s tatic patients , 
but not to b re as t  c ance r patients in particular . S ince supportive 
phys ical the rapy procedure s comprise a re lative ly conglome rate group 
of  treatment approache s , no one me thod has grown to be followe d as 
pro tocol for the se patients  with advance d d i sease . In ge ne ral , 
patients  with me tas tase s from bre ast  carc inoma will e xhibit  a 
myriad o f  di sabilitie s  and d i s t inct s ymptoms , but ge ne ral we akne ss , 
pain , malaise and we ight los s are the mos t  common one s that  are 
encounte re d . Phys ical the rapy is  nee de d  in the form of  mi ld , 
gentle e xe rc ise , palliative pain re lie f  by  accepte d  moda l i t ie s , 
and p rogre s s ive ambulat ion ac tiv i t ie s  with appropriate as s i s t ive 
device s . 
Die tz (19 69 )  s t re ssed  func tional ac tivitie s , e spe c ially 
ambulat ion , as pe rtinent  to the e ffe c t ive pat ient management in 
the treatme n t  of the me tastatic pat ient . This  approach fre que ntly 
require s inte rd iscip l inary care - the phys ical the rap i s t  be ing only 
one e ffe c t ive me mbe r of  the te am . Die tz (19 69 )  sugge s ted  s tarting 
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patients we akene d  by me tastatic cance r and i ts tre a tme nt - the 
anemia , nause a ,  and othe r sys te mic e ffe c ts of chemo the rapy and 
radiation . contr ibute gre atly to the gene ral ac t iv i ty ab ility of 
the patient - with grade d whole body exercise s , and e arly ambula­
t ion . Although he  was ac tually spe c i fying ambulation and p rogre s ­
s ive mobilizat ion for advance d leukemia  p atien t s , the concepts  are 
app l ic ab le to the me tas tatic bre as t c ance r patient . 
Coran (19 68)  reporte d  on 3 1  me tas tatic bre as t  cance r 
patients  p re senting with pathological frac ture of  one o f  the maj or 
long bone s . Var ious ope rative te chnique s are employe d , with d if­
fe rent  appliance s inse rte d  depending on the location of  the tumor , 
amount of  tumor le ft at  the frac ture s i te , among othe r fac tors . 
Phys ical the rap y  re gime s  fo r post  ope rat ive care are not typ ically 
spe c i fic for pathological fracture s due to me tas ta tic breast  carc i­
noma ; p rogr ams followe d are those outl ine d for re gular traumatic 
hip frac ture s . Prope r mod i fica tion , if  deeme d ne ce s s ary due to 
cache x ia , sys temic e ffe c ts of  dise ase , age , othe r s ite s of me tas ­
tase s , and untoward comp l icat ions o f  the tre a tment for the cance r ,  
might be ne ce s s itate d . An inte re s t ing and p ract ical consensus of  
seve ral authors was that we ight be aring , i . e .  on  a pos tope rat ive 
Jewe tt  nail , was commonly be gun e arlie r on cance r patients with 
pathological frac ture s as compare d to patie nts with re gular trau­
mat ic fracture s (Coran e t  al . ,  1 9 68 ; Le ach and Torgenson , 1 9 6 7 ; 
Parrish and Murray , 1 9 7 0) . The ra tionale was to sacrifice a ce r­
tain but l imite d amount of stab il i ty at  the fracture s i te in favor 
o f  e arlie r  ambulation and mob i l izat ion , be cause o f  the expe c te d  
shorte r l i fe span of  the se pdtients . 
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A knowledge o f  the e xac t s ite s of bony me tastase s and 
the ir  e x tent  and type of involveme nt , i . e .  o s teoblas tic vs . os teo­
lytic , i s ' imperative in making dec i s ions concerning the ac tivity 
level of  the patie nt as we ll  as  in se le c tion of  tre a tment approache s 
of  mob i lizat ion o f  the we akened  patient . The phys ical the rap i s t  in 
particular mus t  be cognizant of  the se mat te rs , and safe guard 
against  exce s s ive or s trenuous mobi li zation which might re sul t  in 
a pathological frac ture . 
Me tas tase s of  the ve rtebral column may cause incapaci tat ing 
paln . This is  e ffe c tive ly tre ate d wi th radiation - the need  for a 
lumbosacral corse t or  support or othe r variations o f  sp inal orthose s 
i s  not gre at .  Cancer patients suffe ring pain due to ve rtebral 
involvement  as a whole do not tole rate the phys i cal pre s sure s  of 
orthotic dev ice s on alre ady tende r body surface s (Parrish and 
Murray , 1 9 7 0) . 
The physical the rapy nee ds of  the me tas tatic cance r patient 
are incre ased treme ndously by the concomitant dise ase s of the enlarg­
ing ge riatric population (Zis li s , 1 9 7 0) . The c l inic ian o ften is  
tre a t ing the patients  for ge ne ral i zed  deb il i ty , we akne s s , and dys ­
func tion which i s  a re sult of  the comb ination of  the dis ab i l i t ies  
o f  the cance rous proce ss  and accompanying maj or dise ase or s yn­
drome s , such as  arte rioscle rotic he art d ise ase , obe s ity ,  diabe te s , 
seni l i ty , and o thers . Even though the ave rage age of the breas t 
c ancer patie nt is  approx imate ly 5 0  ye ars , pe riods o f  survival are 
incre as ing , and more wome n wi ll be l iv ing longe r  with the ir  d i se ase , 
and will approach age cate gorie s whe re the y will be more like ly to 
develop additional cond it ions which will furthe r tax the patie nt 
and contribute to d isab i l i ty . 
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Emphas i s  i s  on separating the re sultant disab i l i t ie s  and 
re lat ing i t  to the ir corre sponding dise ase entitie s , a task no t 
always pos s ib le in the cance r patie nt with mul t ip le p roblems . For 
pre sent purpose s ,  phys ical the rapy approache s concentrate on the 
gene ral e ffe c t s  o f  chronic , debili tat ing illne s s  syndrome s as  a 
whole - cance r and its  re late d d isab i lity be ing one of the many 
cause s of the se syndrome s (Die tz , 1 9 69 ) . 
In summary , spe c ialized phys ical the rapy programs for the 
me tas tatic bre as t  carc inoma pat ie nt are non e x i s tent in the l i te r­
ature ; howeve r ,  various authors  have publishe d loose guide l ine s 
which approach embryonic protocols , for pathological fracture s 
of  the long bone s , lumbar d ise ase , and mos t  commonly for the gen­
e ral problems of  all me tas tatic cance r patie nts . S ince the the ra­
p€ut ic proce dure s pre sently play the bigge s t  role in pathological 
frac ture s and the i r  post ope rative manageme nt , more inte re s t  seems 
to be s t imulate d he re . Furthe r e xplorat ion will  re ve al add i tional 
c l inical s i tuat ions in me tas tatic cance r patients whe re phys ical 
the rapy will be found advi sable or ne ce s s ary . 
SUMMARY 
The me tas ta t ic pote nt ial of bre as t  carc inoma has been 
de scribed with emphas i s  on the four maj or are as of  invo lveme nt ; 
the pulmonary , s ke le tal , hepatic , and central ne rvous sys tems . 
The chapte r be gan with a re view of the pre sent  clas s i ficat ion of  
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bre as t  carc inoma ; the nee d  for a s ys temic c las s ification and 
cate gorization of  me tas tatic d i se ase was c le arly indicate d . Fo l­
lowing this · nee d  spe c i ficat ion , basic pathological conside rations 
of the me tastatic proce s s  re lated to breast  cance r was depicte d ; 
the ve ry p rope ns ity for bre as t  c ance r to dis seminate both lymphat ­
ically and hematogenous ly was out l ine d . S tandard the orie s of 
me tas tatic growth - the soil vs . the me chanical hypothe se s  we re 
d iscusse d in the l ight  of the freque ncy of me tas tase s to rep re ­
sentative organs . Spe c ial importance was given to the role o f  the 
ve rtebral venous sys tem in the spre ad of  b re as t  c ance r to the spine , 
hip and pelvi s , and shoulde r girdle . 
A short  sec tion d iscussed the pre sent pos ition of  phys ical 
the rapy in me tas tatic  cance r ;  the l imite d  numbe r of  outlined pro­
grams have the me tas tatic , advanced patient as a group as the ir 
targe t ,  and are suffic iently applicable , but not sole ly de s igne d 
for me tas tatic bre as t  c ance r patients . 
The bulk of  this  chapte r con s i s ted  of s ys temic out l ine s  of 
the incidence , d iagnos i s , phys ical s igns and s ymptoms , maj or impli­
cations , and the t re a tment o f  the mos t  common s i te s  involve d  with 
me tastatic b re as t  carc inoma . A de taile d account of  the natural 
his tory of thi s  dise ase was deeme d  ne ce s s ary in orde r to re late 
spe c i fic me tas tatic charac te ris tics with c l inical disab ility , and 
i t  was for this re ason that chapte r two o f  thi s  the s i s  was wri t ten . 
Chapte r 3 
PROCEDURES 
This chap te r will  outline the bas ic proce dure s used in data 
colle c tion ; data we re comp ile d in an attemp t  to support the hypoth-
e se s  given in Chapte r One . The first  two se c t ions de scribe the 
proce dure s  employe d  in the c ons truc tion and approval o f  the two 
ope rational mode l s  which we re conce ive d  spe c i fically for the pur-
pose of  thi s  s tudy . Following this , the me thods o f  ac tual data 
colle c t ion , the s ub j e c ts and mate rials use d , are de l ine a te d . The 
me thods use d for the s tatis t ical analys is  of the data are mentione d , 
and the chapte r conc lude s with a short  summary . 
CONS TRUCTION AND PHYS IC IAN APPROVAL FOR 
OPERATIONAL MODEL A 
Mode l A ,  or  the Ex te nt of  Me tas tase s Ope ra t ional Mode l for 
disseminated breast  c arc inoma , i s  give n in i ts ent ire ty in Appen-
dix A .  Inc luded i s  the l i s t  of  phys ic ians who re ad and approve d  
the mode l be fore data colle c ti on . This mode l is  base d on a foun-
dation o f  s c ie n t i fic and c linical obse rvations of the d i s semina-
t ion of  human bre as t  c arc inoma . This  mode l was deve loped to ove r-
come the inade quac ie s o f  the UICC and AJCCS systems . The rationale 
for furthe r clas s i ficat ion has bee n  demonstra te d  in Chap te r Two of  
thi s  p ape r .  
The re ade r i s  re fe rred to the introduction to Mode l A in 
Appendix A which offe rs a more pre c ise e xplanation . Bas ically , a 
s ystem was devised whe reby a patient was graded on two leve ls for 
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e ach particular s i te o f  me tas tase s :  on seve rity o f  e x tent o f  the 
me tas tase s , and on the seve r i ty o f  the s ymptomatology that  was 
· manife sted as a re sult of the re spe c tive me tas tatic depos i t . 
Addendum I to  Appendix A i s  a comb ine d gene ral de scription 
of  the s cale used to grade both e x tent of me tas tatic dise ase and 
se ve r i ty o f  s ymp tomatology as s ta te d  suc c inctly in the addendum 
introduction . One mus t  v iew c lass ification of a patient  for e ach 
me tas tatic s i te as a dynamic and at be s t  temporary phenomenon . The 
mode l has bee n  const ructed with thi s  fac t in mind ; score s  can be 
change d  e as ily to de scribe the progre s s ion of the patie nt T s s tate 
of d ise ase . 
Mode l A i s  d iv ided into 15  groups , o r  s ite s of  invo lvement  
and parame te rs o f  d i se ase . Groups I through X inclus ive , and 
Group X I I  are anatomical d ivi s ion s  whe re me tastatic d i sseminat ion 
of  bre as t  carc inoma mos t  commonly occurs ; pulmonary ,  pleural , bone , 
hepatic , b rain , pe riphe ral ne rvous syste m ,  intrasp inal , dis tant 
l ympha t ic , and skin and soft tis sue are as are s ome of the many s i te s  
that are thre atene d b y  d i se ase . Group XI I was c re ate d as a col­
lec tive are a  for o the r than maj or organ s i te s . The remaining groups 
include score s obtainable for complications  of  s ys temic d i se ase , 
such a s  hype rcalcemia (Group XI) and cache x i a  (Group XI I I) . 
Group XIV , v incri s tine neurotox ic i ty , was deeme d  appropriate 
s ince thi s  medication i s  commonly use d  as  a chemothe rape utic age nt 
in d i s seminate d  bre a s t  c arcinoma , and the e nsuing pe riphe ral 
neuropathy that is  poss ible c an be potentially incapacitating . 
Group XV grade s the comp l ic at ions due to tre atme nt o f  the d ise ase . 
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Be cause s ys temic manife s ta t ions o f  t re atme nt can grossly and at 
t ime s cons ide rably  influe nce func t ional pe rformance , it was 
included as  part o f  the mode l de scrib ing me tas tatic dise ase and 
i ts e ffec ts . 
The mode l was subje cte d to e x tens ive e d i t ing and re vis ion . 
In Augus t of 1 9 7 5 , cop ie s we re s ubmitte d to a pane l of  three med i -
c a l  onco logi s t s  and one oncology fe llow for edi ting , sugge s tions , 
and final approval . 
CONSTRUCTION AND THERAPIST APPROVAL 
OPERATIONAL MODEL B 
Mode l B ,  or  the Leve l of  Func tional Disab i l i ty Ope rational 
Mode l ,  i s  give n in its  ent i re ty ,  including the corre sponding data 
collec t ion form and l i s t  of membe rs of the validation pane l , in 
Appendix B .  Unl ike Mode l A ,  Mode l B was based on se ve ral e s tab-
l ished e valuat ion forms de s c r ibing ac t iv i t ie s  of  daily liv ing and/or 
ge ne ral func tional leve l o f  the patient . The re are twe lve group s 
or cate gorie s to the mode l ,  and the y c lose ly paralle l those cate -
gorie s of  the Barthe l Inde x , a func tional e valuation form use d by 
many ins t i tut ions to score patients on funct ional ac tivity le ve ls 
(Mahone y and Barthe l , 1 9 65) . In the mode l prepare d  for this  the s is , 
the format for scoring was reve rse d from the Barthe l Inde x ; highe r 
score s  repre se nt gre ate r  le ve l s  of  phys ical dys func tion . In mos t  
data e valuat ion forms , including the Barthe l Inde x , the re ve rse i s  
true - highe r score s repre sent gre ater leve l s  o f  physical func tion-
ing . Mode l B was formulate d  in thi s  reve rse d manne r in orde r tha t  
i t  could be prope rly corre lated wi th Mode l A ,  whe re highe r score s 
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signify gre a te r  amount s  of  me tas tatic dise ase and its accompany­
ing s ymp tomatology . 
Different approache s de scribing phys ical dys func tion we re 
c ombine d to de ve lop maj or  cate gorie s o f  e s se ntial daily func tion­
ing : fee d ing , trans fe rs , pe rs onal toile t , bathing , ambulat ion on 
le ve ls and s tairs , whee lchair  ac tivitie s , s itting tole rance , be d 
ac tiv itie s , fuowe l and bladde r manage me nt , and dre ssing activitie s . 
For d re s s ing ac tivitie s , four separate group s we re li ste d  for 
various maj or article s of  c lothing . 
Mode l B was formulate d to distinc tly demons trate the le ve l 
of  dys funct ion in the me tastatic bre a s t  cance r patien t ,  and in this 
sense is  not re ally an ADL te s t  or evalua tion that is commonly 
emp loye d  by physical or occup ational the rapists . This  mode l was 
also  subjecte d  to e x te ns ive re vis ion , and in its final form was 
submitted to a pane l consist ing of nine re gis te re d  phys ical the ra­
pists  for final sugge s tions , e diting , and approval . 
SCORING OF THE MODELS 
The scale use d to grade patients on Mode l A for seve rity 
of  e x te nt of me tas tase s and seve rity of  s ymptomatology is  from 
ze ro to four for both parame te rs . For e x te nt o f  dise ase , a score 
o f  ze ro indicate s that no me tas tase s we re pre sent , whe re as a score 
of four demonstra te s seve re , profound , involvement of the organ or 
system . Likewise , a ze ro score on the s ymp tomatology parame te r 
indicate s no s ymptoms are pre se n t , whe re as a score of four indi­
cate s  and reports an  e x treme de gre e  of symp tomatology . 
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The two p arame te rs for one particular s i te nee d  not have 
the same score , although the y often coinc ide . For e xample , lung 
me tastase s grade two (mult ip le nodule s ,  mode rate involvement) might 
be asymp tomatic  - grade ze ro on the symptomatology parame te r . For 
some group s , such as Group V I I , Pe riphe ral Ne rvous System , and 
Group VI I I , Intraspinal Me tasta se s , the e x tent of d ise ase is d i ffi­
cult if no t impos s ible to grade c l in ically .  The re fore , patients 
with me tastase s to the se areas re ce ive d score s  on that group re fle c t ­
lng degree of s ymp tomatology only . 
For Mode l B ,  performance was grade d according to a p re ­
c ise ly de fine d system ; the scale from ze ro to four use d ve ry 
close ly paralle ls  the ze ro to four scale used in the scoring of 
the parame te rs contained within Mode l A .  For examp le , ze ro he re 
imp l ie s no problem with the ac tivity in que s t ion , and a score of 
four imp l ie s  and re fle c ts max imal ass i stance be ing re quired . The 
re ade r is  re fe rre d  to Appendix B for a comple te de script ion of 
this  ope rational mode l . 
METHODS OF PATIENT SELECTION 
Thi rty female tumor c l inic patie nts with a proven  d iagno s i s  
o f  me tas tatic b re as t  carc inoma se rve d a s  the s amp le i n  this  s tudy . 
The y we re se le c te d  from the patients be ing treated  at the chemo­
the rapy c l inic s , which are he ld in  the Tumor Clinic , located in 
the Me d ical  Colle ge of Virginia North Hosp i tal . For a 49  day 
pe riod , all me tas tatic breast  cance r patients coming to c l inic 
the ore t ically enj oye d  an equal chance of be ing inc luded in the 
s budy . The pe riod of data colle c tion was from Augus t 28 unt il 
Oc tobe r 15 , 19 7 5 . 
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The tumor c linic i s  d ivided into two maj or  div i s ions , or  
are as ;  the regular tumor c linic which se rve s anyone requiring care 
for cancer ,  mos tly me d ically indigent pe rsons ; and the private 
tumor c l in ic whe re private phys ic ians care for me tas tatic cance r 
p atients . E ach tumor c l inic see s both ambulatory and non-ambulatory 
patients . This  particular separation o f  patients into tumor c l inic 
and private tumor c linic will be important during data analys i s , 
and will  be explaine d more ful ly in Chapte r Four . 
The me thod of  patient se le c t ion was as follows : tumor 
c l inic charts (records)  we re re viewe d  as  the patie nts  came through 
in the course of re ce iving tre atme nt for the ir  dise ase . The name s 
and chart numbe rs of patients  hav ing breast  carc inoma we re re corde d . 
I f  two me tastatic bre a s t  cance r patients atte nded c l inic on a par­
ticular  day , both we re e valuate d for the s tudy , providing the y me t 
the e s tablishe d c r i te ria . I f  more than two patients at tende d the 
c l inic and bo th me t re se arch crite ria , a random se le c t ion of  
patients  was made . The re gular and private tumor c linics  we re 
screene d  for potential patients on a lte rnate days ; i f  no me tas ta­
tic bre as t carc inoma patients  atte nde d one divis ion on a particular 
day , the othe r divi s ion was s c reene d on that day . The 30  subje c ts 
se le c te d  cons t i tute s an accep table random samp le of  all  me tastatic 
bre as t  carc inoma pat ie nts attending the Me dical Colle ge of Virginia 
tumor c linics during the e s tablished pe riod of  data colle c tion . 
Each tentative patie nt me t the fol lowing s imple criteria , 
or we re dismissed from furthe r e valuation : patient  must  be female , 
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have a p roven d iagno s i s  o f  bre as t  carcinoma (sarcomas of the 
bre a s t  are e xc lude d) , and p re sent  with c l inical . evide nce of d i s -
seminated d i se ase (di stant  me tas tase s) , a s  de fine d i n  Chapte r  One . 
An obvious e x is t ing le ve l of dys func tion was not cons ide red as  a 
ne ce ssary crite ria for admis s ion to the s tudy . Subjects  also  did 
not have to e xhibi t  seve re me tastatic involvement and/or c ons t i tu-
t ional symptomatology . Both the patient populat ion and the sample 
the re fore cove re d a cons ide rable age range , as we ll  as scope in 
amount and type of d i s t ant  me tastatic spre ad and phys ical dys func -
tion . 
PROCEDURES IN PATIENT EVALUATION AND 
DATA COLLECTION 
Pre liminary Asse s sment  
The init ial screening was fo llowe d  by a pre l iminary patient 
information surve y which was obtaine d  from the patient T s  tumor 
c l inic record and me dical record . The purpose of thi s surve y was 
to che ck the me dical re cord for ade quate work-up , and to document 
that informat ion which would a s s i s t  1n the e valuation of the 
patie nt on the ope rational mode ls . In total 3 6  patients we re 
re viewe d  at thi s  s tage of  the data collect ion . If  a patient T s  
record demonstrate d  inade quate work-up , i . e .  outdated diagno s t ic 
proce dure s , such as bone surve y or l ive r scan pe rformed more than 
three months p rior to the date o f  evaluat ion , that patient was 
unacceptab le for the s tudy . Four charts we re found de fic ie nt 1n 
this manne r , and those patients we re droppe d from the s tudy . 
Following the record rev iew , the author me t pe rsona lly 
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with the pat ient , and the purpose s ,  me thods , p rocedure s , rationale , 
and use o f  the mate rial to be gathe re d pe rtaining to the s tudy we re 
explaine d  to the patie nt in layme n T s  te rms . Informe d consent  was 
obtaine d  in wri t ing at this time . A copy of the consent form use d 
follows Appendix E .  
The pre l iminary patient information survey is  outline d  in 
Appe ndix C .  Informat ion pe r t inent  to thi s phase o f  the s tudy 
inc lude d name , age , hosp i tal chart numbe r ,  and addre s s . Each 
patie nt was as s igned a numbe r to be used to ide nti fy he r during 
all phase s o f  the re se arch . Als o  note d was the date of bre as t  car-
c inoma d iagno s i s  (or surge ry) , an important parame te r used to 
d ivide patients  re lative to le ngth o f  d i se ase . The chart was 
rev iewe d  noting the maj or  s i te s  of  me tas tase s ,  and date s of first  
e vi dence of  d i se ase  at  thi s  s i te . Thi s  was done in orde r that the 
dise ase free inte rvall be e s timate d . The bulk of the p re liminary 
informat ion conce rne d  s ite s and date s of surgical , radiation , hor-
monal , and chemothe rapeutic  manageme nt of the b re as t  carc inoma 
me tastase s . 
The n ,  the pre l iminary func t ional clas s i fication - pe rfor-
mance s tatus  was de te rmined , us ing repre sentative cate gorie s . This 
clas s i fication is  de fine d in Appendix D ,  and was de ve loped in orde r 
to o ffe r an e asy , acce s s ible , me thod o f  de scrib ing the func tional 
lDe fine d , for purpose s of this s tudy , as the length o f  
t ime be twe e n  bre a s t  cance r d iagno s is and the fir s t  evide nce of  
d i stant me tastatic dise ase . 
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leve l o f  the patient . Th i s  pe rformance s tatus grade , with modifi­
cations , i s  currently in use  by the Cance r Rehab ilitat ion Project  
o f  the Medical Colle ge of  Virginia Hosp i tal s . Thi s  s tudy in part 
has a t temp te d  to validate the use · of this  class i fication in de scrib ­
ing the pe rformance s ta tu s  o f  cance r patients i n  ge ne ral . Each 
patie n t  was also  class ified according to the rehab i litation goals 
that  would be chosen as part of the tre atment plan . All patie nt s  
by de finit i on , fall into group B or C ,  a s  outlined i n  Append ix E .  
Las tly , the type of  p r imary c ance r was no ted and recorded , i f  this  
informat ion was availab le . 
Pat ie nt Evaluation - Mode l B 
The ne x t  phase of  the data collec tion involve d  the evalua­
tion and scoring  of the p at ient on Mode l B ,  the Leve l of Func tional 
Disab i l ity  Ope rat ional Mode l . I t  was dec i de d  that Mode l A scoring 
would follow Mode l B scoring , and not the reve rse . In this  way , 
any b i as conce rning the func tional s tate o f  the patient  would be 
kep t  to a minimum . For e x ample , i f  a patient was scored  firs t on 
Model A and she achieved a high score re fle c ting a gre at amount of  
me tasta t ic d i se ase , one might tend to view or score he r as be ing 
more pote n tially dys func tional . 
In total , 3 2  patients  we re revie we d  and examined at  this 
s tage of the data colle c t ion . Two patients we re found unusable 
for furthe r progre s s ion through the s tudy : the firs t due to volun­
tary withdrawal during the asse ssment of  func tional disabil ity , 
and the se cond due to coe x is t ing d i se ase which rende red he r 
unacceptable . 
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The e quipment and space nee de d  to c onduct the Mode l B 
evalua�ion we re p rovided by  the tumor c l inic . Several rooms we re 
available for patient  e valuation , whe n the y we re no t be ing utili ze d  
for patient  v i s i ts . Each was e quipped with a s tandard hosp i tal be d , 
a cha ir , and door . In one of  the se rooms , a patient toile t  was 
locate d , e quippe d in the usual manne r .  Staircase s for a s se s sme nt  
on Group VII  o f  Mode l B we re within e as y  acce ss . Any article s , 
i . e .  comb , b rush , towe ls , handc loth , e tc . which we re nee de d  were 
grac iou s ly p rovide d  by the tumor c linic s taff . For ambulatory 
patients , a comfortable chair  and the ne arby bed we re the maj or 
e quipment ne ce s sary . 
Thi s  phase was be gun with a pe riod of  conve rsation with 
the patien t , lasting approximate ly 30  minute s .  Maj or top ics  cen­
te re d on the patient T s fee l ings about he r dise ase , and ge ne ral ab i l ­
i ty to manage in  the home s ituat ion . Much conce rning the tentat ive 
func t ioning le ve l  and ability  of the se patients could be disce rne d 
during this  pre l iminary inte rview . During this t ime the purpose s 
and me thods o f  the re se arch we re again e xplaine d to the patient . 
The ac tual a s se ssment  and scoring of  Mode l B ,  was done 
s tarting with Group I (fe e d ing) and proce e d ing to the end . The 
patient was carr ied  through many of  the activi t ie s  with modifica­
t ion ; for e x ample , the ab i l i ty to re ach the fee t ,  back and e x trem­
i t ie s  with a handcloth with appropriate washing mot ions was the 
proce dure for as se s s ment  on Group V (Bathe s Se l f) . In add i t ion to 
the ac tual obj e c t ive scoring , the patients we re ve ry willing to 
out line a re as whe re the y nee ded  as s is tance . Thus , the patient T s 
ve rbal re sponse s corroborate d the obje c t ive re sults of  the te s ting . 
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tn almos t all case s , a spouse , family  membe r ,  o r  friend who knew 
the pat ient we ll  accompanied he r to the tumor c l inic and was p re ­
sent during the e valuation ; this  pe rson was he lpful in corroborat-
1ng the ac tivity leve l of the patients . Each patient  was score d  
according t o  the scale given in the introduction to Mode l B .  At 
the conc lusion o f  the evaluation , e ach group of the mode l was 
s ucce s s ive ly  re viewe d  with the patient , to assure a re l iable asse s s ­
men t  of  her level o f  dys func t ion . The pat ient was then dismi s se d . 
All patients that we re e xamine d  and e valuate d for the s tudy we re 
thoroughly coope rative and s e ve ral e xpre ssed  intere s t  in the out­
come of the s tudy . 
Pat ient Evaluat ion - Mode l A 
The nex t  phase , the longe s t  and mos t  involved , was the 
scoring o f  the patient on Mode l A ,  the Extent of  Me tastase s 
Ope rational Mode l . Thirty patients were carried through this 
s tage of the data colle c t ion , and this  con s t itute d the samp le s ize 
used in the s tudy , N=3 0 . The tumor c l inic re cord and the med ical 
record of the patient we re again rev iewe d ; if not alre ady in the 
tumor c l inic , the me dical re cord was made available from the 
Department  o f  Medical Records . This  stage of the re se arch project  
incorporated evaluat ion and p re c i se asse s sment of the patient as  
a whole , with spec i fic emphasis  on the e ffec ts o f  the s i te s  of  the 
cance rous me tas tase s in e ach pat ie nt . 
Maj or me tas tatic s i te s  be ing note d , the patien t was score d  
according t o  the guide l ines given i n  Model A (Appendix A) . Radio­
graphs we re obtainab le for most  patients from the hosp i tal X- ray 
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Department . Radiographs i n  the form of  che s t  films , PA and late ral 
views , and the s tandard bone surve y (skull , ve rtebral  column , and 
pelvis)  we re mos t  fre quently neces sary for comple te pat ient asse s s ­
ment . 
Che s t  radiographs d i splaye d pulmonary me tas tase s and p leural 
e ffus ions , and the se we re graded according to crite ri a  se t forth in 
Model A .  Dr . Harold Floyd o f  the Departme nt o f  Radiology provided 
much initi al and continuing as s is tance in the inte rpre tation o f  
the se films . Unfortunate ly , radiograph inte rpre tation is  all too 
often e quivocal , e spe c ially be tween two or more radiologi s t s , and 
fine d i s t inc t ion and j udgments are d i fficult and approximate . I t  
i s  also  true that pulmonary me tas tase s may be p re sent but not be 
demons trated on radiographs . 
Bone surve ys we re performe d on all but four patie nts in the 
s tudy , and the se too we re inte rpre ted and graded according to 
c ri te ria in Group IV of  Mode l A .  Not only the prese nce o f  me tas ­
tase s in the bone , but also the frequency o f  occurrence at e ach 
s i te , and pre dominant type o f  invo lvement  we re re corde d . The fre ­
quency of me tastase s to various bone s ite s is  a s tat i s t ic of 
inte re s t  to physic ians de ciding which bone s to surve y for poss ible 
me tas tase s . (Re ade r p le ase consul t  Mode l A - Group IV) . An exce l­
lent  adjunct ive diagnos tic procedure was  bone scanning , pe rforme d  
i n  21  of the patients i n  the s tudy . The se reports we re read and 
the re sul t s  re corded and compared with those of the bone surve y . 
Live r  involvement had been de te c te d  by various p rocedure s ; 
c l inically , by palpation of a large nodular live r ,  diagnos tically , 
8 9  
b y  use o f  the l ive r scan , o r  b y  live r function te sts . Mos t  o f  the 
patie nts  having l ive r d ise ase due to me tas tatic involvement we re 
diagnosed by the l ive r s can . The advantage s and d isadvantage s o f  
this  d iagnos tic  procedure we re discussed i n  Chap te r Two . 
Brain me tas tase s we re large l y  diagnosed  by the brain scan , 
usually afte r the p at ie n t  p re sente d  with some neurological s ymptoms 
that would sugge s t  s uch a diagnos is . The me d ical record was c are ­
fully  se arched for s ymptoms re fe rrable to the l ive r or brain . 
Documentat ion on are as  of  dissemination for the remainde r 
of  the mode l were l arge ly a matte r  of  p atient  record . In all are as , 
both maj or and minor , symp tomatology for the corre sponding s i te was 
based both on me dical re cord documentation and subje ctive s tateme nts 
by the patie nt . The atte nd ing  phys ician ofte n  he lpe d In corroborat­
ing  the de gree o f  me tas tatic symptomatology e xhibited by the se 
patients . No patien ts  pre sented with spinal cord compre ss ion . 
Howeve r ,  scoring on per iphe ral ne rvous s ys tem involvement wi th 
tumor was by seve r i ty of  symptomatology produce d by pre s sure or 
obs truc t ion on the pe r iphe ral ne rve ; an anatomical score for e x te nt 
of  dise ase is  d i fficult to inte rpre t c l inically for this  cate gory . 
Dis tant lymph node involveme n t  is  also d ifficult to disce rn in the 
c l inical se t t ing , unle s s  the node s invo lve d we re supe rfic ial and/or 
suffic iently large to be palpate d d ire c tly . Skin and soft tis sue 
me tastase s we re e as ily app re c iate d c l inically by inspe c t ion , 
me asureme n t  with a calipe r ,  or palpa tion ; this was done in con­
j unct ion with the physician during routine phys ical e x aminat ion . 
Othe r organ s ite s we re indicate d  as be ing involve d  if  so 
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mentioned or  documented by patient history . The re cord was che cked  
for chemothe rapy re gime - drugs , route s and date s o f  the agent  we re 
note d . Comp l ications due to tre atme nt and vincristine neurotox icity , 
i f  p re se nt , we re among the last  parame ters  to be evaluated . In 
the se p arame te rs , sub j e c t ive informat ion was obtaine d from the 
patien t conce rning symptomatology due to tre atment e ffects , and 
mo�e obj e c tive evaluat ion , such as de cre ased blood counts and s ys ­
temic s ymptoms due to chemothe rapy o r  othe r tre atment  approache s , 
was obtaine d from the patie nt ' s  medical  and tumor c l inic re cord . 
Afte r the med ical re cord was thoroughly examined for pe rti­
nent  information applicable to Mode l A ,  i t  was  reche cked  to insure 
tha t  eve ry me tastatic s i te was de te c te d , and indicate d  on the data 
colle c tion form for Mode l A,  and given an appropriate score . At 
this time , i f  ne ce s sary , radiographs , s c an reports , and laboratory 
work , we re all re - e x amine d  for accuracy . As a final s tep  to this  
phase , the physician who e x amined and tre ated the patient on  tha t  
day was consulte d . With the phys ic ian , a brie f review of  the 
patient ' s  progre s s , he r e xte nt  of dise ase , e ffec ts of  tre atment , 
and any new deve lopme nts  we re d is cusse d in light of  the data 
require d  for Mode l A .  Any e quivocal matter pe rtaining t o  score s  
for the various  me tastatic s ite s  we re c le ared up at  this  time . 
Formal data c ol lection ended on Oc tobe r 15 , 197 5 . After 
comp le tion of  the data gathe ring proce s s , a folde r for e ach patient  
(N=3 0) was  comp i le d . This folde r containe d  Mode l A and Mode l B 
data colle c t ion forms , signe d consent forms , and pre l iminary 
p at ient  information shee t .  
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The final pha se o f  data colle c t ion was the follow up rev iew 
to covroborate the c linical condit ion re garding me tastatic disease 
for e ach patient . The tumor c l inic re cord for each patient was 
again obta ined , chie fly for the purpose of che cking the dic tation 
by the phys ic ian of the most re cent tumor c l inic visit by the 
patient . This  dictat ion contained  the mo st  re cent documentat ion of 
the patient T s me tas tase s and ge ne ral condit ion . Any data that might 
have been ove rlooke d  wa s also colle cte d at this t ime . I f  an add i ­
tional diagnost ic proce dure had been orde re d i n  the inte rim, this  
was s tudie d . Afte r all 30  re cords we re re - re viewed, score s  we re 
tallied  for the ope rat ional mode l s ,  and da ta submitted  for sta­
tis tical analys i s . 
METHODS OF DATA ANALYS IS 
Table s we re cons truc ted base d on the collecte d data . 
Eve ry patient re ce ive d  a tota l score on Mode l A and Mode l B ,  
and the se we re the maj or quantitative items of  in te re st tha t we re 
tabulate d . The major  s ta t i s t ical te st employe d wa s the Pe arson 
Product mome nt corre lat ion coe ffic ient, r , which re late d score s  
on Mode l A and score s  on Mode l B for the 3 0  patients . Patients  
we re divide d  into various group s depend ing on  se ve ral variable s . 
One divis ion separate d patients into one group comprise d  of wome n 
unde r the age of  60 , and anothe r group of  patients ove r the age of 
60 . Corre la tion coe ffic ie nts we re compare d, aga in based on Mode l 
A and Mode l B s c ore s . Al l coe ffic ients found by this analysis  
we re subje c t  to  appropriate te s ts of s ign ificance . 
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Two separate groups we re then forme d of patients hav ing 
the ir  d i se ase le ss  than or more than 3 . 3  ye ars (40 months) . A 
second pairing was obtaine d by dividing the patients according to 
whe the r the i r  d i se ase free inte rval was le s s  than or more than two 
ye ars (24  months) . A third pairing was based on duration of me ta ­
s tatic d i se ase . Ano the r d ivis ion separate d private from regular 
tumor c l inic patients . For each of  the se groups me nt ione d above 
that was fo rme d , Mode l A and Mode l B score s  we re comp iled , and for 
e ach group a corre lat ion coe ffic ient was ob taine d , re lating Mode l 
A with Mode l B .  The se we re the n analyzed for prope r le ve ls of 
s igni ficance . 
In a fi fth comparison , patie nts we re also groupe d accord­
lng to maj or s i te s of  me tastatic involvement , and the se re sults 
ana lyze d .  In this  way , a corre lat ion coe ffic ient was ob ta ine d 
re lat ing Mode l A score s with Mode l B score s  for all pa t ie nts  
e xhibit ing lung me tas tase s , anothe r for all  patients ha rboring 
ple ural e ffus ions , e tc . 
A freque ncy distribut ion of the 30  patie nts  ove r S lX cate ­
gorie s of  func tional status , as de fine d In Appe ndix D ,  is  re porte d 
and te s ted  by the Chi Square Goodne s s - of-Fit te st . Fina lly , 
se ve ral addit ional table s and two figure s outl ine variable s such 
as chemo the rapy , rad iat ion , type of mas te c tomy , othe r surgical 
tre a tment , pathologic al c lassification , and freque ncy of me tastase s 
to various o s se ous s i te s . 
9 3  
SUMMARY 
This  chapte r has outline d the me thods , subjec ts , mate rial , 
and proce dure s utilize d  in the unde rtaking of this  res e arch pro-
je c t . The construc tion , approval and validat ion of the two ope ra-
t ional mode ls use d in data colle c t ion we re summarize d . The me thods 
of patient se le c t ion for the s tudy we re de l ine ated , along with an 
explanation of the crite ria use d to d iscard patients that we re 
unaccep table for the s tudy . The ac tual proce dure s in patient eval-
uat ion and data colle c t ion cons ti tute d five maj or phase s  pe rforme d  
i n  the fol lowing orde r : 
1 .  ini tial screening to identify the me tastatic bre as t  
cance r patients 
2 .  pre liminary patie nt evalua tion and background 
information 
3 .  consent ha ving bee n  obtained , patient evaluat ion 
and scoring on Mode l B 
4 .  pat ient evaluation and scor ing on ope rational 
Mode l A 
5 .  re v iewing of  e ach tumor c l inic and me dical re cord 
to as sure accurate colle c tion of all nece s sary data . 
The chap te r conc lude d with a brie f outl ine of the me thods 
of data analys is . 
Chap te r 4 
RESULTS OF THE STUDY 
The re sul ts of the e valuation of the patie nt sample mode ls 
and parame te rs discusse d in Chap te r Three will be summarize d  in 
the fo llowing orde r : 
1 .  Total score s  on Mode l A and Mode l B for all patien ts . 
2 .  Mode l A and Mode l B d ivided by inc lusive group lngs for 
the following parame te rs : age , length of disease , 
le ngth of dise a se free in te rval , duration of me tas ta t ic 
d ise ase , and c l inic attende d . 
3 .  Mode l score s and charac te r i s t ics  for s ix ma j or ind i­
vidua l s i te s o f  me tastase s .  
4 .  D i s tribut ion of patients ove r s ix func tional class ifi­
cation cate gorie s . 
5 .  Re late d charac te ristics  of  the samp le . 
6 .  Fre que nc y  of  spe c ific disab i l i t ie s . 
MODEL A AND MODEL B TOTAL SCORES 
Thirty patie nts we re evaluated according to the me thod and 
se quence de scribe d in Chap te r Three . The se patients repre se nte d 
the population of  all me tastatic breast  carc inoma patients  attend­
ing the Me dica l  Colle ge of  Virginia Tumor C l inic ove r a spe c i fied 
t ime le ngth . Table 3 give s the to tdl Mode l A and total Mode l B 
score s for e ach of  the patients in the sample . Mode l A score s 
Tab le 3 
Score s on Ope rat iona l Mode ls A and B 
All Patients N = 30  
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Pat ient Mode l A Mode l B Patient Mode l A Mode l B 
# 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12  
13  
14  
15 
Total Score To tal Score # Total Score Total Score 
Me an 
Me dian 
38  
2 4  
13 
2 4  
30  
10 
1 7  
1 1  
3 1  
9 
2 2  
6 
10 
13  
21  
Mode l A 
1 7 . 0  
14 . 0  
4 6  
18 
0 
20  
2 
5 
8 
5 
3 3  
6 
14  
2 
2 
7 
5 
1 6  
17 
18 
19 
20  
21  
2 2  
2 3  
24  
25  
2 6  
27 
28 
29  
30  
19 
13 
7 
2 7  
2 3  
1 2  
5 
15 
30 
11 
1 3  
1 5  
21  
12  
8 
Mode l B 
9 . 3 3 
6 . 0  
Corre lation coe ffic ient be tween Mode l A and Mode l B 
For sample ; r = . 7 5 5 1  s i gn ificant at p = . 0 001  
3 
8 
1 
11 
9 
1 
1 
10 
24  
3 
13 
2 
6 
5 
7 
9 6  
could the ore tically range from ze ro to 160 , de pending on the num-
be r of  s i te s  of d i s tant me tas tase s ;  highe r score s repre sent a 
gre ate r e x te nt of  d i sease . Mode l B score s could range from ze ro 
to 60 , depending on the e x te nt of func tiona l disability ; highe r 
score s re pre se nt a gre ate r de gree of phys ical dysfunc tion . 
Score s on Mode l A range d from five to 38 , with a me an of 
17 . 0  and a me dian of 14 . 0 .  Score s for Mode l B ranged from ze ro to 
46  with a me an of 9 . 3 3 and a me dian of 6 . 0 .  Only two pa t ients 
score d  highe r on Mode l B than the y did on Mode l A ;  the y we re 
patient # 1 ,  and patie n t  # 9 .  The corre lation coe ffic ient , from 
this point  on re fe rre d to as r , was . 7 551  for the patient samp le . 
This  is  a highly s ignificant corre lat ion at p = . 0 001 . �e corre -
lation coe ffic ient computed  for this samp le , and for all othe r 
groups in this  re se arch , is  one which re la te s  score s attaine d on 
Mode l A with those at taine d on Mode l B .  
Age Fac tor 
MODEL A AND MODEL B SCORES AND 
CORRELATION COEFFIC IENTS FOR SELECTED GROUPS 
The s amp le was d ivide d into groups based  on se le cte d  
variable s o f  inte re s t . The first o f  the se , age , is  depicte d  ln 
Tab le 4 .  The age range of  the full patient s amp le was 3 6  to 8 2 , 
wi th a me an of 58 . 1 6 and a me dian o f  5 9 . 5  ye ars . Al though this 
range is  comparable to large se rie s  of breast  carc inoma patient s , 
the me an age is  somewha t highe r . 
Corre lation of  Mode l A and Mode l B .  S ixteen patients were unde r 
the age of  60 , thi s group was de s ignated Group Y ,  i ts membe rs 
Table 4 
Analys is  o f  Score s on Ope rational Mode ls A and B - Divis ion by Age 
Group Y Pat ie nt s  Unde r Age 60  
Pat ie nt # Age 
22  3 6  
19  42  
25  45  
10  47 
13 47 
18  5 1  
2 3  5 1  
11 5 2  
15 5 2  
1 5 3  
4 5 3  
3 54  
7 54  
28  5 6  
5 5 8  
1 7  5 9  
N = 1 6  Me an 5 0 . 5 2 
Me dian 5 2  
r = . 7 1 9 9  p = . 0 019  
Mode l A 
Score 
5 
2 7  
1 1  
9 
10  
7 
15  
22  
2 1  
38  
24  
13  
17  
2 1  
3 0  
1 3  
17 . 68 7  
1 6 . 0  
Mode l B 
Score 
1 
11  
3 
6 
2 
1 
10  
1 4  
5 
4 6  
2 0  
0 
8 
6 
2 
8 
8 . 9 3 7  
6 . 0  
Group 0 Patients Ove r Age 60 
Patient # Age 
2 60 
14 60 
2 1  60  
2 7  61  
9 62  
16  62  
6 63 
24 65 
30 65 
20 68 
8 7 2  
2 9  7 6  
1 2  7 9  
2 6  8 2  
N = 14 Me an 6 6 . 7 8  
Median 6 4  
r = . 8 2 69 p = . 0 005  
Mode l A 
Score 
2 4  
1 3  
1 2  
1 5  
31  
1 9  
1 0  
30  
8 
2 3  
11  
1 2  
6 
1 3  
1 6 . 214  
13 . 0  
Mode l B 
Score 
18 
7 
1 
2 
3 3  
3 
5 
24  
7 
9 
5 
5 
2 
13  
8 . 9 3 3  
6 . 0  
Diffe re nce be twe e n  Group Y and Group 0 me ans ; for Mode l A not s igni ficant , t = . 4 68 2 ;  for Mode l B 
not s igni ficant , t = . 0 011  Alpha = . 0 5 
\D 
....... 
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having a me an age o f  50 . 62 ,  a me d ian of  5 2 , and a range from 3 6  to 
59 . This  me an and range are compatible to large se rie s of breast  
carcinoma patients . The me an score for Mode l A for Group Y was 
17 . 68 7 , and for Mode l B ,  8 . 9 37 . The corre lation be tween Mode l A 
and Mode l B score s for Group Y �atients younge r than age 60) was 
r = . 7 1 9 9 , a value s i gnificant at p = . 0 0 1 9 . 
Group 0 was comprise d  of patients aged 60 or ove r ;  14  
patie nts made up this  part ic ular group . Age s and mode l score s  for 
the se patie nts are shown in the right ha lf of Table 4 .  The me an 
age was 6 6 . 7 8 ye ars , with a me d ian of 64 ye ars . The me an score for 
Mode l A was 1 6 . 214 ; and for Mode l B ,  8 . 9 3 3  for this group . The com­
pute d corre lation coe ffic ient  was r = . 8 629 , and was s ignificant at 
p = . 0 005 . 
Comparison of Age Group Me ans . A s tatis tical te s t  was employe d to 
de te rmine if the d iffe rence s be tween Group Y and Group 0 me ans for 
Mode l A and Mode l B we re s igni ficant . For Mode l A ,  a s tude nt T s  t 
te s t  was pe rforme d on the diffe re nce be tween Group Y and Group 0 
me ans ; t = . 4 68 2 ,  which was not s ignificant at alpha = . 0 5 ,  and 28 
de gre e s  o f  free dom . Likewise , for Mode l B ,  the same te s t  yie lde d a 
t value of . 0011 , which was not s i gnificant at alpha = . 0 5 .  
The te s t  for homogene i ty of corre lat ion coe fficients was 
appl ied in orde r to de te rmine i f  the coe ffic ie nts found diffe r 
s ignificantly for the two groups . This te st  transpose s the r T s 
algebraica lly into the normally d i s tribute d Fi sche r T s  Z value . For 
r = . 7 19 9  and r = . 8 2 6 9  for Groups Y and 0 re spe c t ive ly , the dif­
fe re nce was not s ignificant ; Z = . 6 6058  and alpha = . 05 .  
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Le ngth of Dise ase Fac tor 
The patient  s ample was also divide d into two group s based 
on length of d isease , which was the pe riod from the date of  diag­
nos is or radical mas te c tomy , to the date of the evaluation for the 
s tudy , expre ssed  in months and ye ars . For mos t  patients , the date 
o f  radical maste c tomy , or  in case s whe re this surge ry was no t pe r­
forme d , the date o f  primary de te c t ion or treatmen t  was taken as  
the approximate date of  diagnos is  o f  breast  carc inoma . S ince for 
mos t  patients , the e x ac t  date of  de te ction is  unknown , we assume 
that the date o f  primary tre atment i s  a re asonable e s t imate of this 
parame te r .  
Table 5 shows the score s  for Mode l A and Mode l B div ided 
into two group s , base d on le ngth of d ise ase . Group S ,  the le ft 
s ide of Table 5 ,  was compose d of patien ts having the ir  d i se ase 
le ss  than 3 . 3  years ; N = 1 3 . The range in le ngth of  dise ase was 
from five months ( . 4 2 ye ars)  to 39 months (3 . 25 ye ars) wi th a me an 
of 21 . 4  months (1 . 7 8 ye ars) and a me dian of 2 0  months (1 . 6 6 ye ars) . 
The ave rage score s for Mode l A and Mode l B for Group S we re 14 . 38 
and 7 . 5 4 re spe c t ive ly . By inspe c tion , the se score s  are somewhat 
lowe r than the ave rage score s  for the total s amp le ; r = . 6948 was 
s ignificant at p = . 0 0 8 3 . 
Group L patients , the ir length of d ise ase and mode l score s , 
are de scribed in the right half of Table 5 .  This group numbe re d 
1 7  patients ; me an length of d ise ase was 7 2  months (six ye ars) , 
with a range o f  43  months (3 . 5  ye ars) to 1 2 0  months (ten ye ars) . 
The ave rage Model A score was 19 . 0  and the ave rage Mode l B score 
Table 5 
Analys is  of  Score s  on Ope rat ional Mode l s  A and B - Divis ion by Dise ase Pe riod S ince Biagnosis  
Group S Patients Having Dise ase Group L Patients Having D ise ase 
< 3 . 3  Ye ars 140 months) > 3 . 3  Ye ars (40 months) 
Patie nt Length of Dise ase * Mode l A Mode l B Patient  Length of  Dise ase * Mode l A Mode l B 
# Months (Ye ars) 
4 5 ( . 42)  
12  8 ( . 6 6) 
2 2  10 ( . 8 3) 
2 12  (1) 
1 0  1 4  (1 . 1 6) 
11  2 0  (1 . 6 6) 
1 3  20  (1 . 6 6) 
8 25  (2 . 1) 
1 6  2 7  (2 . 25 ) 
2 7  27  (2 . 7 5 ) 
2 6  3 3  (2 . 7 5 )  
1 5  3 9  (3 . 25 ) 
3 0  3 9  (3 . 25)  
N = 1 3  Me an 21 . 4 6 (1 . 7 8)  
Me dian 20  (1 . 6 6) 
r = . 6448 p = . 0 0 8 3  
Score 
24  
6 
5 
24  
9 
2 2  
10 
11 
19  
15  
1 3  
21  
8 
14 . 38 
12  
Score # Man ths (Ye ars) 
20  25  43  
2 2 8  44 
1 5 45 
1 8  21  45 
6 3 4 6  
14  9 5 7  
2 17  60 
5 19  60 
3 29  7 2  
2 24  7 3  
1 3  2 3  8 5  
5 7 8 7  
7 14 8 7  
1 9 3  
18 9 6  
6 111 
20 120  
7 . 5 4 N = 17  Me an 7 2  
5 Me dian 7 2  
(3 . 58)  
(3 . 6 6) 
(3 . 7 5 ) 
(3 . 7 5 ) 
(3 . 8 3 )  
(4 . 7 5 )  
(5) 
(5) 
( 6) 
(6 . 08 ) 
(7 . 08 )  
( 7  . 25)  
(7  . 25)  
(7 . 7 5 )  
(8) 
(9 . 25 ) 
(10) 
(6) 
(6) 
r = . 7 7 9 4  p = . 0 004  
Diffe rence be tween  Group S and Group L me ans ; for Mode l A not s ignificant , t = 
not s igni ficant , t = . 7 8 69 Alpha = . 05 
*Ye ars in parenthe se s 
Score 
11 
21  
30  
12  
13  
3 1  
13  
2 7  
1 2  
3 0  
15 
17 
13  
3 8  
7 
10  
2 3  
19 . 0  
15 
Score 
3 
6 
2 
1 
0 
3 3  
8 
11 
5 
24  
10 
8 
7 
4 6  
1 
5 
9 
10 . 5 3 
7 
1 . 5 198 ; for Mode l B 
f-' 
Cl 
Cl 
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was 10 . 5 3 .  By inspe c tion the y are s l i ghtly highe r than the 
ave rage score s for the full  patient  sample (Table 3) . The corre la­
t ion be tween  mode l score s  for Group L was . 7 7 9 4 , a value s igni fi­
cant at p = . 00 0 4 . 
In re lation to Mode l A ,  the pe rson having breast  carc inoma 
le ss  than 3 . 3  ye ars score d  on the ave rage 4 . 6 points  be low the 
woman having he r d ise ase longe r than 3 . 3  ye ars . The diffe rence , 
howe ve r ,  was not s ignificant at alpha = . 0 5 ;  t = 1 . 5198 . In 
re fe re nce to Mode l B ,  the pat ie nt hav ing bre as t  carcinoma le s s  
than 3 . 3  ye ars attained a score three points lowe r than that 
attained by a woman having he r disease longe r than 3 . 3  ye ars . 
He re too the d i ffe re nce was not s igni ficant ; t = . 7 8 69 . 
As in the pre v ious tab le , a te s t  for homoge ne ity of  cor­
re lation coe ffic ients  was appl ie d  to r = . 69 48 (Group S) and 
r = . 7 7 9 4  (Group L) . The d i ffe rence be tween the corre lations was 
not s igni ficant at alpha = . 0 5 le ve l ; Z = . 45 100 . In summary , 
then , both groups - those having the ir  d i se ase le ss  than 3 . 3  ye ars 
or more than 3 . 3  ye ars - reporte d  s i gn ificantly high corre lation 
c oe ffic ients , that for Group L be ing s lightly highe r , but the dif­
ference be tween them was not s igni ficant . 
Dise ase Free Inte rval Fac tor 
The sample was divide d  to de te rmine if  the le ngth of  the 
disea se free inte rval had any e ffe ct  upon the me an score s  of  Mode l 
A and Mode l B or the re lat ionship be tween the two mode ls . The 
d i se ase free inte rval , that pe riod be tween d iagnosis  and time of  
evide nce of first  dis tant recurrence , is  a fac tor that has bee n  
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corre lated in the past  with longe r  survival t ime s , le s se r  morb id i ty , 
be tte r  re sponse to various tre atments , and ove rall brighte r prog­
nos i s  for various type s of cance r .  
Tab,le 6 give s the score s  for patients based on whe the r  the 
disease free inte rval i s  le s s  than two ye ars (Group F) or longe r 
than or  e qual to two ye ars (Group G) . Each group containe d 15 
patie nts . The le ft s ide of  the table shows analyse s of mode l 
score s for Group F ;  o f  imme diate inte re s t  is  the fact that for two 
patie nts , the re was no DF! (dise ase free inte rval) , or in e ffe c t , 
the re was d i s tant spre ad at the time of ini tial d iagno s i s  for the se 
patients . The me an value for the DF! was only 8 . 4  months ( . 7 0 
ye ars) for this  group , with the me dian of 5 mon ths ( . 42 ye ars) 
be ing more indicative of the bre v i ty of the pe riod without c l in­
ically ac tive d i se ase . This  is in sharp contrast  to Group G ,  
whe re the DF! ave rage d  ove r four ye ars . (See Tab le 6) . 
For Group F ,  the me an Mode l A score was 1 6 . 6 , and the me an 
Mode l B score was 9 . 7 3 . Thi s i s  a peculiar find ing , the forme r 
be ing smalle r and the latte r la rge r than the re spe c tive full sam­
ple me ans for the mode ls . Howe ve r ,  the y diffe r ve ry little from 
the se me ans . For Group F ,  r = . 8 417  was highly significant at  
p = . 00 0 2 ; this  was highe r than the corre lat ion found for Group G 
(r = . 65 99 ) . 
Group G ,  dep i c ted  in the right half of  Tab le 6 ,  de scribe s 
the score s for those patients with a DF! longe r than or e qual to 
two ye ars . The DF! ranged  from 24  months (2 . 0  ye ars) to 81  months 
(6 . 7 5 ye ars) , with an ave rage of 48 . 6 6 months (4 . 05 ye ars) and a 
Tab le 6 
Analys is  of  Score s  on Ope rat ional Mode ls  A and B - Divis ion by D i se ase Free Inte rva l 
Group F Pat ients Hav ing Dise ase Free 
Inte rval < 2 Ye ars (2 4 months� . 
Dise ase Free 
Pa t ient Inte rval* 
# Months (Ye ars) 
1 0 (0) 
2 7  0 (0) 
2 1 ( . 08)  
22  2 ( . 1 7 )  
4 3 ( . 25)  
8 4 ( . 3 3 )  
2 6  4 ( . 3 3) 
1 2  5 ( . 42)  
10 10 ( . 8 3 )  
1 5  1 2  (1 . 0) 
25 1 2  (1 . 0) 
13  15  (1 . 25 ) 
1 6  15  (1 . 25 ) 
11  20  (1 . 67 ) 
28  2 3  (1 . 9 2) 
N = 15 Me an 8 . 4  
Me dian 5 
( . 7 0) 
( . 42)  
r = . 8 417  p = . 0 0 0 2  
Mode l A 
Score 
3 8  
1 5  
2 4  
5 
24  
11  
13  
6 
9 
21  
11 
10  
19  
22  
21  
1 6 . 6  
15  
Mode l B 
Score 
4 6  
2 
18 
1 
20  
5 
1 3  
2 
6 
5 
3 
2 
3 
14 
6 
9 . 7 3  
5 
. 
Group G Patients Hav ing Dise ase Free 
Inte rva l > 2 Ye ars (24 months) 
D i se ase Free 
Pa t ient Inte rval* 
# Months (Ye ars) 
2 1  2 4  (2 . 0) 
3 0  3 0  (2 . 5) 
1 9  3 1  (2 . 58 ) 
5 3 9  (3 . 25 ) 
17  41  (3 . 42 )  
2 3  44 (3 . 6 7 )  
2 4  44  (3 . 67 )  
3 48 (4 . 0) 
9 5 4  (4 . 5 ) 
20  5 6  (4 . 67 ) 
7 5 7  (4 . 7 5 ) 
6 60 (5 . D )  
14 60  (5 . 0) 
29  61  (5 . 1) 
18 81 (6 . 7 5) 
N = 15 Me an 48 . 6 6 (4 . 05)  
Me dian 48 (4 . 0) 
r = . 65 9 9  p = . 0 0 7 4  
Mode l A 
Score 
12  
8 
2 7  
30  
13  
15  
30  
13  
3 1  
2 3  
1 7  
1 0  
1 3  
1 2  
7 
17 . 4  
13  
Diffe rence be tween Group F and Group G me ans ; for Mode l A ,  t = . 2 55  not  s i gnificant at  
alpha = . 0 5 ;  for Mode l B ,  t = . 2 6 2  not s ignificant at alpha = . 0 5 
*Ye ar give n in parenthe se s  
Mode l B 
Score 
1 
7 
11 
2 
8 
10 
24 
0 
3 3  
9 
8 
5 
7 
5 
1 
8 . 7 3 4  
7 
I-' 
o 
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median o f  48  months (4 . 0  ye ars) . The me ans for Mode l A and Mode l 
B score s  we re 1 7 . 4  and 8 . 7 3 4 re spe c t ive ly .  He re the s i tuation is  
the reve rse of  that for Group F ;  now the Mode l A me an is  large r  
and the Model B me an smalle r than the full  s ample me ans (17 . 0  and 
9 . 3 3) . Again , howe ve r ,  the d i ffe rence is only s light . For this 
group , r = . 65 9 9 , which was s igni ficant at p = . 0 0 7 4 . 
The t te s t  re ve ale d  that the d i ffe rence s be tween Group F 
and Group G me ans for the ope rational mode l score s  we re not s ig­
n ificant at  the . 05 le ve l ; the te s t  s tatistics  we re t = . 2 55  for 
Mode l A and t = . 2 62  for Mode l B .  Las tly , the te s t  for homoge ­
ne ity of c orre lation coe ffic ients  was pe rformed ; Z = 1 . 0 63 7 , was 
not  s igni ficant at  alpha = . 0 5 ,  even though at  firs t glance the re 
appe ars to be a c ons ide rable d iffe re nce be tween the corre lation 
coe ffic ients  obtained for the two groups . 
Dura t ion of  Me tastatic Dise ase 
Although not spe c i fically use d to te s t  the hypothe se s out­
l ine d in Chapte r One , the durat ion of me tas tatic disease  is  one 
concep t  which i s  c lose ly re lated to the dise ase free inte rval . I f  
for e ach patient  the d i se ase  free inte rval is  subtracted  from the 
total length of  d i se ase , the re sult is  the durat ion of  me tastatic 
d i se ase for that patient . Table 7 give s the score s for patients  
based  on  the durat ion o f  the c l inical me tas tatic proce ss . The 
le ft half of Table 7 l i s ts the score s  for Group M ,  those patients 
having a duration of  me tastatic d ise ase le s s  than 1 . 5  years . The 
me an duration was 6 . 5  months ( . 5 4 ye ars) with a median of 5 . 5  
months ( . 4 6 ye ars) . The ave rage Mode l A and Model B score s  we re 
I Table 7 
Analys i s  of  Sc,ore s on Ope rational Mode ls A and B - Division by Duration of Me tastatic Disease 
Group M Patients Having Me tas tatic Dise ase Group N Patie nts Hav ing Me tastatio Dise ase 
< 1 . 5  Ye ars (18 months) 
Duration of* 
Patie nt Me tastatic Dise ase 
# Months (Ye ars} 
11 0 (0) 
3 2 ( . 17 )  
4 2 ( . 17 )  
1 2  3 ( . 25)  
9 3 ( . 25)  
10  4 ( . 3 3) 
1 3  5 ( . 42)  
5 6 ( . 5) 
2 2  8 ( . 67 )  
3 0  9 ( . 7 5) 
2 9  1 1  ( . 9 2) 
2 1 1  ( . 9 2 
1 6  1 2  (1 . 0) 
18 15 (1 . 25 ) 
N = 14  Me an 6 .  5 
Median 5 . 5  
( . 5 4) 
( . 4 6) 
r = . 8 2 6 6  p = . 0 005  
Mode l A 
Score 
2 2  
1 3  
2 4  
6 
3 1  
9 
10 
3 0  
5 
8 
1 2  
2 4  
1 9  
7 
15 . 7 1 
1 6  
Mode l B 
Score 
14  
0 
20  
2 
3 3  
6 
2 
2 
1 
7 
5 
18  
3 
1 
8 . 14 
6 . 5  
� 1 . 5  Ye ars (18 months) 
Duration of* 
Patient Me tas tatic Dise ase 
# Months (Ye ars) 
1 7  19  (1 . 5 8)  
2 8  2 1  (1 . 7 5 )  
8 21  (1 . 7 5) 
2 1  2 4  (2 . 0) 
2 7  2 7  (2 . 25 ) 
1 4  2 7  (2 . 25 ) 
15  27  (2 . 25)  
24  29  (2 . 42)  
2 6  2 9  (2 . 42)  
1 9  2 9  (2 . 42)  
7 3 0  (2 . 5) 
25  31  (2 . 5 8) 
2 3  41 (3 . 42)  
6 5 1  (4 . 25 ) 
20  64  (5 . 3 4 ) 
1 9 3  (7 . 7 5 )  
N = 1 6  Me an 35 . 2  
Median 29  
(2 . 9 3) 
(2 . 42)  
r = . 8 7 07 p = . 0 004  
. Mode l A 
Score 
1 3  
21  
11  
1 2  
15 
1 3  
21  
30  
13  
27  
1 7  
1 1  
15 
10 
23 
38 
18 . 1 2 5  
1 5  
Diffe rence be tween  Group M and Group N me ans ; for Mode l A not s ignificant at alpha = . 0 5 ,  
t = . 7 7 67 ;  for Mode l B not s igni ficant at alpha = . 0 5 ,  t = . 5 5 05 
*Ye ars given in pare n the s e s  
Mode l B 
Sco re 
8 
6 
5 
1 
2 
7 
5 
24  
13  
11 
8 
3 
10 
5 
9 
46  
10 . 19 
9 . 5  
I-' 
a 
l/1 
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15 . 7 1 and 8 . 18 re spe c t ive ly ; the se do  not  di ffe r ma rkedly from the 
full patient sample me ans in Table 3 .  For thi s  group , r = . 8 2 6 6 , 
significan t  at  p = . 0 005 . 
The right hal f  of Table 7 lists  the score s for Group N ,  
those pat ients having a duration of me tas tatic d i sease longe r  than 
1 . 5  ye a�s . Thi s  duration range d from 19  months (1 . 58 ye ars) to 
9 3  months (7 . 7 5 ye ars) with an ave rage of 35 . 2  months (2 . 9 3 ye ars) 
and a median of  29  months (2 . 42 ye ars) . Patients in this group 
had c l inical ly e vide nt  me tastatic d i se ase approx imate ly five t ime s  
longe r than patie nts  in Group M .  For Group N ,  the ave rage Mode l A 
score was 18 . 1 2 5  and Mode l B score 10 . 19 .  A high corre lat ion 
coe ffic ient  was also found for this group ; r = . 8 7 0 7  was s ignifi­
cant at p = . 0 004 . Eve n though a patient  having me tas tatic d ise ase 
longe r than 1 . 5  ye ars score d  more than two points highe r on the 
e x tent of me tas tase s mode l than the patient having me tas tatic 
dise ase le s s  than 1 . 5  ye ars , the d iffe re nce was not s i gnificant at 
alpha = . 0 5 ,  (t  = . 7 7 6 7) . Nor was the d iffe re nce be tween Group M 
and Group N me ans for leve l of func tional di sability signi ficant 
at this  le ve l , (t = . 5 505) . The d i ffe re nce be tween the corre lat ion 
coe fficients  for the two groups  was not s ignificant . 
C linic Fac tor 
The samp le was d iv ide d into two groups according to the 
tumor c l in ic the patient attende d ; the analys is  is  given In 
Table 8 .  The le ft half of thi s  table shows score s  for Group P ,  
the 1 3  private tumor c linic patients . The y ave rage d  15 . 38 on 
Mode l A and 7 . 0 on Mode l B ,  score s  s l i ghtly be low the full samp le 
Table 8 
Analys is of  Score s  on Ope rational Mode ls  A and B - Div i s ion by Clinic Attended 
--- -- -- - -- - - -
Group P 
Private Tumor C l inic Patients 
Patient 
# 
6 
8 
1 0  
1 1  
1 6  
18  
19  
20  
23  
25  
2 6  
2 8  
29  
N = 13  
r = . 5 65 7  
Mode l A 
Score 
10 
1 1  
9 
2 2  
19  
7 
2 7  
23  
15  
11  
13 
21 
1 2  
Me an 15 . 3 8 
Med ian 13 . 0  
p = . 0 420 
- -- - -- -_ ..- - -
Group R 
Regular Tumor Clinic Pat ie nts 
Mode l B 
Score 
5 
5 
6 
14  
3 
1 
1 1  
9 
10  
3 
13 
6 
5 
7 . 0  
6 . 0  
Patient  
# 
1 
2 
3 
4 
5 
7 
9 
1 2  
1 3  
1 4  
15  
17  
21  
22  
24  
27  
3 0  
N = 17  
r = . 8 0 0 9  
Mode l A 
Score 
3 8  
24  
13  
2 4  
3 0  
1 7  
31  
6 
10  
13  
2 1  
13  
12 
5 
30  
15  
8 
Me an 18 . 2 3 
Median 15 . 0  
p = . 0 0 0 2  
D i ffe rence be twe e n  Group P and Group R me ans ; for Mode l A ,  t = . 9 29  n o t  s igni ficant a t  
alpha = . 05 ;  for Mode l B ,  t = 1 . 05 2  n o t  s ignificant at alpha = . 0 5 
Mode l B 
Score 
46  
18  
0 
20  
2 
8 
33  
2 
2 
7 
5 
8 
1 
1 
24  
2 
7 
10 . 9  
8 . 0  
I-' 
o 
'-.I 
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me ans , at  inspe c t ion i t  can be  see n that the me dians agreed  wi th 
the full s amp le more close ly .  The c orre lation c oe ffic ie nt found 
was . 5 65 7 , lowe r than any c ompute d for dny of the othe r groups in 
this  discuss ion , but s ti ll s ign ificant at p = . 0420 . 
Score s are shown in the right ha lf of Table 8 for Group R ,  
the 1 7  re gular tumor c linic p at ients . The me an Mode l A sc ore here 
was 18 . 2 3 ,  and Mode l B score 10 . 9 ,  both slightly highe r than the 
full sample me ans o f  the re spe c t ive mode ls . A highe r coe fficient  
be tween  mode ls was  found he re ; r = . 8 0 0 9  was s ign ificant at p = 
. 00 0 2 . 
A patie n t  in the private tumor c l inic score d on Mode l A an 
ave rage of about three points be low a patie nt from the re gular 
tumor c l inic . Conce rning the score for func t ional disability 
(Mode l B) , aga in a patient from the private tumor c linic score d 
approx imate ly thre e points be low a pa t ient from the re gular tumor 
c l in ic . Ne ithe r of the se d i ffe rences  be tween me ans was s ignific ant 
at accepte d  leve ls . 
The te s t  for homogene ity of corre lat ion coe fficients was 
app lie d  to the two groups ; in spite of a d iffe re nce (ari thme ti-
ca lly) o f  ove r . 2  be tween the r T s  for Group s P and R ,  the dif-
fe re nce was not  s igni ficant (Z = 1 . 0 6 3 7 ) . 
SCORE ANALYSES AND CORRELATION COEFFIC IENTS 
FOR S IX MAJOR S ITES OF METASTASES 
Me an mode l score s , appropriate corre lations , total and 
me an s i te s  of me ta s tase s ,  and othe r charac te ris tics  will be out-
l ined for the following maj or site s  of  me tas tase s :  lung , pleura , 
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bone , live r , brain , d is tant lympha t ic , and skin and soft tissue . 
Lung Me tas tase s 
Pat ie nts  hav ing lung me tas tase s from the ir bre ast  carc i ­
noma are l is te d  i n  Table 9 .  This  group was comprised of 11 
(3 6 . 67%) subje c t s ; of  tho se 11 , four ( 3 6 . 4%) exhibite d  uni late ral 
me tas tase s ,  and se ve n  ( 63 . 6%) b ilate ral pulmonary me tas tase s .  The 
total s ite s of  me tastase s is  that numbe r obta ine d by add ing all 
maj or and minor s ite s of c l inical  me tas tase s . For the full patient 
sample the mean was 2 . 8 6 ,  wi th a ran ge of one s ite to  five separate 
anatomical  s ite s of  tumor invo lvement . (Bone me tastase s , for 
e x amp le , was counte d  as  one maj or  s ite of spre ad ,  re gardle s s  of  
the numbe r of  bone s involve d) . The ful l s ample mean was compute d 
so that the total numbe r of me tas ta tic s ite s could be compare d 
be tween group s . For e xample , patients with lung me tas tase s had a 
me an of  3 . 45 s ite s of  involvement , somewhat highe r than the ful l  
samp le me an . Thi s  s imp ly me ans that patients  with lung me ta stase s 
from bre as t  c arc inoma te nd to have more areas  o f  invo lvement in 
c omparison to the ful l  sample . The di ffe re nce be tween  the me ans 
for thi s  parame te r was not s ignificant . 
The me an Mode l A sc ore and Mode l B s core we re 1 6 . 5 4 and 
8 . 5 4 re spe c t ive ly ,  with an r = . 8 189  � = . 0 0 24) . A d i ffe rence 
be tween  me ans t te s t  was done , us ing the ful l  sample me ans as a 
c omparison , to de te rmine i f  patien ts with lung me tas tase s score d  
s igni ficant ly lowe r than the ful l  sample on Mode ls A and B .  For 
this statistic , t = . 14 6 6  for Mode l A and t = 1 . 0 1 for Mode l B ,  
ne ithe r fi gure was s ignifi c ant . The te st  of homogene ity o f  cor-
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Table 9 
Mode l Score s  and Total S ite s of Me tas tase s for 
Pat ients With Lung Me tas tase s - Group LM 
Patient Involvement  Mode l A Mode l B 
# Uni lat . 
1 X 
7 
12  X 
13  
15  
1 6  
1 8  X 
20  
28  
2 9  X 
30  
N = 11 
B ilat . Score 
X 
X 
X 
X 
X 
X 
X 
38  
17  
6 
10 
21  
19  
7 
2 3  
21  
12  
8 
Me an 1 6 . 5 4 
Me dian 1 7 . 0  
Score 
46  
8 
2 
2 
5 
3 
1 
9 
6 
5 
7 
8 . 5 4 
5 . 0  
Lung Me tas tase s Patients N = 1 1  r = . 8 1 8 9  
All o the rs N = 19  r = . 7 0 2 9  p = . 0 011 
Total S i te s  Of 
Me tastase s 
5 
5 
3 
2 
3 
3 
4 
3 
3 
4 
3 
3 . 45 
3 
Mode 3 
p = . 0 024  
Di ffe rence be tween ful l  samp le me an and Group LM me an ; for Mode l 
A ,  t = . 14 6 6  not s ign i ficant at alpha = . 05 ;  for Mode l B ,  t = 1 . 0 1 
not s ignificant at alpha = . 0 5 
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re lation coe ffic ie nts  was pe rformed comparing the r for lung me tas­
tase s group with the full samp le r ,  . 7 5 5 1 . The d i ffe rence was not  
s igni ficant a t  the accepte d  leve l (Z = . 41 9 6 6 , alpha = . 0 5) . 
Ple ural E ffus ions 
Those patients  with pleural e ffus ions are listed  in Table 
10 . Thi s  group , de s ignate d PD , contained nine (30%) membe rs ; seve n  
(7 7 . 7 8%) of  whom had unilate ral involvement , and two (2 2 . 2 2%) o f  
whom had b ilate ral involveme n t . The me an numbe r of s i te s of  me tas­
tase s was 2 . 88 ,  comp ar ing favorably with the full  samp le me an of  
2 . 8 6 .  
A patre nt with p leural e ffus ion score d  almost  s ix points 
be low the full s ample me an on Mode l A (11 . 11 ve rsus 17 . 0 ) . The 
diffe rence was s igni ficant at alpha = . 10 whe re t = 2 . 0014 , but 
not at the . 05 leve l . In add i t ion , al though the ave rage pat ient 
wi th p leural e ffus ions score d almo s t  four points be low the full 
s ample me an on Model B (5 . 44 ve rsus 9 . 3 3)  the d i ffe rence was no t 
s igni ficant at e ithe r leve l , t = 1 . 11 7 5 . The corre lation coe f­
fic ien t  for Group PD was . 3 649 , quite low , and s ignificant only 
at p = . 3 3 5 6 . Pos s ible re asons for this low value will be d i s ­
cussed  i n  Chap te r Five . S ince the re were le s s  than te n obse rva ­
tions in Group PD , no compar ison can be made be tween r = . 3 69 9  and 
the full s ample corre lation coe fficie nt . 
Bone Me tas tase s 
Bone me tastase s we re harbore d by 25  (8 3 . 3 4%) of  the patient  
s ample . Mode l score s  and total s ite s of me tastase s are given in 
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Table 10  
Mode l Score s and Total S ite s of Me tas tase s for 
Patients With Pleural E ffus ions - Group PD 
Patient  
# 
6 
10  
12  
14  
1 6  
17  
18  
2 3  
3 0  
N = 9 
Involveme nt Mode l A 
Unilat . B ilat . Score 
X 
X 
X 
X 
X 
X 
X 
X 
X 
10 
9 
6 
13  
19  
13  
7 
15  
8 
Me an 11 . 11  
Me dian 1 0 . 0  
Mode l B 
Score 
5 
6 
2 
7 
3 
8 
1 
10 
7 
5 . 44 
6 . 0  
Pleural E ffus ion Pat ients  N = 9 r = . 3 649  
All othe rs N = 21  r = . 7 7 34 p = . 0 001  
Total S i te s  of  
Me tas tase s 
3 
2 
3 
2 
3 
2 
4 
4 
3 
2 . 88 
3 
Mode 3 
p = . 3 35 6 
Diffe re nce be twe e n  full  s ample me an and Group PD me an ; for Mode l 
A ,  t = 2 . 0014  s igni fican t  a t  alpha = . 10 ,  not s ignificant at 
alpha = . 0 5 ;  for Mode l B ,  t = 1 . 11 7 5  not s i gnificant at 
alpha = . 05 
1 1 3  
Table 11 ; ln add ition , the fifth column l i s t s  the to tal numbe r o f  
bony s ite s involve d ,  by anatomical d ivis ion . The latte r  ranged  
from one to  nine bony s i te s , or are as , invo lve d  wi th me tastase s ;  
with a me an of  6 . 3 6 ,  a median of  four , and a mode o f  three . The 
total numbe r o f  s ite s o f  me tas tase s had a mean of  2 . 8 4 ,  not s ig­
nificantly d i ffe ren t  from the full samp le me an of 2 . 8 6 .  
The me an score on Mode l A was 18 . 48 and on Mode l B ,  10 . 28 .  
Ne ithe r o f  the se score s was s ign i ficant  whe n compare d to the full 
sample me ans and a t te s t  for the di ffe rence be tween me ans was 
employe d . By  inspec tion , the means for Group BONE we re only 
s lightly highe r than the full s amp le me ans on both mode ls . An 
r = . 7 3 9 8  was found for this  group , s ign i ficant at p = . 0 0 0 1 . A 
te s t  for homoge ne ity of  corre lation coe fficients , again comparing 
the r for patients  wi th bone me tas tase s with the r of  . 7 5 5 1  reve aled  
no s ignificant d i ffe rence (Z = . 1 2 5 9) at  accepted le ve ls .  
Live r Me tas tase s 
Me tas tase s to  the l ive r we re found in te n (33 . 3%) women from 
the pat ient  sample . Thi s  percentage compa red  we ll with the fre ­
quency o f  me tas tase s to the l ive r  in large ser ie s  o f  bre a s t  carc i ­
noma patients . Mode l score s , and total s ite s of  me tastase s are 
l i s ted  in Table 1 2  for thi s  group . The me an va lue for the total 
s ite s of  me tas tase s was 3 . 6 , wi th a me d ian of four . By inspe c tion 
this value i s  highe r than the full sample me an o f  2 . 8 6 ;  pat ient s 
with l ive r me tas tase s ,  had , on the ave rage , one more s i te of  
involveme nt than the full sample . The d i ffe rence , howeve r , is  no t 
s i gn ificant . 
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Table 11 
Mode l Score s  and Total S i te s  of  Me tast ase s for 
Pat ients  With Bone Me tas tase s - Group BONE 
Patie nt Mode l A Mode l B Total S i te s  of  No . of  Bony 
# Score Score Me tas tase s S i te s  Involved 
1 38  4 6  5 9 
2 2 4  18  3 6 
3 1 3  0 1 5 
4 2 4  2 0  5 2 
5 3 0  2 2 8 
6 10  5 3 1 
7 1 7  8 5 7 
8 11  5 2 3 
9 3 1  3 3  2 8 
1 0  9 6 2 2 
11  22  14 1 9 
1 4  1 3  7 2 1 
1 5  2 1  5 3 3 
1 6  1 9  3 3 7 
1 7  1 3  8 2 4 
18  7 1 4 1 
19  2 7  11  4 7 
20  2 3  9 3 5 
21  12  1 2 3 
2 4  3 0  24  2 8 
2 5  1 1  3 2 3 
2 7  15 2 4 3 
2 8  2 1  6 3 5 
3 0  8 7 3 3 
2 6  1 3  1 3  3 2 
N = 2 5  Me an 18 . 48 1 0 . 2 8 Me an 2 . 8 4 6 . 3 6 
Me dian 17 . 0  7 . 0 Median 3 . 0 4 . 0  
Mode 2 . 0  3 . 0  
Bone Me tas tase s Pat ie nt s  N = 25  r = . 7 3 9 8  p = . 0 358  
All o the rs N = 5 r = . 8 9 9 7  p = . 0 001  
Diffe rence be twe e n  full s ample me an and me an for Group BONE ; for 
Mode l A, t = . 6417  not s igni ficant at  alpha = . 0 5 ;  for Mode l B ,  
t = . 3 2 9 5  not s igni ficant at  alpha = . 05 
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Table 12  
Model Score s and Total S i te s  of Me tastase s for 
Pat ie n ts With Live r Me tas tase s - Group LIV 
Pat ient 
# 
1 
2 
4 
7 
2 1  
2 2  
2 3  
2 4  
2 7  
2 9  
N = 10  
Mode l A 
Score 
3 8  
2 4  
2 4  
1 7  
1 2  
5 
15  
30  
15  
12  
Me an 19 . 2  
Median 1 6 . 0  
Liver Me tas tase s Pat ients 
All o ther s  N = 20  
Mode l B 
Me an 
Median 
Score 
4 6  
1 8  
20  
8 
1 
1 
10  
24  
2 
5 
1 3 . 5  
9 . 0  
N = 10 
r = . 5 43 5  
Total S ite s o f  
Me tas tase s 
5 
3 
5 
5 
2 
2 
4 
2 
4 
4 
Me an 3 . 6  
Median 4 
Mode s 2 ,  4 and 
5 
r = . 9 5 1 4  P = . 0 001  
p = . 01 2 7  
D i ffe rence be twe e n  full sample mean and me an for Group LIV ; for 
Mode l A ,  t = . 6 85 2 no t s igni ficant at  alpha = . 0 5 ;  for Mode l B ,  
t = 1 . 0 0 9 3  not  s igni ficant at alpha = . 0 5 
1 1 6  
The me an score s for Model A and Mode l B we re 19 . 2  and 13 . 5  
re spe c t ive ly . The woman with liver me tas tase s scored  on the ave r­
age two points higher on the e x te n t  of me tas tase s ope rat ional 
mode l ,  and fully four points highe r on the le ve l of functional 
disab i l i ty ope rational mode l , in comparison to the full sample 
me ans . The d i ffe re nce s we re no t s igni fic ant at alpha = . 0 5 
(t = . 68 5 2  for Mode l A and 1 . 00 9 3  for Mode l B) . 
The corre lat ion coe ffic ient  was r = . 9 5 1 4 , which was highly 
s igni ficant at  p = . 0 0@1 . In reporting a non- s tatis tical compari­
son , all  patie nts  without l ive r me tas tase s had an r of . 5 435 , at 
p = . 0 1 2 7 . 
The c oe fficient  for Group LIV a t  . 95 1 4  was the highe s t  
obtaine d  for any divis ion or group I n  thi s  re se arch . The te s t  for 
homoge ne ity was appl ied , us ing the full  s ample corre lati on coe f­
ficie n t  of . 7 5 5 1 . A Z value of  2 . 03 1  was obtained ; the d i ffe rence 
be twe e n  coe ffic ients  was s i gnificant at alpha = . 0 5 .  The patients 
with l ive r  me tas tase s ,  then , had a s igni ficantly  highe r corre la­
tion be tween e x tent  of me tas tase s and leve l of  func tional disa­
bility than the ful l s ample corre lat ion . 
Brain Me tas tase s 
Me tas tase s to the central ne rvous system , e x c lud ing the 
sp inal cord , we re found in seven (23 . 3 4%) patients in the sample . 
This pe rcen tage compare s we ll and is  within the range reported in 
large se rie s of b re a s t  c arcinoma patients . The mode l score s  and 
total s ite s of me tastase s are summarize d  in Table 1 3 . The me an 
total s i te s  of  me tastase s was 3 . 43 ,  somewhat highe r ,  but not s ig-
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Table 13  
Mode l Score s  and Total S ite s of  Me tas t ase s for 
Pat ie n ts With Brain Me tas tase s - Group BR 
Patient 
# 
1 
2 
7 
9 
1 3  
1 9  
28 
N = 7 Me an 
Me dian 
Mode l A 
Score 
3 8  
2 4  
17  
3 1  
1 0  
2 7  
2 1  
2 4 . 0  
2 4 . 0  
Brain Me tas tase s Patients 
All o the rs  N = 23  
Mode l B 
Score 
4 6  
18  
8 
3 3  
2 
11  
6 
Me an 1 7 . 7 1 
Me dian 1 1  
Total S i te s  o f  
Me tas tase s 
Me an 
Me dian 
Mode s 
5 
3 
5 
2 
2 
4 
3 
3 . 43 
3 
2 ,  3 and 5 
N = 7 r = . 9 0 61 p = . 0 0 5 7  
r = . 5 69 5  p = . 0 047  
D iffe re nce be twe e n  Group BR me an and full s ample me an ; for Mode l 
A ,  t = 1 . 9 445 s igni fic ant  a t  alpha = . 10 ,  but not s igni ficant at  
alpha = . 0 5 ;  for Mode l B ,  t = 1 . 7 37 7  s igni ficant at  alpha = . 10 ,  
but not s ign i fic ant  at  alpha = . 0 5 
1 1 8  
nlficantly , than the full sample me an . 
Patie nts  with b ra in me tas tase s had a me an Mode l A score o f  
24 , and an identic al median . The me an and me dian Mode l B scores  
we re 17 . 7 1 and 11 re spe c t ive ly . By inspe c t ion the se value s are 
large r  than those for the full sample me ans o f  17 . 0  and 9 . 3 3 . A 
person with bra in me tas ta se s score d  on the ave rage seven points 
highe r on Mode l A and 8 . 37 points highe r on Mode l B when compared 
to all patient s . 
A t te s t  was used to inspe c t  these  d i ffe rence s .  On Mode l 
A ,  the d i ffe rence be tween  me ans for Group BR and the full sample 
was s igni ficant at alpha = . 10 (t = 1 . 9 445) but not at alpha = . 0 5 .  
Like wise , for Mode l B me an s , the d i ffe rence be tween that for Group 
BR and that for all patients was s i gn i ficant at  alpha = . 1 0 
(t = 1 . 7 3 7 7 )  but not at alpha = . 05 .  
For Group BR , r = . 9 0 6 1  for the seven patients . This ,  like 
the reporte d  r for Group LIV , was highly s ign ificant a t  p = . 0 057 ; 
the p value would be highe r i f  the re we re a gre ate r  numbe r o f  
observations in Group BR . This corre lation coe ffic ient is  s light ly 
h ighe r than that for all patients , and is conside rably highe r than 
the coe ffic ie nt for all  patients  without brain me tas t ase s ,  r = 
. 5 695 . Ne i the r of the se d i ffe re nce s are appare ntly s igni fic ant . 
In fac t , s ince there are le s s  than ten observations in Group BR , 
no s ta t i s t ical comp arison can be made be twe e n  its  corre lat ion and 
that for all  patie nts . 
Me tas tase s to D i s tant Lymphatic s ,  Skin and Soft Tis sue 
The las t group in the pre sent  discuss ion was forme d by 
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combining patients  who had de ve loped d i s t ant lymph node me t as tase s 
or  spre ad to the skin or  soft tissue . This maj or group was de s ­
ignate d Group LYM , and was made up of  15  (5 0%) women from the sam­
ple {Table 14) . Of the se , five (33 . 3%) had d i s tant lympha t ic 
involvement , five (33 . 3%) had skin or soft  t i s sue involvement , and 
anothe r f ive (3 3 . 3%) harbore d  me tas tase s to both areas . The me an 
total s it e s  of  me tas tase s was 3 . 4 , identical to that for bra in 
me tasta se s patients . Although highe r than the full  patient s ample 
of 2 . 8 6 ,  the d iffe rence was not s i gnificant . 
The me an Mode l A and Mode l B score s  we re 1 6 . 67 and 8 . 9 3 3  
re spe c t ive ly ,  s l i ghtly lowe r than those for all patients . A t 
te s t  was pe rforme d  us ing the me ans for Group LYM and those for the 
full s ample , and the di ffe re nce be tween  me ans te s te d  for s igni fi ­
C aQce . For Mode l A ,  t ; . 12 0 1 , and for Model B ,  t = . 11 8 4 , ne i ­
the r be ing s igni ficant a t  the alpha = . 0 5 leve l . 
For patie nt s  in Group LYM , r = . 7 1 7 7  was s igni ficant at 
p = . 0 0 2 9 . This  value is  cons i s te n t  with the high corre lat ion 
coe ffi c ients  found for all groups  examine d in this re se arch . This  
s ignifie s that patients  with d is tant lymphatic and/or skin and s o ft 
t�ssue me tas tase s show a high corre lat ion be tween Mode l A score s 
(exte nt  o f  me tastatic  d isease)  and Mode l B score s  (le ve l of  phys ical 
d isab i l ity) . The te s t  for homogene i ty be tween corre lation coe f­
ficients was app l ie d , us ing r = . 7 1 7 7  for Group LYM and the full 
s amp le r of . 7 5 5 1 . The d iffe re nce was not s igni ficant  a t  alpha = 
. 05 (Z = . 2 3 5 9) , which i s  e xpe c ted  s ince the d i ffe rence be tween the 
coe ffi c ients  i s  ari thme t ically smal l . 
Figure 2 demonstrate s the frequency o f  me tas tase s to s ix 
Patient 
# 
1 
4-
5 
7 
1 2  
1 4-
15  
18  
2 0  
2 2  
2 3  
25  
2 6  
2 7  
29  
Table 14-
Mode l Score s  and Total Site s of  Me tas tase s for 
Patients  With Dis tant Lymphatic  and/or Skin 
and Soft Tissue Involvement - Group LYM 
Dis tant 
Lymphat ic 
Involveme nt  
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
Skin and 
Soft Tissue Mode l A 
Involvement  Score 
3 8  
X 24-
X 30  
17  
6 
X 1 3  
X 21  
X 7 
X 2 3  
X 5 
X 15  
11  
X 1 3  
X 15  
12  
Me an 1 6 . 67 
Me dian 15 . 0  
Mode l B 
Score 
4-6  
2 0  
2 
8 
2 
7 
5 
1 
9 
1 
10 
3 
1 3  
2 
5 
8 . 9 3 
5 
1 20 
Total 
S ite s of 
Me tas tase s 
5 
5 
2 
5 
3 
2 
3 
4-
3 
2 
4-
2 
3 
4-
4-
3 . 4-
3 
Mode s 2 ,  3 
and 4-
Patients  with D i stant  Lymphatic and/or Skin and Soft Tis sue 
Involveme n t  N = 15 r = . 7 1 7 7  p = . 00 2 9  
All o the rs N = 15  r = . 8 0 9 6  p = . 0 004-
Di ffe rence be tween  Group LYM me ans and full  sample me ans ; for 
Mode l A ,  t = . 1 2 0 1  no t s ign i ficant at  alpha = . 05 ;  for Mode l B ,  
t = . 11 8 4- not s igni ficant a t  alpha = . 05 
Pe rcent  o f  
Total S ample 
1 0 0  
9 0  
8 0  
7 0  
60 
5 0  
40 
3 0  
2 0  
1 0  
0 
3 6 . 67% 
Lung 
Figure 2 
8 3 . 3 4% 
Pleura Bone Live r 
S i te of  Me tastase s 
1 2 1  
B rain Dis tant 
Lym . Skin , 
Soft Tissue 
Pe rcentage of  Patients Having 
Me tastase s to the S ix Maj or  S i te s  
1 2 2  
maj or s i te s  o f  tumor involvement . By inspec tion , bone me tas tase s 
i s  the mos t  common s ite o f  disseminate d d isease , fol lowe d by skin , 
soft tissue , or  d i s t an t  lymphatic ; lung me tas tase s ;  live r  me tas -
tase s ; p le ural e ffusions ; and b rain me tas tase s in orde r of de c re as -
ing freque ncy . Figure 3 illus t rates the ave rage mode l score s  for 
bo th mode l s  for the s ix maj o r  s ite s of tumor involvement . 
FREQUENCY DISTRIBUTION OF PATIENTS OVER S IX 
CATEGORIES OF FUNCTIONAL ABILI TY 
In orde r to support or  re fute the hypothe s is that the 3 0  
patie nts  i n  the s ample will b e  dis tribute d eve nly ove r a s ix cate -
gory func tional clas s i fica tion s ys tem , a de scrip tion of  the pe r-
formance s tatus require d for e ach leve l was ne ce s s ary . Appendix D 
succ inc tly out line s the crite ria for e ach class ification , and 
dep ic ts pe rtinen t  de finitions . The re ade r should note that the 
p a tien t  clas s i fie d in cate gory one is  comple te ly func tional ; the 
totally dys func tional and comple te ly depende nt  patie nt would be 
class i fie d in cate gory s ix .  The s ix leve l s  repre sent a progre s -
s ion through func tional disab ility le ve ls . This schema was 
de vised  to afford a quick re fe re nce to the func tion al leve l of  
any given patie nt . 
E ach patient in the s ample was class ifie d , but the dec is ion 
as to the p rope r c ate go ry was often e quivocal . For this  re ason , 
an uppe r l imit o f  fun c tion was de fine d as that potential le ve l of 
func tion rep re senting the highe s t  cate gory for tha t particular 
patie n t . For e xample , for a patient  al te rnate ly func tioning at 
leve l  one and two , one would be the uppe r limi t . Conve rse ly , the 
Ave rage 
Mode l Score 
3 0  
2 5  
2 0  
1 5  
1 0  
5 
Lung 
Figure 3 
24 . 0  
1 2 3  
Mode l A 
Extent o f  
Me tas tatic 
Dise ase 
Mode l B 
Le ve l  o f  
Phys ical 
Dysfunction 
1 7 . 7 1 
1 6 . 6 7  
Pleura Bone Live r Brain D i s tant Lym . 
S i te of  Me tas tase s 
Ave rage Mode l Score s  for the 
Six  Maj or S i te s  of Me tas tatic 
Tumor Involvement 
Skin , Soft 
Tissue 
1 2 4  
lowe r limi t of func tion was that leve l repre sen ting the lower 
le ve l for tha t part icular patient . A patient alte rnate ly func tion­
ing at leve l two and three would have three as the lowe r l imit . 
For the 14  e quivocal  patients , the uppe r and lowe r limi t s  are give n 
in columns s ix and se ve n  o f  Table 1 7 . For the remaining 16  patients  
who le le ve ls  we re not  e quivocal , the uppe r l imi t is  equal to the 
l owe r limit . 
Table 15  summarize s  the numbe r of patients in e ach cate ­
gory accord ing to both uppe r l imit of  func tion (Part I)  and lowe r 
l imit of  func t ion (Part I I) . I t  was hypothe s ize d that  the patients 
would be d i s tr ibute d e ve nly ove r the pe rformance s tatus cate gorie s . 
A Chi square Goodne s s - of-Fit te s t  appl ied  to both parts re vea le d a 
s ign i ficant dev i a t ion from this  proposed freque ncy ; the leve l of 
Chi square wa s 11 . 0 7 ,  and value s for both the uppe r and lowe r lim­
its o f  func t ion e xcee de d  that value , me aning that the patients 
could no t be d i s tribute d e venly ove r the cate gor ie s .  The s i gn i f­
icance o f  this  find ing will  be discus sed in Chapte r Five . 
RELATED DESCRIPTIVE SAMPLE CHARACTERISTICS 
Charac te ris t ic s  of the patient samp le which are re le vant  
to the total  unde rstanding of the patient  wi th me tastatic bre as t  
c ance r are de l ine ate d  i n  this  sect ion . Patte rns o f  bone me tas ­
tase s are important in de c id ing on appropriate diagnostic  proce ­
dure s to de te rmine e x te nt of  involvement  in the ske le tal  s ystem . 
The table s de scribe data which supports the contention tha t the 
s tudy sample i s  a random repre sentative sample of the popula t ion 
1 25 
Table 15  
Fre que ncy D i s tr ibution Ove r Six  Cate gorie s 
of  Pe rf0rmance Status - Func t ional Classificat ion 
Part I 
Uppe r  Limit of  Function 
C las s i fication No . o f  Patients 
1 7 
2 4 
3 12  
4 4 
5 2 
6 1 
Chi square = 16  
Re j e c t  Hypothe s i s  of e ven 
dis tribut ion of  patients 
(E = 5)  
Part I I  
Lowe r Limit of  Func tion 
C las s i ficat ion No . of Pat ie nts  
1 3 
2 10 
3 9 
4 3 
5 3 
6 2 
Chi square = 12 . 4  
Re j e c t  Hypothe s i s o f  eve n  
d i s tribution of  patients  
(E = 5)  
Significant Chi square value = 11 . 0 7 at alpha = . 0 5 
1 2 6  
o f  patients  with me tas tatic breas t  carc inoma attend ing the Me di­
cal Colle ge of Virginia Tumor C l inic s . In addition , the func tional 
s tatus and rehab il itation goa ls of  the patient are tabula ted ; the se 
items are d is cusse d more fully in Chap te r Five . 
Bone Me tas tase s Patte rns 
Of part icular inte re s t  was the freque ncy of  me tas tase s to 
various bony s ite s , which is  summarized  in Tab le 1 6 . Me tastase s 
we re mos t  common in the ve rtebral column , part icularly in the lum­
bar and thorac ic ve rtebrae . The se s i te s  led all othe rs in pe rcent­
age of  pat ients  having bony me tas tase s . Mos t  large se rie s of  
patients reporte d  s imilar fre que nc i e s  to  the various bony s ite s  
(Galasko , 19 7 2 ; Hoskins , 1 9 7 1) . The maj ority o f  the se pat ients 
e xhibi ted  a mixture of bo th oste oblas t i c  and osteo lytic bony 
me tas tase s .  Mos t  authors have not d ivide d the femur or pe lvis 
into separate anatomical components  to report frequenc ie s of  
me tas tase s .  In thi s  re se arch , howeve r ,  the pe lvis was subd ivide d 
into five are as (wing o f  i l ium ,  i s chium , ace tabulum , pubic bone , 
and sacrum) and the fe mur into three are as (he ad and ne ck , inte r­
trochante ric , and subtrochante ric) for furthe r clas s i fication . By 
inspe ction one can no te that the ilium and ischium make up the 
maj ority of me tas tase s to the pe lvis , the ace tabulum and sacrum 
be ing o f  le s s  importance in bony spre ad , as found by thi s inve s t i ­
gat ion . 
Also  note d is  the obse rvat ion that most  femoral me tas tase s 
occurred in the he ad and neck (32%) and in the inte rtrochante ric 
1 2 7  
Tab le 1 6  
Frequency o f  Me tas tase s to Spe c i fic Bony S i te s* 
Bony S i te 
Lumbar Ve rtebrae 
Thorac ic Ve rtebrae 
Ribs 
Wing of I lium 
Skull 
Ischium 
Femur-He ad and Ne ck 
Femur- Inte rtrochante ric 
Ace tabulum 
PubiQ Bone 
Sacrum 
Shoulde r girdle (c lavic le , 
s capula , uppe r hume rus) 
Femur- Subtrochante ric  
Ce rv i cal Ve rtebrae 
S te rnum 
N = 25 
Pe rcent of  Pat ients  
Having Bony 
No . of Pat ie nts Dise ase , N = 25  
15  60% 
15 60% 
1 3  5 2% 
10 40% 
9 3 6% 
8 3 2% 
8 3 2% 
7 28% 
6 24% 
6 24% 
4 1 6% 
4 16% 
2 8% 
2 8% 
1 4% 
*De tec te d  by bone surve y , bone scanning , or both 
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re gion (2 8%) - the sub trochante ric are a and the shaft of  the femur 
(8%) be ing much le s s  common s ite s of me tastatic spre ad . The role 
of the ve rtebral ve nous system  in the distribution of me tas tase s 
to the spine and pe lvis , as  we ll as proximal femur , has bee n  d i s ­
cussed at  length l n  Chap te r Two . 
Of patients  with bone me tas tase s ,  two suffe red patho logi ­
cal frac ture s :  patie n t  # 9 - a frac ture through the right hume rus , 
and patie nt # 28  - a frac ture o f  the right femoral neck . The for ­
me r was tre ate d  b y  closed  reduc tion and the latte r b y  surgical 
inse rtion of an Aus t in Moore pro s the s is . Only one patient  (# 9 )  
had hype rc alcemia . 
Gene ral Pat ient Information 
Table 17  summarize s ge ne ral patient information that  was 
found in e x amining the patient sample . The e ight columns depic t  
the fol lowing information , from le ft to r ight : patient ide ntifica­
t ion numbe r ,  proximal (bre as t ,  ipsalate ral ax illary or inte rnal 
mammary) radiation , d i s tant  radiation , whe the r oophore c tomy or 
adrenale c tomy was pe rforme d , uppe r l imit  of func t ional c las s i fica­
tion , lowe r l imi t of functional c lass ification , and rehabilitation 
goal . 
From this table , 5 6 . 67 pe rcent of the patie n t  samp le had 
radiation the rapy to the bre as t ,  ipsalate ral ax illary node s or  
inte rnal mammary node s . The supraclavicular node s we re usually , 
but not always , inc lude d in the tre atme n t  fie ld of the se patient s . 
Als o , 6 6 . 67  pe rcent  had rad iation therapy to d is tant me tas tatic 
s i te s , such as os seous , de rmal , or lymphatic  me tas tase s .  Only two 
12 9  
Table 1 7  
Ge ne ral Patien t  Information Part  I 
, 
--
Functional 
Clas s ifica-
tion 
Patient Radiation Oophor . Adren . Uppe r Lowe r Rehab . 
# Prox imal* Dis tant Limit Limi t Goal 
(1) (2) (3) (4) (5 ) (6) (7) (8) 
1 X X X X 6 6 C 
2 X X X 4 4 B 
3 X 1 2 B 
4 X 4 5 C 
5 X X X X 2 3 B 
6 X 3 3 B 
7 X X X 3 3 B 
8 X 2 3 C 
9 X 5 6 C 
10  X X X 3 3 B 
11 X 4 4 B 
1 2  1 2 B 
1 3  X X X 2 3 B 
14  X X 3 3 B 
15 X X 2 2 B 
16 X 1 2 B 
17 X X 3 3 B 
1 8  X 1 2 B 
19  X X X 3 3 C 
2 0  X X 3 3 B 
2 1  1 2 B 
2 2  X X 1 1 B 
2 3  X X 3 4 C 
2 4  X 5 5 C 
2 5  X X 1 1 B 
2 6  X 4 5 C 
27  X 2 3 B 
2 8  X X 2 2 B 
2 9  X 2 2 B 
3 0  X X 3 4 B 
*Bre as t ,  ax i l lary node s or inte rnal mammary node s 
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p a  ' ants  d i d  not rece ive any form o f  radiation the rapy . 
An oophorectomy was pe rformed in 11 (3 6 . 67%) patients , 
o Le an adre nalec tomy was performed on five (1 6 . 67%) . The two 
a re s ome times combined into one surgical ope ration , and while an 
oop�onec tomy i s  c ommonly done alone in pre -menopausal patie nts , 
on�y once was an adrenale ctomy pe rfo rme d without s imultane ous or  
p re v ious s te ri l ization �at ient # 2 3 ) . The numbe r of  patients �n 
e ach of s ix functional c lass i ficat ions has been summarized in 
�able 15 . Columns s ix and seve n  of Table 17 illus trate the cate ­
gory for e ach patie n t . 
Column e ight lis ts the rehabili tation go al for each 
patient , chosen i f  that patient  we re to hypothe t ically re ce ive 
physical the rapy tre atme n t . Appendix F give s an explanat ion of  
the c rite r i a  fo r the se goals . For  purpose s o f  this re search , all 
patients  we re e ither olass ifie d  as  Goal B (supportive ) or Goal C 
(palliative ) . The re we re 2 2  (7 3 . 3 4%) patients in C las s B and 
e ight (2 6 . 67� patie n ts in C las s C .  
Othe r s ite s of me tas tase s not inc lude d in the s ix maj or 
s i te s  d i scus sion we re var iable , e ach s i te exhibited by only a few 
patie nt s . Three women (10%) had per iphe ral ne rve involvement : 
patie nt # 4 - in the s ac ral plexus ; patient # 6 - in the right 
s ix th c ranial ne rve ; and patie nt # 2 0  - in the le ft twe l fth cran ial 
nerve . That none of the se patients  had brachial plexus involve ­
men t  i s  probably due to the small s ample s i ze ; gene rally pe riphe ral 
nerve impinge me nt is more common he re due to lymphatic me tastases  
tID the scale ne and supraclavicular node s . The me sente ric lymph 
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node s we re c l inically involved in one patie n t  (#23) , produc ing 
s igns of inte s t inal obs t ruction and abdominal discomfort . One 
pgtlent Of 1 9 )  had me tastase s to the re tina of  the e ye ,  tre ated 
by rad iation ; another deve loped a me tas tas i s  to the pe riorbi tal 
re giDn , also tre ate d by  radiation . The former i s  be coming more 
common (Fulle r e t  al . ,  1 9 7 0) and be ing recognized  e arlier . 
Two p atients had ovarian me tas tase s , patie nt # 19  - to the 
le ft ovary , and patie n t  # 25  to both ovarie s . The se we re inciden­
tal  findings d iscove red by a pathologis t re ce iving t i ssue spe c i ­
mens  from oophorec tomie s ,  and d o  not repre sent true c l inical 
me tastase s . 
Table 18  summarize s  the following patient  samp le informa­
t ion in s ix co lumns : from le ft to right : patient identification 
numbe r ,  type of bre as t  surge ry ,  whe the r a bone surve y or scan was 
pe r forme d , whe the r chemothe rapy was used in tre atment , and the 
pathologic al type o f  b reast  carc inoma . The breakdown for type of 
surge ry was as follows : radical mas tec tomy , 20  ( 6 6 . 67%) ; mod i fie d 
radical mas tec tomy , one (3 . 3 4%) ; s imple mas tec tomy , two ( 6 . 67%) ; 
lurnpe ctomy , two ( 6 . 67%) ; and b iopsy only , five (1 6 . 67%) . 
Bone surve ys we re pe rformed in 2 6  (8 6 . 67%) patients , and 
bon� scans in 21 (7 0%) patients . Of inte re s t  is the fac t  that in 
ten bone surve ys pe rfo rme d , no e vidence of me tas tase s was found , 
but me tas tase s we re subse que ntly de te c te d  by scanning te chnique s .  
The re fore , in 10/21 (47 . 62%) scans pe r forme d , the re we re false 
negative bone surve ys for one or more bony are as . This clearly 
indicate s the value of sc anning in c l inic al de te rmination of bone 
Table 18 
Gene ral Patie nt Information Part I I  
Type o f  
Patien t  Bre as t  Bone Bone 
# Surge ry Surve y Scan 
(1) (2) (3) (4) 
1 Biopsy Ye s No 
2 RM Ye s Ye s 
3 RM No Ye s 
4 RM Ye s Ye s 
5 Biops y  Ye s Ye s 
6 RM Ye s No 
7 RM Ye s Ye s 
8 MRM - Ye s Ye s 
9 RM Ye s Ye s 
10 RM Ye s No 
11 RM Ye s Ye s 
1 2  Biopsy No No 
1 3  RM Ye s Ye s 
14  RM Ye s Ye s 
15  RM Ye s Ye s 
1 6  RM Ye s Ye s 
17  RM Ye s Ye s 
18  RM Ye s Ye s 
1 9  LUM Ye s Ye s 
2 0  RM Ye s No 
2 1  RM Ye s Ye s 
2 2  B iopsy No Ye s 
2 3  B iopsy Ye s Ye s 
2 4  RM Ye s No 
2 5  RM Ye s No 
2 6  LUM Ye s No 
27  SM Ye s No 
2 8  SM Ye s Ye s 
2 9  RM Ye s Ye s 
3 0  RM No Ye s 
Abbre viations 
IDC - Infiltrating Duc tal Carc inoma 
RM - Radical Mas te c tomy 
MRM - Modi fied Radical Mas te c tomy 
LUM - Lumpe c tomy 
SM - S imple Mas te c tomy 
Chemo-
the rapy 
Tre atment 
(5) 
Ye s 
Ye s 
Ye s 
Ye s 
Ye s 
Ye s 
Ye s 
Ye s 
No 
Ye s 
Ye s 
No 
Ye s 
Ye s 
Ye s 
Ye s 
Ye s 
Ye s 
Ye s 
Ye s 
Ye s 
Ye s 
Ye s 
Ye s 
Ye s 
Ye s 
Ye s 
Ye s 
Ye s 
Ye s 
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Bre a s t  
Carc inoma 
Pathological 
Type 
(6) 
IDC 
IDC 
IDC 
Me dullary 
Lobular 
Unavailable 
IDC 
IDC 
IDC 
IDC 
IDC 
IDC 
Medullary 
IDC 
IDC 
IDC 
IDC 
Unavailable 
IDC 
IDC 
IDC 
IDC 
IDC 
IDC 
IDC 
IDC 
IDC 
Muco id 
IDC 
IDC 
1 3 3  
me tas tase s .  
Al l but two pat ie nts were rece iving or had re ce ived some 
form o f  che mothe rapy . Not indicate d  in the table was the obse rva­
tion that ten ( 3 7 . 3%) patients re ce ive d e s trogen therapy and one 
(3 . 34%) patient re ce ived androge n the rapy . Vincristine was admin­
i s te re d  at  one time or  ano the r to 1 1  (3 6 . 67%) patients . Neuro ­
toxic i ty was obse rved in seve n , or  63 . 64 pe rcent of  the se patients ; 
in three thi s  was of  a minimal nature , and in four the leve l of  
neurotox ic ity was o f  a mode rate de gree . The fre que ncy of use  of  
the maj or  the rapeutic  drugs in the patient sample was not  tabulate d . 
Las t ly , column s ix of  Tab le 18  l i st s  the pathological type s 
of  b re as t  carc inoma ; this  information was unavailable for two 
( 6 . 67%) patients . Twe nty- four (80� of  the patient sample had 
infiltrating duc tal c arc inoma , two (6 . 67%) had me dullary carc inoma , 
one (3 . 3 4%) lobular , and one (3 . 3 4%) colloid carc inoma . The se fig­
ure s c ompare favorably with those given by Haagensen (19 7 1) , who 
found 7 5  pe rcent infil t ra ting duc tal carc inomas in a large patient  
se rie s , and s imilar pe rcentage s for the othe r pathological type s . 
This column i s  o f  inte re s t  mainly be cause it  give s support to the 
obse rvation tha t  the 3 0  patient s ample s ize in this  s tudy cons t i ­
tute s a n  accep te d  random sample , s ince i t s  d i s tribution accord ing 
to p athological type of c arc inoma c lose ly approximate s that of  
large se rie s o f  bre as t  carc inoma patients . 
FREQUENCY OF SPECIFIC  DISABIL ITIES 
Table 1 9  de scribe s the fre que ncy of disabil ity in the 
I .  
I I . 
I I I . 
IV . 
V .  
V'r .  
V I I . 
V I I I . 
IX . 
X .  
XI . 
XI I . 
Table 19  
Fre quency Distribut ion of  Disab i l i t ie s  in 
Mode l B Groups 
Func tional Group 
Fee d ing 
Tran s fe r  Gene ral 
Pe rsonal Toi le t 
Tran s fe r ,  Use of Toi le t 
Bathing 
Ambulation on Le ve ls 
Ambulation on Stairs 
Whee lchai r  Manageme nt* 
S i tt ing Act iv i t ie s  
Bed Ac t iv i t ie s  
Dre s s ing 
A .  Uppe r Body 
B .  Lowe r Body 
C .  Hose  and Shoe s 
D .  Bedc lothing 
Bowe l and Bladde r Continence 
No . of Patie n ts 
Exhibi ting 
Dysfunc tion 
3 
13  
10  
7 
18  
24  
27  
13  
1 0  
5 
1 1  
1 2  
3 
4 
1 3 4  
Pe rce nt 
10 % 
43 . 3  % 
3 3 . 3  % 
2 3 . 3  % 
60 % 
8 0  % 
9 0  % 
43 . 3  % 
3 3 . 3  % 
1 6 . 7 % 
3 6 . 7  % 
40 % 
1 0  % 
1 3 . 4  % 
*No patients in this s tudy employe d a whee lchair as an 
as s i s t ive dev ice . 
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various Mode l B groups . From this tab le , the physical the rap ist  
can  ide n t i fy are as whe re the patie nt with me tastatic bre as t  carc i ­
noma is  mo st  l ike ly t o  e xhibit  dysfunc tion . The data ind icated 
that i f  the total patient sample , 27  (90%) e xpe rienced at least  
some disab i l ity in  a scending or de sce nding s tairs , and 24 (8 0%) 
we re dys func tional to s ome de gree in ambulating on le ve l surface s .  
More than one hal f  (60%) of  the patie nt samp le e xpe rienced diffi­
culty with bathing . Le s s  than one hal f  of the patient s ample 
e xhib ite d  dys func tion in e ach of the remaining groups . More 
patie n ts tende d to have d i fficulty with lowe r body c lothing and 
hose and shoe s in comparison to uppe r body c lothing or be dcloth­
ing . Re lative ly few patients e xhib ited dys func t ion in feeding 
ac tivitie s or in bowe l and bladde r cont ine nce . 
SUMMARY 
Chap te r Four has summarize d  the re sults of a de scriptive 
s tudy of 30  patients  wi th disseminate d  bre ast  carc inoma . The maj or 
items o f  inte re s t  we re total and me an score s  for ope rat ional Mode l 
A - Ex tent  of ' Me tastase s , and total and me an score s  for Ope ra tiona l 
Mode l B - Le ve l  of Func tiona l Disab i l i ty . The se we re fi rst de te r­
mine d for the full sample , and subsequently for group s base d on 
age , le ngth of  d i sease , d i se ase free inte rval , duration of me ta­
s tatic d i se ase , and tumor clinic atte nded . 
For each group , inc lud ing the full  samp le , a corre lation 
coe ffic ient was compute d ,  be tween the me an score for Mode l s  A and 
B .  Appropriate s tatis tical  te sts  of s i gnificance we re employed  to 
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te s t  the corre lat ion coe ffi c ient s , and the d iffe rence be tween 
me ans for the various group s . The re sults  were placed in table 
form and summarized with in the chapte r .  
In a s imil ar manne r , me an mode l score s  and corre lat ion 
coe ffic ients  were computed for the following s ix maj or me tas tatic 
s i te s : lung , p leura , bone , l ive r ,  bra in , and dis tant lymphatic -
skin and s o ft t is sue ; the re sults  tabulated , and the the prope r 
s tatis t ical te s ts employe d . The distribution of  the patient  sam­
p le ove r a six  cate gory c las s i fication of pe rformance le ve ls  
me asuring func t ional abi lity was outl ined and the Chi square 
Goodne s s - of-Fit  Te s t  app l ie d . The chap te r  ende d with a discuss i on 
o f  per t inent  general patient info rmation that was colle c te d  in the 
c ourse o f  this s tudy . 
Chapte r 5 
CONCLUSIONS AND RECOMMENDATIONS 
Chapte r Five is divided into three p arts in orde r to out­
line and discu s s  the conclus ions , inte rpre tations , and recomme nda­
tions of  this  re se arch proje c t . The first part de scribe s the con­
c lus ions and inte rpre tation of  the data that was gathe red ;  he re the 
hypothe se s p roposed  in the introduction o f  the the s i s  (Chapte r One ) 
are tes te d  for accep tance or re j e c tion . The second part of the 
chapte r give s recomme ndations for further s tudy and re se arch in 
b re as t  carc inoma , b ase d on the find ings of the s tudy , and re late s 
them to physical the rapy needs  and prac tice s . The chapte r ends 
with a re view of the s tudy and short summary of the the sis  as a 
whole . 
CONCLUS IONS AND INTERPRETATIONS 
Full Sample Corre l ation 
The firs t hypothe s is (Hol) s tate d that the re would be no 
or a ne gative s ta t i s t ical corre lat ion be tween the e x tent  of me tas­
tase s in  the me tas tatic b re as t  c arc inoma patient , as measure d by  
Model A ,  and the leve l o f  functional disab il i ty , as measure d by 
Mode l B .  Since the corre l ation coe ffic ien t  was . 7 5 5 1 , which was 
s igni ficant at p = . 0 001 , we can , based on the data , re ject  the 
null  hypothe s is and accep t  the alte rnate , Hal ' which s tate s that 
the re is  a p os i t ive corre lation be tween the e x tent  of  me tas tatic 
dise ase and the leve l of func tional disability . In summary , a 
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high s ta t i s t ical  corre la t ion was found , s ugge s t ing that the amount 
o f  me tastatic dise ase in a typical patient with dis seminate d b re a s t  
oarc inoma w i l l  re late s trongly to the amount o f  functional disa-
b il i ty she will d i sp lay . The conve rse of this s tatement  can also 
be acce p te d , that the amount of func t ional d i s ab il i ty found in a 
patie n t  with me tastatic  b re a s t  carcinoma will re late strongly to 
the amount of me t as tatic d ise ase that is  pre sent . A cursory glance 
at Table 3 demonstrate s that  as s c ore s on Mode l A incre ase , score s 
on Mode l B te nd to incre ase also . 
Divis ion by Age , Length of  Dise ase , Dise ase Free Inte rva l ,  Tumor 
C l inic 
Age .  Anothe r maj or  hypothe s i s  (H0 3) in re ality has two parts . 
One examine s age (olde r or younge r than age 60)  and the o the r 
examine s length of  d i se ase (longe r than or le s s  than 3 . 3  ye ars) , 
and the ir re lat ionship to mode l me ans . H03 s tate d that  those 
patie n ts ove r the age of 60 and those patie nts living longe r  than 
3 . 3  ye ars with the ir  d i se ase will not e xhib i t  any gre ate r amounts 
of  d isab i lity ( i . e . attain a highe r sc ore on Mode l B) . In examin-
ing Tab le 4 once again , patients ove r age 60 (Group 0) did  not 
attain a highe r Mode l B score in compar ison to patients unde r age 
60  (Group Y) . The t te s t  appl ie d  to the d i ffe re nce be tween  me ans 
was not s ignificant . This  finding tends to support H03 ; we can 
conclude that patie nts  under or ove r age 60 showe d little dif-
fe rence in the amount o f  func tional disability as measure d on 
Mode l B .  
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This  finding might b e  e xplained by the fac t that the me an 
age of  Group 0 was only 6 6 . 7 8 ,  and that only four patients we re 
o�e r 7 0  years of age . This  represents a group of  pe ople bare ly 
over the age of 65 , and many disabilitie s due to incre ased age , 
whiCh would i nflate Mode l B score s , we re not found . One might 
also pos tul ate that patients ove r age 60 s imply do not carry a 
greate r risk of incre ased morbidity from the ir  b re a s t  carc inoma . 
One can also sugge s t  that tumor growth might be le s s  aggre s s ive in 
olde r patients . The corre lation coe ffic ients d id not d i ffe r s ig­
n i fi c antly , although patients  ove r age 60 showe d a highe r r ,  sug­
ge s ting that wha t  disab i l i t ie s  that the y do have might be more 
c lo se ly  re late d  to the amount of  me tast atic d ise ase pre se nt . 
Thi s me an age for all patients  was 58 . 1 6 ,  somewhat highe r 
than mos t s tudie s . Howeve r ,  the ave rage of  5 0  reported in mos t  
se rie s i s  the age o f  onse t o f  breast  carc inoma , s o  the me an age o f  
all the patients with the dise ase will be expe cte dly highe r - the 
add i t ional years probably due to pat ients  liv ing longe r with the i r  
d ise ase due to improve d tre a tment me thods . 
Length of  Disease . To te s t  the se cond part of  H03 - that  o f  length 
o f  d i se ase e ffe c t , Table 5 mus t be examine d . The hypothe s is s tate d 
tha t  patients  l iv ing longe r  than 3 . 3  ye ars with the ir  dise ase will 
not show incre ased d i s ab il i ty . For Group L ,  the mean Mode l B score 
was 1 0 . 5 3 , which is s omewhat highe r  than the full  sample me an , and 
three points higher than the Group S me an . A t te st  applied to 
the d iffe rence be tween means was not s ignificant . This  finding 
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also tends to support Ho3 , the re fore we accept the null hypothe s i s  
of  n o  d iffe rence , and conc lude that b y  this  data , patients having 
the i r  d isease ove r 3 . 3  years do not show s igni ficantly gre ate r  
l e ve ls o f  funct i onal d i s ab il i ty . Conclus ion from the two separate 
parts of the hypothe s i s  is to accept H03 and re j e c t  Ha3 . 
Table 5 doe s ind ic a te that  those . patients  having the ir  
b re as t  c arc inoma longe r (Group L) tend to have more me tas tatic 
dise ase as  e xpre s sed  by  Mode l A score s , but this di ffe re nce is  not 
s igni fican t . Howe ve r , the tre nd appears to be toward new s i te s  of 
me tast ase s deve loping as the length o f  disease inc re ase s .  Those 
patie nts  in Group L corre late s lightly highe r be tween Mode l A and 
Mode l B than those patients  in Group S .  Although the diffe rence 
is not  s igni fican t , one c an spe culate that as a p atien t has he r 
d isease longe r ,  the disab i l i t ie s  she does have will  re late more 
c losel y  to he r e x tent  of  me tas tatic d isease . This might imply 
that as  pat ients  l ive lon ge r  with the ir d i se ase , disabili t ie s  wi ll  
be a gre ate r re fle c t i on o f  the me tas tatic proce s s  within the body . 
Dise ase Free Inte rval , Duration of  Me tas tatic Dise ase . Table 6 
divide s p a t ie nt s  accord ing to disease free inte rval . Although 
none o f  the accep te d  s tatistical  te sts  prove d s igni ficant di ffe r­
e nce s be tween  Groups F and G ,  the fol lowing inte rpre tation may be 
made : patients with a DFI longe r than two ye ars had a lowe r r than 
those wi th a DFI of  le s s  than two ye ars . I t  is  pos tulated  that 
Group F patie nts de ve lop more dise ase and its  concomitant dys ­
func t ion , and that the leve l o f  dysfunc tion i s  be tte r  re lated to 
1 41 
the amount o f  me tast at ic disease . One hypothe s i s  is  that patients  
with d ise ase free  inte rvals of  longe r  than two years might have 
the i r  me tast atic  d ise ase a shorte r pe riod , on the whole , and not 
sufficiently l ong  to p roduce o r  affe c t  s igni ficant incre ase s in 
leve ls o f  physical dys func tion . This  might e xp lain the lowe r 
Model B score and s lightly lowe r corre lation coe fficient found 
he re . 
Data from Table 7 do not support this hypothe sis . Of  the 1 5  
patients  having a d i se ase free inte rval o f  more than two ye ars , 
ten had the i r  me tas tatic d ise ase longe r than 1 . 5  ye ars , and only 
five had the ir  me tastatic disease less  than 1 . 5  ye ars . This sug­
ge s t s  that patients  wi th long disease  free inte rvals also te nd to 
have a longe r duration o f  me tastatic dise ase . I t  is  pos s ible 
though that those  patients with shorte r dise ase free inte rvals 
can deve lop more d i se ase and d i s ab il ity e ve n  in the re lative ly 
sho rte r duration of  me tas tat ic dise ase . 
Those patie nts  who had a longe r  duration of me tas tatic 
disease tend to have somewhat more me tastatic d i se ase than those 
patients with a shorte r duration . This finding is  expe c te d  s ince 
a patie n t  with b re as t  cance r runs the risk o f  deve loping new are as 
o f  involveme nt as  the duration of  me tastatic d ise ase incre ase s .  
Incre ase s in func tional disab il ity are e xpe c ted  in conjunc t ion 
with this  phenome non . In the pre sent s tudy this  was re fle cted in 
the highe r Mode l B soore s  found in patients  e xpe rie nc ing a longe r 
duration o f  me tastatic d isease . 
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Tumor Clinic . Table 8 ,  summarizing score s  according to tumor 
c l in i c  a t te nde d , also  demons trate d some in te re s t ing findings . 
Again , none o f  the te s ts of  statistics  emp loye d  showe d any s ig­
nificant  d i ffe rence s be twe e n  Groups P and R .  The lower c oe fficient 
(r = . 5 65 7 )  for private patients sugge s ts that this  group of 
patients  do not re late as  highly be tween amount of d i se ase and 
amount o f  phys ical  dys func tion . Appare ntl� fac tors , such as  type 
of t re atme n t , length of dise a se , psychological parame te rs , mot iva­
tion and o the r s  se rve to  mod i fy thi s  corre lation . Unfortunate ly , 
the p re sent s tudy c anno t p re c i se ly de fine all the variab le s upon 
which private and re gular tumor c linic  patie nts would d i ffe r .  
Anothe r f inding from Table 8 me rits  furthe r attention : 
that  Group R patie nts  tende d to have s lightly more me tas tatic 
d i se ase and gre ate r leve l s  o f  fun c tional d isab i li ty than Group P 
patients . A pos tulat ion is  that  re gular tumor c l inic patients  
o ften p re sent  with more advance d  d i se ase , large r primary tumors , 
and l onge r lengths of  d ise ase , among o the r factors , which would 
alte r the i r  c l in ical  course to the point whe re the y would be more 
l ike ly to have more dise ase and d i s ab il i ty . On the othe r hand , 
patients in Group P might be managed s omewhat d i ffe re n tly , and 
p robably enj oy more c on s is ten t  me dical  follow up , re fle c te d by 
lowe r Mode l A and Mode l B score s . Las tly , Group R has a d ispro­
portionate numbe r of me dical ly indigent  patie nts , the soc iological 
and p sychological ramificat ions of which might pos s ibly be 
re fle c te d  in s core s atta ine d on Mode ls A and B .  
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Major S i te s  of Me tas tase s 
Table s 9 through 14  de scribe s core s and coe ffic ients  for 
s ix de s ignate d  maj or  s i te s  of me tas tase s .  This data i s  re levant  
to the fol lowing nul l  hypothe s is (Ho 2) :  for the patie nt demon­
s t rating a spe c i fie d s ite of  me tas tase s (i . e . ,  lung , bone , brain , 
e tc . )  the re wou l d  be no or a ne gative c o rre lation be tween the 
e x tent  o f  me tas tase s (Mode l A) and the leve l o f  physical d isab i l ­
i t y  (Mode l B) . By furthe r e xamination , this  hypothe s is can be 
te s te d  individually for e ach of the maj or  s i te s . 
Each group reported high corre lation coe ffic ients , with 
the e xception o f  patients  having pleural e ffus ions . For all othe r 
group s , the r was gre ate r than . 7  and s igni ficant at accepte d 
leve ls . The c onclus ion then i s  to  re je c t  the null hypothe s is 
(Ho2) and accept  i t s  alte rnate hypothe s is , Ha 2 : the re is  a posi -
t ive corre lat ion be twe e n  e x tent of  me tas tase s a s  me asured  on 
Mode l A and leve l of  phys ical disab i l i ty , as  me asure d on Mode l B 
for se le c te d  s ite s o f  me tastase s .  Be cause the various s ite s 
showe d d i ffe rent  corre lation coe ffic ients and variable me an mode l 
score s , a summary and inte rpre tation of  the re sults  for e ach s i te 
follows . 
Lung Me tas tase s .  Pat ients wi th lung me tastase s c orre late d highly 
be twe e n  Mode l A and Model B (r  = . 8 1 8 9 ) , thus this group supports 
the re j e c ti on of Ho2 . Clinically bilate ral me tas tase s we re found 
more o ften than uni l ate ral me tas tase s in this group . Me an mode l 
score s did no t d i ffe r s igni ficantly from those for the full sample . 
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Thi s  s ugge s t s  tha t  patients with lung me tas tase s are charac te r­
i stically rep re sentative of  patients wi th d i sseminated bre as t  
c arc inoma a s  a whole . None o f  the p re se nt patient sample e xhib­
i te d  lymphangitic  me tastase s ,  the s ymp tomatology of which might 
have incre ase d both mode l score s . The patie n t  with lung me tas ­
tase s ave rage d a s l i ghtly large r  numbe r o f  ove rall s ite s of  me tas ­
tase s , which sugge s ts that the se patie n t  are like ly to have more 
s ite s involve d than the ave rage patient or the patie n t  without 
lung me tastase s .  The data do not allow one to c onclude that lung 
me tastase s only occur afte r seve ral  othe r s ite s have bee n  seede d  
with tumor . A s tudy which documents  the orde r o f  occurrence of 
me tastatic s ite s would be nee de d  to make assumpt ions or cono lus ions 
o f  this nature . 
Pleural E ffus ions . Pat ie nts  having p le ural e ffusions showe d the 
smalle s t  c oe ffic ie nt re lating e x tent  o f  me tas tatic  d ise ase and 
leve l o f  phys ical dys func tion , r = . 3 649 . Howeve r ,  the value is  
s t i ll pos i tive , although s igni ficant a t  only p = . 3 3 5 6 .  Due to 
this l ow p v alue , the conclus ion i s  to accept the null hypothe s is 
(Ho2) and re j e c t  Ha2 ' Patie nts w i th p leural e ffus ions do not cor­
re late at  an  accepte d  s i gn i ficance le ve l be tween  e x tent  of  d i se ase 
and leve l of func t ional d i s ab il it y . The re asons for thi s  lowe r 
c oe ffic ie nt c ould be pos s ibly explained in light of the s igni fi­
c an t ly lowe r Mode l A score s  - Group PD patients  tended to have 
s igni ficantly  le s s  me tas tatic dise ase than the full s ample , and 
thi s  d id not re l ate as we ll  to the leve l of func tional d is ab il ity . 
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Anothe r re ason for the low coe fficient might be the fact  that the 
patie nt with a p le ural e ffus i on ave rage d  2 . 8 8 me tastatic s i te s , 
which d id not much e xcee d  the full s ample ave rage . The se patient s , 
having re lative ly le s s  e xtens ive d i se ase , and re lative ly fewe r 
s i te s  involve d , would not be e xpe c te d  to c or re late highly with 
leve ls  o f  func t ional d i s ab il i ty . S ince most  of  the patients had 
only unilate ral involvement  and were not s trongly s ymptomatic , one 
c an p o s tulate that  much o f  the d is ab ility  (Mode l B) might be due 
to the influence of o ther maj o r  s i te s  of me tas tatic involvement . 
Las tly , patients  with p le ural e ffus ions as the sole or 
maj or  are as  of involveme n t  usually do quite we ll  c l inically . This 
would e xplain the corre sponding lowe r Mode l B score s that we re 
obse rve d he re . Anothe r postulat ion i s  tha t  p le ural e ffus ions 
occur e arlie r in the course of the bre as t  c ance r T s history , be fore 
many othe r s i te s  are seede d , and long be fore s igni fic ant s ymp toma­
tology from o ther are as could affe c t  a gre ater de gree of phys ical 
dys func tion . 
Bone Me tas tase s .  Pat ients with bone me t as tase s (Table 11)  cor­
re late d  . 7 3 9 8  be twe e n  Mode l A and Mode l B ,  thus also le nding sup ­
port t o  Ha2 , that the re is  a pos i t ive corre lation be tween e x t
e nt 
of me tastase s and le ve l  of  physical  disability  for maj or me tas ta­
tic  s ite s . Since 25  patients e xhibi te d  thi s  phe nomenon , this 
group c ould be v ie we d  as  close ly repre sent at ive of  the full s ample . 
That  the mode l me ans we re only slightly higher than the full  sample 
probably re flec t s  the s light inc re ase in s ymp tomatology and disa-
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b ility  b rought on by  d i s t re s s ing bone pain . 
Patients  wi th bone me tastase s mos t  frequently reported 
only two maj or me tas tatic s ite s �one be ing one of them) , whi le 
other groups usually reporte d  three s ite s involve d . The me an o f  
2 . 8 4 is  comparable t o  that for a l l  patients ; patients with bone 
me tastase s are not l ike ly , then , to have seve ral additional are as 
involve d with me tas tase s ,  as  comp are d  to othe r groups . In the 
c linical s i tuation , phys icians and othe r he alth pe rsonne l often 
find tha t  in  a pat ient deve loping bone me tas tase s ,  long pe riods of  
time may pass  be fore any othe r are as of dis tant spre ad make the ir  
p re se nce known . With e ffec t ive t re atment , the onse t of add i t ional 
me tas tase s may be de l aye d e ve n  longe r . Pe rhaps this e ffe c t  also 
has a be aring on the lowe r me an for total s i te s  of  me tas tase s that 
was obse rved he re . 
Galasko (197 2)  s tate d  that  8 5  pe rcent of  patients dying 
from b re as t  carc inoma have bone me tas tase s at autopsy . The fig­
ure in this re se arch , 8 3 . 3 4 percent , c lose ly approache s this  the o­
re t ic al and obse rve d  pe rcentage . That the re search figure is  some ­
what  highe r than tha t e xpe c ted  c l inically (5 0 to 60  pe rce nt) is  
p robably due to the incre ase d use of both bone s c anning te chn ique s 
and cor roborative bone surve ys . To conclude that the re are a d i s ­
proportionate numbe r o f  patients  with bone me tas tase s i n  this  
patient s ample would be  e rrone ous ; rathe r the fac t that  the 
obse rved pe rcentage approximate s the the ore t ical found at autopsy 
lends support to  the contention that the present  3 0  patient  sample 
is a good rep re se ntation o f  the total population of patients  with 
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me tastatic  b re as t  c ar c inoma . 
Patte rns o f  osseous me tastase s to various bony s i te s  we re 
summarized in Table 1 6  and d iscussed  in Chap te r  Four . Galasko 
(19 7 2) and S tale y (195 6) reported frequenc ie s comparab le to those 
observe d in this  re se arch . Of p articular importance to the phys i­
c al the rap i s t  are me tastase s to the femur. which carry a frac ture 
rate of 5 0  pe rcent . The fac t that  only one p atient (out o f  1 7  
with femoral me tas tase s )  suffe red a pathological frac ture p rob­
ably ind icate s that  an insuffic ie nt numbe r of  patients have had 
the ir  femoral me tastase s long enough to de ve lop a frac ture . Als o , 
p rompt rad iation and o the r supportive me asure s and tre a tment  for 
s ymp tomatic patients with femoral me tas t ase s have probably c on­
tributed to the lowe r  inc ide nce o f  patho logical fracture s in  the 
p re sent  patient s ample . 
Live r Me tastase s .  Pat ients with l ive r me tastase s we re obse rved 
to have the large s t  c orre lat ion c oe ffic ien t , r = . 95 1 4 , s ignifi­
cant at p = . 0 0 0 1 . The c onclus ion from this group is to re j e c t  
H02 and acce p t  Ha2 . Inte re s tingly e nough , patients no t having 
live r  me tas tase s only  c orre l ate d . 5 435  be tween Mode l A and Mode l 
B .  The c orre lation for Group LIV was s igni ficantly diffe rent from 
tha t  for all  patients . The c onc lus ion is  that patients with l ive r 
me tast ase s show a s i gn i ficantly highe r  c orre lation be tween  e x te n t  
of d i s e a s e  and leve l o f  phys ical dys funct ion ; women i n  this  group 
e xhib i t  d i s ab il ity that is  more c le arly re late d to the ir s tate of  
me tas tatic dise ase . One e xplanation for this  phenomenon might be 
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found in the fac t  that the me an total s ite s  was 3 . 6  - patie nts 
with l ive r me tastase s we re l ike ly to have seve ral additional are as 
i nvolve d with tumor . The adde d are as , taking into account the 
de gree of involveme n t  and s ymptomatology , add to the ove rall Mode l 
A and Mode l B s core s  and se rve to inflate the c orre lation c oe ffi­
c ients . 
Patie nt s  with l ive r me tas tase s might have re lative ly 
incre ase d s ymptomatology (j aundice , naus e a  and eme s is , abdominal 
discomfo rt)  which c ould s ignific antly affe c t  the patient ' s  le ve l 
of func t ioning , and pe rhaps in a large r se rie s of  patients , dis ­
proportionate ly change the leve l of  physic al dys func tion . Las tly , 
the data would sugge s t  that l ive r me tas tase s usually occur when 
seve ral addi tional s ite s a re involved s imultane ously or previous ly ; 
howeve r ,  that two p atients pre se nted with live r me tastase s as the i r  
firs t s ign o f  d i s t an t  re currence provide s contradic tory data to 
this  conte ntion . 
B rain Me tast as e s .  The brain me tas tase s group (N = 7 )  also attaine d 
a high c orre lat ion be twe e n  Mode l A and Mode l B score s , r = . 9 0 61 .  
For this  group , the de c is i on is  to re j e c t  the null hypothe s i s  
(Ho2) and accep t the alte rnate (Ha2) o f  a pos i tive c orre lation 
be twe e n  the e xtent of d i se ase  and the leve l of physical disab il ity . 
As with Group LIV , those patients not hav ing brain me tastase s 
eN = 2 3) only c orre l ated . 5 695  be tween Mode l A and Mode l B .  This 
sugge s t s  that  for a given numbe r of patients , those who have b rain 
me tastase s are more l ike ly to show a highe r  corre lation be tween 
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e xten t  of  me tas tase s and leve l of  phys ical dysfunc t ion than those 
patients  who do not demonstra te such me tastase s .  
Seve ral inve s tigators (Fulle r  e t  al . ,  19 7 0 ; Le sse and 
Ne tsky , 1 9 5 4 ; Vie th and Odom , 1 9 65)  have sugge s te d  that ce rebral 
me tas tase s occurre d late r  in the course of bre ast  carcinoma and 
a fte r the dise ase was fairly wide spre ad . Bec ause the me an numbe r 
of me tas tatic  s ite s involve d  was 3 . 43 ,  l arge r than the ful l  samp le 
me an of 2 . 8 6 ,  the imp l ic ation is that patients with brain me tas ­
tase s are also l ike ly to have seve ral othe r s it e s  of  me tas tase s .  
This  l ike lihood is  given furthe r support if  one examine s 
the s igni ficantly highe r me an score s on Mode l A and Mode l B ,  in 
c omparison to the ful l sample me ans . The hypothe s i s  that the re l S  
no d iffe re nce be tween  me ans for Both Mode l A and Mode l B compare d 
to the full s ample mus t  be re j e c te d . The me an Mode l A score , 24 , 
probably repre sents the influence of e x tent of  me tas tase s and 
se ve r i ty of s ymptomatology from the re lative ly large numbe rs of 
s i te s  of  me tastas e s  in this group , and may not be a t rue re fle c ­
t ion of  the brain me tas tase s � se e Thi s  s ame e xplanat ion may 
app ly to Mode l B ,  whe re the influence of a he ighte ne d me an of  
1 7 . 7 1 might be  due to the c omb ined e ffec t  of the greate r numbe r 
o f  s ite s of  me tas tase s ,  e ach contributing cons ide rab ly to the 
leve l o f  func t ional disabil i ty _ Al so , the two patients  wi th the 
highe s t  Mode l A and B score s of  all pat ients both had brain me tas ­
tase s , and the i r  high score s  within a small  numbe r of  obse rvations 
(seven) se rve d  to cons ide rably inflate the me ans for both mode l s  
for this  group . 
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In re trospe c t , only two of  the seve n  patie nts (# 1 and 
# 2) demonstra te d  mode rate to seve re phys ical dys func tion due 
mainly , i t  was be lieve d , to the neurological  e ffe c t s  of the brain 
me tas tatic deposi t s . The remainde r of  the patients in this  group 
demonstrated s core s that  sugge s ted  le s s  seve re le ve l s  of phys ical 
disab i l i ty . 
The d iffe rence be tween  me ans be ing te s ted  at  alpha = . 10 ,  
one c an c0nc lude that  patients  with brain me tas tase s have a s ig­
nificantly gre a te r  e x te n t  of me tas tatic d i se ase , and exhibi t  s ig­
nificantly gre ate r leve ls  of  phys ical dys func tion , as  me asure d  on 
Mode l A and Mode l B score s  re spe c tive ly .  This  conc lus ion is base d 
on a c ompari son with the me ans on Mode l A and Mode l B o f  all 
patients c omb ine d . 
Distant  Lymphat ic , Skin and Soft Tissue Me tas tase s . Pat ients hav ­
ing me tast ase s t o  the dis tan t  lymphatics , and/or skin and soft 
t i ssue , c omprise the last maj o r  group upon which the null hypoth­
s is (Ho2) was te s te d . This group , de scribe d in Table 14 , had an 
r of  . 7 1 7 7 , s ignificant  at  p = . 0 0 2 9 . The re fore , the data indicate 
that the H0 2 mus t  be re j e c ted , and the alte rnate hypothe s i s , Ha2 
be accepte d  for this group - the re is  a pos itive s tatis t ical cor­
re lation be tween  the e x te nt of me tastase s and the leve l of  phys ical 
dys func t ion for that group of  patie nt s harboring me tas tase s to the 
d i stant lymph node s and/or skin and soft t i ssue . 
Group LYM had a mean o f  3 . 4  total s ite s of  me tas tase s ,  
sugge s t ing too that  the se patients we re l ike ly to have seve ral 
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o ther are as of me tas tat i c  involvement . Howeve r , the d i ffe rence 
be tween  this me an and that for all  patients was not s ign ificant . 
By examining the me ans for both mode l s , it cannot be conclude d 
that patie nts in thi s  cate gory have a gre ate r e x tent  of  me tasta­
tic  d isease nor a gre ate r leve l o f  func tional disability . 
C l inic ians should remembe r that a patient c ould pos s ibly 
have wide spre ad lymphatic  involvement which is  asymp tomatic , and 
the re fore not de te cte d  c l inically . For this  re ason , it is re ason­
able to assume that the inc idence of d i s tan t  lymphatic involvement  
(3 3 . 3%) reported in this patient s ample might in  re ality be  highe r . 
In summary , for all s i x  maj o r  me tas tatic s ites , pos i t ive 
s tatis tical corre lations we re found , thus the null hypothe s is , 
Ho2 , o f  no re lationship be tween  e x tent  of dise ase and leve l of  
phys ical  dys func t ion in  the me tas tatic bre as t  carc inoma patie nt 
was re j e c te d , and the alte rnate hypothe s i s  was accepted . 
Func t ional Clas s ification - Performance Status 
The s ix cate gory functional c las s i fication use d to group 
patie n ts according to the le ve l of phys ical func tion was de scribe d 
in Table 1 4 , Chap te r Four , and outlined c omp le te ly in Appe ndix D .  
A Chi square Goodne s s - o f- Fi t  te s t  was app lied to te s t  the null 
hypothe s i s  that the re was an e ven distribution of the 30 patient 
s ample ove r the s ix func t ional clas s ific ations . This te s t  was pe r­
forme d for both the uppe r and lowe r l imits of  func tion for the 
patient s ample . In both c ase s , the compute d Chi square value s 
e xceede d  the the ore t ic al value o f  1 1 . 0 7 .  The re fore , the null 
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hypothe s is i s  re j e c te d  and i t s  al te rnate accepted : the patie nts 
a re d i s tribute d unevenly ove r the six leve l s  de scrib ing pe rfor­
mance s tatus . 
The patie nt s  we re c le arly he te roge nous in te rms o f  func ­
tional ab i l i ty and pe rformance s tatus . A large se rie s of  bre as t  
c arc inoma patients would pe rhaps be d i s tribute d more eve nly ove r 
the s ix c ate gorie s  of  pe rformance . The re asons for the uneven 
d i s tribution of  the p re sent  samp le are only pos tulations . At 
inspe c t ion , the gre ate s t  concentration of  patients appe are d to be 
in c ate gorie s two and three , sugge s ting that mos t  pat ie nts with 
d i sseminate d  bre as t  carc inoma are able to care for all pe rsonal 
nee d s , carry on mos t  normal daily ac tivitie s ,  and re turn to at 
le ast  part t ime employme n t , dut ie s , or age appropriate tasks . For 
both uppe r and lowe r l imits o f  funct i on , ove r two thirds of  the 
p a t ie nt s  fe ll within cate gorie s one to three , demons trating that 
the y are capable o f  the leve l of func t ion des c r ibe d above . 
From this  data , one can speculate that most  patie nts with 
d i s seminate d b reast  c arc inoma , evaluate d at various pe riods of 
the i r  d i se ase , will  no t be seve re ly dys func tional . The data pro­
v ide d from this  re pre sentative sample sure ly would indicate thi s  
conclusion . Howe ve r ,  the sample was composed o f  outpatients only , 
and did  not inc lude any acute ly ill  patients , nor any patients in 
the ve ry te rminal s tage s  of  cance r .  This would partly e xp lain the 
fac t the patients we re not e ve nly distributed ove r the c lass ifica­
tion schema , as  we ll as the fac t  that the maj ority we re not 
seve re ly dysfunc t ional . 
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I n  inspe c tion o f  Table 15 once again , the find ing i s  that 
le ss  than one third of the patients  we re c lass i fie d in leve ls four , 
five , or s ix . This  sugge s ts tha t  only a minority o f  patie n ts will 
requi re a s s i s tance in the i r  daily ac tiv i t ie s , or prote c t ive con­
d i t ions or  mod i fied e nv ironments , or suffe r a los s  of  independence . 
Phys ical the rapy p roce dure s , the n , would mos t  l ike ly be 
concen t rated w i thin thi s  group of patients ; le s s  than one third of  
all  outpatients with me tas tatic bre as t  carc inoma . The y would be 
the t arge t o f  p rograms de s igned to incre ase the leve l of func t ional 
abi li ty through e xe rc ise , mob ilization , or appropriate modality 
tre atme nt . Within this group would p robably be pre - te rminal and 
te rminal patie nts , as we l l  as those with pathological frac ture s 
due to bone me t a stase s ,  those with l ive r me tas tase s ,  those patients 
with brain me tast ase s ,  and those patients having the ir  dise ase a 
s igni ficant length of t ime , and finally , quite probably those 
patients with shorte r d i se ase free inte rvals .  
In summary , a top priority group could be identified  within 
the s ample , making up le s s  than one third of the patients  s tudied , 
whose me mber s  will  be more l ike ly to re qui re ass i s tance in daily 
funct ional ac t ivitie s . It  is  this  group toward which the phys ical 
the rapi s t  would d ire c t  more intensive rehab il itation e fforts to 
bring the se pat ie nts  to highe r  leve ls  of func tioning . 
Rehab ilitative Goals 
Two points me rit  furthe r inte rpre tation in add i tion to the 
information afforded by Table s 1 7  and 18 . Column e ight of  Table 17  
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l i s ts the rehabi l itation goal for e ach patient . Almo st three 
fourths (7 3 . 34%) o f  the patie n t  s ample we re clas s i fied as having 
a support ive goal for the ir  proposed rehab i l itation program . S inc e  
the se patie nts  are c ontrollab le for varying periods o f  time , inten­
s ive rehab i l itat ion e fforts , including physical the rapy , should be 
offe red to thi s  group . The pre sent  data support the conte ntion 
that d i s tant me t as tatic spre ad doe s not ne ce s s ar i ly pre sage a 
s te ady downhill  course o r  eve n  s igni fican t  leve ls  o f  phys ical dys ­
func t ion . Rathe r the phys ical the rap is t  should be ale rt  to 
p romptly asse s s  and t re at those d i s ab il i t ie s  that do arise in the 
course of  the d i se ase , thus ass i s t ing in kee p ing the pat ient  func ­
tional throughout the c ontrollab le pe riod of  he r di sease . 
Only one fourth (2 6 . 67%) of the patie nts , those in C lass C ,  
could be c l as s i fied as  te rminal or  p re - te rminal ; this too is  a 
subj e c t ive j ud geme nt s ince a numbe r of  the se patients can be 
brought to a supportive goal leve l .  For those outpatients  wi th 
me tas tatic bre as t  c ance r in Class  C ,  the rehab ili tation goal is  
palliative . He re would be  include d the palliat ive care , both 
physical  and psychological , a fforded to the dying patient . One 
c an conclude that  only a minority o f  bre as t  carcinoma outpatients  
tre ate d by  the physical the rap i s t  will re quire pal l iative care ; 
probably the gre a te r nee d , at  le as t ln e xpend i ture of  time , will  
be  among patients having supportive rehabi l i tative goals . This  i s  
no t t o  deny the smalle r numbe r of  patients in Class  C the se rvice s 
o f  a p rofe s s ional phys ical the rap i s t  when nee de d . 
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Frequency of Spe c ific D i s ab i l i t ie s  
The re was a wide variat ion I n  the fre quency with which the 
patient s ample demons t rated dys func tion in the 1 2  func tional ac tiv­
i ty groups of  Mode l B .  Table 19 l i s ts the numbe r and pe rce ntage s  
o f  pat ie nts  showing disab i l ity in the d iffe re nt funct i onal ac tivity 
c a te go rie s .  
That mos t  patients showed dys funct ion to some de gree in 
ambulation on s ta irs and le ve l surface s probably re fle c t s  the 
systemic e ffec ts of  the me tastatic d ise ase and its  tre a tment . 
Howe ve r ,  si nce ove r 8 0  pe rcent  of  the patient sample had bone me tas ­
tase s , which we re mos t  c ommon in the sp ine , pe lvis , and prox imal 
femur , the p a in and l imitation of mot ion in the affe c ted  j o ints 
could be e xpec te d  to l imit the bre as t  c ance r patient T s  ambulatory 
s tatus . Dyspne a and othe r pulmonary symptoms re la ted  to lung me tas ­
tase s or p leura l e ffus ions may a lso contribute to the patient T s  
inab i l i ty to tole rate mode rate ly s tre s s ful  ambulation ac tivit ie s . 
A cons ide rab le numbe r of patie n ts e xhibi ted dys func tion in 
bathing ac tivitie s . Approx imate ly 40 pe rce nt showed dys func tion 
in e ithe r dre s s ing ac tiv i t ie s  assoc iate d with lowe r body garments , 
and hose and shoe s ; s i tt ing ac tivitie s ;  or gene ral transfe r  activ­
itie s . Dre s s ing the lowe r ha l f  of the body , transfe rs , and bath­
ing involve cons ide rable re aching , s tooping , and fle x ion of the 
trunk and hip . S ince the spine , pe lvis , and prox imal femurs are 
more commonly affe c ted  with bone me tastase s ,  and are apt to be 
painful  upon movement , more patients could be expe c ted  to e xhib it 
some le ve l of  disab i l ity in ac tivitie s  re qui ring ac tive movement 
1 5 6  
of  the se j oints . 
Corre spondingly fewe r patie nts  reporte d disability in 
fee d ing activitie s , pe rsonal toile t activitie s , or dre ss ing ac tiv­
i t ie s  with uppe r body garme nts or be dclothing - all  ac tivi t ie s  
p rimari ly invo lv ing use of  the uppe r e x tremi t ie s . That 1 3  patien ts 
e xpe r ie nce d disab i l ity in s it t ing ac tivi�ie s  is  apparently more a 
funct ion of de crease d s i tting  tole rance than ac tual d i fficulty 
with ac t iv i t ie s  pe rforme d from the se ated  pos ition . Mos t  patients  
reporte d  tha t  the y we re more comfortable lying down than s itting . 
This is  not to postulate that the s tate of  the patient T s 
bone me tas tase s sole ly de te rmine s the a re as whe re dysfunc tion is  
d i splaye d , but  only to sugge s t  the bone involve ment due to bre as t  
c an ce r  can seve re ly l imit the patie n t  ln func t ional activitie s , 
particularly those involv ing movement of  the lowe r e x tremitie s . 
I f  the patie nt has se ve re live r or brain me tas tase s ,  symptoms from 
the se s i te s will  p robably ove rride the e ffe c t  of o s se ous me tas tase s 
in caus ing func tional disabi lity . Pain and s ymp tomatology due to 
me tas tatic s ite s othe r than bone poss ibly have a more gene ral 
e ffe c t  on the patient T s activity  le ve l ,  thus mani fe s ting disabil­
i ty ove r a wide r range of  func t ional ac tiv i t ie s . 
Imp l ic at ions for phys ical  the rapy can be de ve lope d from 
the se findings . The data sugge s t  that me tas tatic breast  cance r 
patients re quiring phys ical the rapy tre atment  will mos t  like ly 
e xhib i t  problems with ambulation and func tional ac tivi tie s involv­
ing the use of  the lowe r trunk and lowe r ex tremitie s . Phys ical 
the rap is ts are advised  to be cogn izant of  the se are as ;  the y can 
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then p re sc r ibe ac t iv i t ie s  and e quipment de s igned to  improve the 
ambulat ion tole rance and func t ional leve l in the se patie nt s . 
As s i stive device s , part icularly walke rs ,  cane s , and se l f  he lp 
e quipme nt , ofte n may be nece s s ary . That  frac ture s o f  the lowe r 
e x tremitie s due to me tastatic cancer a re more common than in the 
uppe r e x t remities  subs tantiate s the content ion that more atten­
t ion will  be  give n  to the forme r are a by the physical the rap i s t  
tre ating the bre as t  c ance r patient with d is seminate d d i se ase . 
Howeve r ,  gene ral fatigue , e x te n s ive me tas tatic d ise ase , s ys temic 
symptomato logy , and tre atment e ffe cts  can re sult in d isabi lity in 
all  func t ional ac t ivitie s - sugge s ting that the physical the rap i s t  
always conside r  the total patie nt in evaluat ion and tre a tme nt . 
RECOMMENDATIONS 
Seve ral re c omme ndations for add it ional re se arch are ge n­
e rate d by the re sults of this  s tudy . The maj or  implication of  the 
data pre sente d  is  that addi t iona l re se arch i s  ne ce ssary in all 
are as of  me tastatic bre a s t  c arc inoma . Some of the se are as are 
s trictly me d ic al , but othe rs be ar a more dire c t  re lat ionship to 
physical the rapy approache s . 
C l inical Ve rsus Autopsy S tudie s 
A study which would compare me tas tase s that are de te c te d  
c l inically with those found a t  autopsy would b e  of tremendous 
value to physic ians , so that are as  whe re improved c l inical diag­
nos t ic procedure s are nee de d  can be docume nte d . S ince the pre sent 
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s tudy is  a c l in ical one , some of the inc idence s o f  me tas tase s to 
se le c te d  s i te s  or groups c ould be compare d favorably to e x i s t ing 
autops y  s tudie s (Shie lds and Withan , 197 3 ; Viadana e t  al . , 197 3) . 
Identification of  Fac tors Affec ting Me an Mode l Scores 
A large r serie s  of patie nts  could be evaluate d on Mode l s  A 
and B to de te rmine i f  the re sults found in this  re se arch could be 
repe ate d  and validate d . In p articular , a large r  numbe r of obse r­
vations o f  women ove r the age of 60 (or 65) would be he lpful to 
de te rmine if  the se pat ients  ac tually do have gre ate r e x tents  of 
me tastat ic d ise ase or  gre ate r  leve l s  of func t ional disab il ity . 
Me thodical proce dure s are nee de d  within the mode ls  to remove those 
fac tors othe r than me tastatic de pos its  which might influence a 
score on leve l of  func t ional di sability . In this  way score s  could 
be c orre c te d  for incre ased d i s abil ity due to advanc ing age . 
Of  inte re s t  would  be to document  the age s  of  those patients  
having a d ise ase free inte rval of longe r than two ye ars , and com­
pare the ave rage age wi th those patients having a dise ase free 
inte rval of  le s s  than two ye ars . Thi s  proce dure c an also be pe r­
forme d for length of  d ise ase groups , on groups divide d  by duration 
of  me tastat ic d i se ase , and on private ve rsus re gular tumor c l inic 
patients . In this way the ave rage a ge s  o f  various groups could 
be c ompare d ; some groups might contain a d isproportionate numbe r 
of  patients  ove r the age of 60 (o r 65) which in o the r s tudie s 
might be found to  influence the le ve l of disability that i s  
e xh ib i ted . 
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Furthe r re se arch could apply the same gene ral proce dure , 
with mod i fications , to the various me tas tatic s ite s , to de te rmine 
if certain  s ite s c ontain a d isproportionate numbe r of pa tients 
with �nge r pe riods of d i se a se , shorte r d ise ase free inte rvals , 
longe r durations of me tastatic dise ase , or private (ve rsus re gu­
lar) tumor cl inic patien t s . Any of the se fac tors , all s tudie d ln 
the pre sent re se arch proje c t , could s ingly or in combinat ion 
e ffec t  the me an s core s attaine d on Mode l A or Mode l B for the 
various me tastatic group s . Studie s o f  this  nature would identify 
fac tors , such as the exact  le ngth o f  the DFI , which could s ta t i s ­
t ic ally alter the amoun t of  me tastase s o r  leve l of  di sab il i ty in 
a part icular me tas tatic s i te . By virtue of this , phys ical the ra­
p i s t s  could more c lose ly evalua te se le c ted  groups , as  de fine d by 
the fac to rs discove re d , for pe rtinent d isabilitie s  and impleme nt 
appropriate tre atment  programs . 
Tre atment and Diagnos t ic Evaluat ion Procedure s 
Re lat ive to med ical tre atment , the fre quency of use of the 
various chemo the rapeut ic agents employed in the patie nt samp le 
would be o f  in te re s t  in orde r to re late this inc ide nce to mode l 
score s . One could the n de te rmine i f  the choice of chemothe rape u­
tic  d rugs has any de fin i t ive e ffec t  upon the patient T s  le ve l of 
phys i c a l  dys func t ion . S ince all but two pat ients re ce ived  some 
type of  chemo the r apy , and mos t  of  th is numbe r de ve lope d at  le ast  
some s ide e ffe c t s  due to  tre a tment , this informa tion would also 
be of  importance in more spe c i fic s tud ie s . A study which would 
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offe r  corre la t ion coe ffic ients of  various group s d ivided  o n  leve ls  
of se ve ri ty o f  s ide e ffe c t s  to  chemothe rapy i s  an examp le of  
de te rmining how tre atment e ffec t s  the amount of  dise ase and the 
leve l of  d i s ab il ity . In addit ion , spe c i fic  docume ntation of  the 
s ymptoms and the ir  de gree of seve rity in vincr i s tine neuro tox ici ty 
are e spe c ially nee de d  to c l inically c o rroborate e x i sting inve s t i ­
gat ions . Thi s  then can be re late d  to me an score s  on the ope rat ional 
mode ls use d  in the pre sent s tudy . Unfortunate ly , an in depth 
e xplorat ion of  the neurotox ic e ffe c t s  o f  vincris tine was be yond 
the scope o f  this  re se arch proje c t . 
Anothe r are a  for potential e xp loration would be documenta­
t ion of  the me thods of diagnosis  of  spe c i fic bony me tastatic s i te s ; 
whe the r by scan , bone surve y ,  or both . This  is  nee ded to support 
ongoing re se arch which me asure s the re liability  of scans and sur­
ve ys , in orde r to d i scern which technique s are more d iagno s t ically 
re liable for spe c i fic osse ous s ite s . 
Re c omme ndat ions for Phys ical The rapi sts 
Of parti cular de s i re would be s tudie s which would docu­
ment  the type s of phys ical the rapy proce dure s currently used for 
patients with me tas tatic d ise ase or , if p o s s ible , for me tas tatic 
bre ast  cance r patients in particular . Conce ivab ly this  ave nue of 
re se arch would outline approache s for various type s of  me tas tase s ,  
s o  that  procedure s applicable to patients expe rienc ing spe c i fic 
symp tomato logy c ould be e nume rated . S tudies  of this type are 
lacking in the l i te rature . The pre sent  re se arch e s tabl ishe d s im-
1 6 1  
ply  that p a t ients  with me tas tatic bre as t  cance r exhibit  func ­
t ional d isability , and that thi s  disability could be re late d  to 
the amount of me tas t at ic d i se ase harbore d  within the se patient s . 
A summary of the phys ical  the rapy t reatme n t  employed would also 
ale r t  the phys ical the rapi s t  to potential are as of  dysfunc tion . 
Thi s  of  c ourse assume s that the tre atme n ts admini s te re d  re fle c t  
trouble s p o t s  i n  the patient T s func tional leve l . The rapi s t s  c ould , 
i f  re sul ts we re adequate ly docume n ted , then more c lose ly monitor 
the c l inical c ourse of  patients having me tas tat ic dise ase in 
highe r risk  areas , (such as l ive r  and brain) , those me tas tatic 
s i te s  more prone to be assoc i a te d  w i th s igni ficant physical dys ­
func t ion . 
I t  was found that patie nt s  with me tastatic bre a s t  cance r 
mor€ frequently e xhib i te d  disab i l ity in func t ional ac tiv i t ie s 
re qui r ing movements  of the lowe r trunk and lower ex tremitie s . Fur­
ther re search into spe c i fic programs which would a s s i s t  patients 
in ambulation and lowe r body mobilization are neede d  to support 
the conte n tion that the phys ical the rapy need  is greater  in the se 
are as . 
From e x is t ing data , phys ical the rap i s t s  are advised  to be 
cognizant  of the patient  with d i sseminated bre a s t  carcinoma who 
might be mor€ l ike ly t o  deve lop physical dys func tion that would 
ne ce s s itate profe s s ional physical the rapy attention . Patients hav­
ing the ir  d ise ase longe r  than 3 . 3  ye ars , patients  having a DFI  of  
le s s  than two ye ars , patients with l ive r or brain me tas tase s , and 
patie nts wi th large lytic le s i ons in the prox imal femur might be 
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include d i n  this  group . 
The final re c ommendat ion is  that the two ope rational 
mode ls deve loped for this re se arch be employe d  in e valuating me ta­
static cance r patie nt s  with primary tumors othe r than breas t . The 
main func t ion o f  a s tudy o f  this nature would be to te s t  the valid­
ity of  the mode ls . Two type s of cance r  that could e as ily be  te s te d  
o n  the e x i s ting mode ls , with minor mod ifications , would be carc i ­
noma o f  the lung and hype rnephroma of  the kidney . Both type s give 
rise to wide spre ad me tas tase s ,  although the behavior of the se 
tumors re gard ing me tastatic spre a d  is no t as d ive rse , and typically 
not as many s ite s of dis tant spre ad are involve d as in disseminate d 
b re a s t  carc inoma . None the le s s , a patient sample could be se le c te d  
and e valuated for e x te n t  of  me tas tatic d i se ase and leve l o f  func ­
t ional d i s ab il ity . Corre spondingly fewe r cate gorie s  on Mode l A 
would be score d , e spe c ially in kidne y c ance r ,  re fle c t ing fewe r 
anatomic al s ite s of  me tastase s .  
In both lung and kidne y cance r , brain and osse ous me tas ­
tase s would be part icularly fre quent ; me tas tase s to the skin , soft 
tis sue , and probably l ive r would not be as fre quent . Mode l B 
would p robably need  l i t t le mod ification i f  use d to evaluate 
patients  with lung or kidney  primarie s ,  s ince i t  me asure s ge ne ral 
func tional ac t ivity , non-spe c i fic for bre ast  cance r patie nts . 
Othe r forms of c ance r could be te s ted  us ing the mode l s , de le ting 
me tastatic  groups or cate gorie s of dys function that would not be 
re levant  to the type of cance r in que s tion . 
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THESIS SUMMARY 
Thirty female outpatients w ith me tas tatic bre a s t  carc inoma 
we re e valuated us ing two ope rational mode ls cons tructe d  for the 
purpose o f  assess ing and ass igning a quanti tative score for (A) 
e x te n t  o f  me tas tat ic d i se ase and (B) leve l of func tional d isabil­
ity . The se patients were drawn from the popula tion of patie nts 
with d i s seminated bre a s t  carc inoma atte nd ing the me dical oncology 
c linics  at  the Med ical  Colle ge of  Virginia Tumor Clin ic s  for a 49  
day pe r iod in 1 9 7 5 . The data from thi s pat ie nt sample we re use d 
to te s t  seve ral hypo the se s . 
Each patie nt unde rwe nt an ini tial screen ing proce dure 
de s igne d to c le arly identify those patie nts with d i ssemina ted 
d i se ase . Thi s  was followe d  by a pre l iminary evaluation involving 
re late d background information . The se le c ted patie n t  sample was 
then e valuate d and scored on the ope rational mode ls . 
The nume rical data we re tabulated and stati s t ically ana­
lyzed for the full patie nt s ample and subsequently for inclus ive 
group ings using the following parame te rs : age , le ngth of dise ase , 
length of  d isease free inte rval , duration of  me tastatic d ise ase , 
c linic atte nde d , and maj or me tas tatic s ite s . In addition , the 
d i s tribution o f  the pat ie nt sample ove r func tional c las s i fication 
c ate gorie s , the fre quency of  spe c ific disabilitie s , and re lated 
s ample characte ris tics  we re tabulated  and analyzed . 
A summary of the maj or findings of this  re se arch proj e c t  
are e nume rated be low : 
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1 .  The re is  a posi tive s tatis tical corre lat ion be tween 
the e x te nt of  me tastatic d i se ase and the le ve l of  disab i l ity and 
physical  dys func t ion for the full sample of patients  with me ta­
s tatic bre a s t  c arc inoma . 
2 .  Those patients ove r the age of  60 , and those patients 
having the ir  d i se ase longe r than 3 . 3  ye ars do not e xhib it s ignif­
icantly gre a te r  leve ls  of funct ional d isability than those pat ients  
unde r the age of  60  or those pat ients having the ir dise ase le ss  
than 3 . 3  ye ars . 
3 .  The length of  the d i se ase free  interval , the duration 
o f  me tastatic d i se ase , and the tumor c l inic attende d did no t have 
a s igni ficant  e ffe c t  on the e x tent of  me tas tase s or the le ve l of 
physical  dys func t ion in the se patients . 
4 .  For e ach of the s ix maj o r  me tas tat ic s ite s (lung , 
pleura , bone , live r , brain , and dis tant lymphat ic or skin and soft 
tissue ) , the re was a positive s tatis tical c orre lation be tween the 
e xtent of  me tastatic d i se ase and the le ve l of  phys ical dys func t ion . 
The value for r e xceede d  . 7  and was signific ant for e ach group 
e xcep t  Group PD - those patients  with pleural e ffusions . 
5 .  Pat ients  with ple ural e ffus ions had s ignificantly le s s  
me tas tatic dise ase i n  comparison t o  the full  pa tient sample . The se 
pat ie nts also  corre lated  the lowe st  be tween e x tent of me tas tase s 
and le ve l o f  func tional  d isab ility . 
6 .  Patients wi th live r  me tastase s showed the highe s t  cor­
re lation coe ffic ient of any of  the othe r groups ; this value was 
s igni ficantly diffe re nt from the ful l  patient sample corre lation 
1 6 5  
c oe ffic ie n t . 
7 .  Patie nts with brain me tas tase s had s igni ficantly 
gre ate r  amounts  of me tastatic disease , and s igni ficantly gre ate r 
level s  of  func tional d is abilit y  in comparison to all patients 
c omb ine d . 
8 .  Pat ie nts with pleural e ffus ions or bone me tastas e s  
we re le s s  l ike ly t o  have seve ral  addi t ional anatomical s i te s  
involved with me tas tatic tumor . 
9 .  Pat ie nts with lung , live r ,  brain , or skin and soft 
t i ssue - d i s tant  lymphatic involvement we re more like ly to have 
seve ral  addi tional anatomical s i te s  involve d with me ta s ta t ic tumor . 
10 . The re was a statistical ly une ven distribution o f  
patie nts  ove r a s ix cate gory func tional class ificati0n schema , the 
maj ority of patie nts not be ing seve re ly dys func tional . 
11 . Approx imate l y  three fourths of the patients with me ta­
s tatic  bre as t  carc inoma would have the supportive goal selected  
for the ir  rehab i l i tation needs . 
1 2 . App rox imate ly one fourth of the patie nts could be 
c las s i fied as te rminal or pre te rminal and would have the pall iative 
goal se le c te d  for the ir  rehab i l i tation needs . 
1 3 . Le s s  than one third of  the patie nt sample could be 
clas s i fied in pe rformance s tatus leve ls  which would indicate that 
the y nee d  ass is tance of  some kind to care for the ir pe rsonal nee ds , 
carry on normal daily ac t ivitie s , or re turn to part time employ­
ment ,  dutie s , or age - app ropriate tasks . The phys ical the rapy nee ds 
for this group are corre spondingly gre ate r . 
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14 . The re mainde r (ove r two thirds)  we re found to be func ­
t ioning at  pe rformance s tatus le ve ls which would ind icate that they 
did  not re quire a s s is tance of  some kind to c a re for the ir  pe rsonal 
nee ds , c arry on normal daily ac tiv itie s , or re turn to part t ime 
emp loyment , dut ie s , or  age appropriate tasks . The physical the rapy 
nee d s  for this group are c orre spondingly le s s . 
15 . More than one hal f  of  the patient sample demons trated 
some de gre e of  dys func tion in ambulation on s t airs or  leve l sur­
face s and in bathing act iv i t ie s . Patients with me tas tatic bre a s t  
c ance r mos t  fre quently e xhib ite d  disability i n  func tional ac tiv i ­
t ie s  requi r ing movements of the lower trunk and lowe r e x tremitie s . 
The pre sent  re se arch hope fully will as s is t  the profe s s ional 
phys ical the rap i s t  in the rational and prope r  evaluation and treat ­
ment  of  the pat ie nts  with dis seminate d b reast  cance r .  Additional 
s tudie s can be e xpe c te d  to incre ase the pre sent knowle dge of the 
mos t c ommon c ance r in women , and supp lement  approache s to care for 
the se patients . 
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APPENDICES 
APPEND IX A 
MODEL A 
EXTENT OF METASTASES OPERATIONAL MODEL 
DISSEMINATED BREAST CARC INOMA 
Introduc t ion : The maj or  obj e c tive of  this mode l is  to de scribe 
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the natural history of  bre as t  carc inoma in regards to i t s  dis­
semination and deve lopme nt  o f  me tastatic depos its . In the p roce s s  
i t  i s  hope d that a semi-mathematical  approach to the de scrip t ion 
of e xtent of me tas tase s in the woman with d i sse minate d mammary 
carc inoma will  be re alize d . This  nove l approach to class ification 
o f  pat� nts  w i th me tas tatic cance r can then be re lated to func ­
tional d isab i l i ty in the pat ient as mani fe s ted  in a te s t  for func ­
t ional leve l in ac tivitie s  of  daily liv ing . The latte r is  out lined  
in  Mode l B ,  the Leve l of  Func tional Disabil ity Ope rational Mode l .  
This  pre sent  mode l de l ibe rate ly exc lude s any primary tumor 
charac te ri s t ics ; or the spre ad , symptomatology , or  condit ion of  
homolate ral axi llary lymph node s , homolate ral  pe c toralis  maj or  or 
minor muscle s , e dema of the arm , de gree of s kin fixation of the 
primary tumor , o r  de gree  of  skin e dema . The se charac te ris t ic s  are 
not c ons ide re d to be d i s tant me tas tase s ,  and are the re fore not 
c las s i fie d in a mode l de scr ib ing disseminated d i se ase . 
A de taile d  de s c r ip t ion of the mode l use d for the data col­
le c tion is  followe d  by  the score shee t that was  used for e ach 
pat ient  in the s tudy . Groups marke d  with an asterisk  we re those 
tha t  we re give n a score ; o ften s ymptom l i s ts , locations whe re 
appl icab le , and tre atment  are include d for comp le tene s s  and accu­
racy for the prope r inte rpre tat ion of the data . 
Group I - Pulmonary Me tastase s .  
*A . Exten t  o f  D i se ase . 
o no me tas tase s . 
1 s ingle pare nchyma l nodule . 
2 multip le unilate ral or bilate ral pare nchyma l nodule s . 
3 multip le amorphous , infiltrative le s i ons , d iffuse , 
miliary me tas tase s . 
4 lymphangi tic me tas tase s .  mass ive consol idation and 
atale c tas i s . 
*B . Symptomatology . 
o a s ymptomatic . 
1 minimal . 
2 mild -mode rate . 
3 mode rate ly seve re to seve re . 
4 ve ry seve re - e x treme . 
c .  Lis t  of  Pos s ible Symptoms . 
a. cough . 
b .  dyspne a . 
c .  tachypne a .  
d .  sputum production . 
0 
1 
or 2 
3 
4 
e .  hemoptys is  or  bloody sputum (rare ) . 
D .  Tre atme nt . 
a .  s ymptoma t ic . 
b .  chemo the rapy . 
c .  radiothe rapy . 
d .  hormonal the rapy . 
e .  othe r tre atme n t , comb inat ion the rapy . 
absent . 
minimal . 
mode rate . 
se ve re . 
e x t reme . 
Group I I  - Pleural Me tas tase s .  Pleural Effus ions . 
*A . Ex tent  of  Involvement . 
o no me tas tase s ;  no p leural e ffus ion p re sent . 
1 small  e ffus ion and/or pleural thicke ning pre sent 
ipsalate ral to the bre as t  primary . 
2 mode rate e ffus ion is  pre sent ipsalate ral or contra­
late ral to the bre a s t  primary . 
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3 a large , seve re , e x tens ive and incapac itating e ffus ion 
pre sent on e ithe r s ide , or a bilate ral pleural e ffus ion . 
4 mas s ive e ffus ion wi th atale c tas i s . 
*B .  Symptomato logy . 
o asymp tomatic . 
1 minimal symptoms . 
2 mild to mode rate . 
3 seve re , cons ide rable . 
4 ve ry seve re to e x treme . 
C .  Symptom Lis t . 
a .  dyspne a .  
b .  cough . 
c .  pain . 
0 absent . 
1 minimal . 
or 2 mode rate . 
3 seve re . 
4 e x treme . 
D .  Tre atme nt . 
a .  thoracente s is with drainage . 
b .  thordcente s is plus intrapleural chemo the rapy . 
c .  quinacrine o r  te tracy cl ine the rapy . 
d .  prolonge d  drainage with thora c ic tube s .  
e .  thorace nte s i s  with infusion o f  1 9 8Au or 3 2 p .  
f .  thoracotomy and pleure c tomy (rare ) . 
g .  systemic chemothe rapy . 
G roup I I I  - Othe r Effus ions (pe ricardial , ascite s) . 
*A . Extent of Involvement . 
o none . 
1 small e ffus ion or  minimal asc ite s . 
2 mode rate e ffus ion or mode rate asc ite s . 
3 large , seve re e ffus ion or asc ite s . 
4 mas s ive e ffus ion or mas s ive asc i te s . 
*B . De gree o f  Symptomatology . 
o asymptomatic . 
1 minimal s ymptoms . 
2 mild to mode rate . 
3 se ve re , cons ide rable . 
4 ve ry seve re to extreme . 
C .  Tre atme n t . 
0 
1 
or 2 
3 
4 
absent . 
minimal . 
mode rate . 
seve re . 
extreme . 
a .  pe ricardioce nte s is or  abdominal drainage . 
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b .  pe ricardiocente s i s  or abdominal tapp ing and drainage 
p lus intrape r icardial or intrape ritone al che mothe rapy . 
c .  continued drainage wi th intrape ricardial or intra­
pe ri tone al tub ing . 
Group IV - Bone Me tas tase s .  
*A . Ribs . 
*B . Skull . 
*C . Pe lvis - wing of  i l ium . 
*D . Pe lvis - ace tabulum 
*E . Pe lvis - ischium . 
*F . Pe lvis - pubic bone . 
*G . Sacrum . 
*H . Femur - he ad and neck . 
*1 . Femur - inte rtrochante ric . 
*J . Femur - subtrochante ric . 
*K .  Ve rtebrae lumbar sp ine . 
*L . Ve rtebrae - thorac ic . 
*M . Ve rtebrae - ce rvical . 
*N . Shoulde r gi rdle (c lavicle , 
hume rus , scapula) . 
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Grade for e ach o f  the above : 
o no e vidence o f  me tas tase s .  
1 me tas tatic spre ad de te c ted  or  suspe cted by scanning tech­
nique or bare ly d i s ce rnible on radiographs as one or two 
iso lated o s te ob las t ic or o s te olytic bone re act ions . 
2 mode rate involveme n t  of  the bone in que s t ion , with vary­
ing de gre e s  o f  lys is  or blas t ic ac t ivity . Cortex is  
typ ically not  involve d or i s  only minimally s o ; radio­
graphs are pos i t ive . 
3 cons i de rab le to seve re involvement of  bone - involvement  
o f  approxima te ly one half of  the " bone or bone s in  que s ­
t ion ; d i ffuse fairly wide spre ad bone re ac t ion and activ­
i ty vis ible on the radiographs . 
4 se ve re involvement of bone or bone s in que st ion , de s truc ­
t ive b las tic  o r  lytic re act ion in we ll ove r one half of  
the bone ; wide spre ad and mul t iple are as involve d ,  patho ­
logical frac ture of hip or one of  the long bone s . 
*Type o f  Involveme n t  (Ove rall) . 
o evident  by  scan only , or suspe c te d  be cause of pain . 
1 inte rtrabecular , o r  primarily o s te oblas tic . 
2 mixe d patte rn ,  oste oblastic  p re domina t ing . 
3 mixe d patte rn , oste o ly t ic pre dominat ing . 
4 pre dominate ly o s te o lytic . 
*Symptomatology (Pa in , de c re ase d ROM , tende rne s s , swe lling) . 
o asymptomatic . 
1 minimal . 
2 mild to mode rate . or 
3 mode rate ly seve re to seve re . 
4 extre me , profound . 
Tre atme n t . 
a .  i rradiat ion . 
b .  che mothe rapy . 
o absent . 
1 minimal . 
2 mode rate . 
3 seve re . 
4 e x treme or profound . 
c .  hormonal the rapy (addit ive o r  ablative ) . 
d .  comb inat ion of  two or more of  the above . 
Group V - Live r Me tastase s .  
*A . Extent o f  Dise ase . 
o me tas tase s not  p re sent . 
1 s ingle d i s c re te le s ion or nodule , or minimal d ise ase 
de te c te d  v i a  l ive r scan , but not c l inically e vide nt . 
2 mul t ip le nodule s ; inte rme diate de gree of  live r involve -
men t . 
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3 di ffuse involveme n t  with cons ide rable hepatome galy . 
4 live r crowded with me tas tase s ;  parenchyma almost  totally 
replaced ; mass ive hepa tome galy . 
*B . Se ve ri t y  of  Symptomatology . 
o no  s ymptoms , asymp tomatic . 
1 minimal . 
2 mild to mode rate . or 
3 mode rate l y  seve re to seve re . 
4 e x t re me , p rofound , 
pote n ti ally fatal . 
o absent . 
1 minimal . 
2 mode rate . 
3 seve re . 
4 extreme , profound . 
C .  Symptom Lis t  secondary to l ive r involvement . 
a .  pain . 
b .  anore xia . 
c .  nause a and eme s is . 
d .  coffee and tobacco intole rance . 
e .  d i s tre s s ing hepatome galy . 
f .  j aundice . 
D .  Tre atme n t . 
a .  gene ral chemo the rapy . 
b .  in traarte rial infus ional chemotherapy . 
c .  hormonal the rapy . 
d .  surge ry .  
e .  combine d t re atment  approach . 
Group VI - Brain Me tas tase s . 
*A . Ex te nt  o f  D isease . 
o me tas tase s not pre sent . 
1 s ingle d i s c re te me tas tatic focus (unilate ral) . 
2 multiple le s ions are pre sent . 
3 men inge al or  dural involvement  or one or two large 
(gre ate r  than thre e cm . )  discre te le s ions . Ce rebe llar 
me tas tase s .  
4 comb ination involvement of ce rebrum , ce rebe llum , or 
meninge s  e tc . with multiple le s ions . D i ffuse and se ve re 
brain spre ad of  the carc inoma . 
*B . Comb ination of  Seve ri ty of Symp tomatology and Func tional 
Le ve l . 
o 
1 
no neurological findings . 
Class  I .  Inte lle c tual and 
pe rform othe r normal daily 
Normal ac tivity pre sent . 
phys ically able to work and 
activitie s . Minimal sympto-
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matology - one o r  two neurological findings may be p re ­
sent but only to a minor de gree . 
2 Clas s  I I .  Pat ie n t  i s  usually inte lle ctually intac t , but 
will  have some phys ical or othe r l imitations which 
although wil l  allow him to be home and pe rform some daily 
activitie s , nurs ing care may be required . Mode rate 
s ymptomatology is e xhibite d  - be tween  two and four s ymp ­
toms p re sent  to a mode rate de gree . 
3 C las s I I I . Patient e xhibits  maj or neurologic al findings , 
more than four , with symptoms that are fairly seve re in 
de gree ; patie nt will  re quire hospi tal i zation , medical 
care , and supe rv i s ion . Patient wi ll nee d  cons ide rab le 
a s s i s t ance in most  daily ac t iv i t ie s . 
4 C lass  IV . Seve ral neurological s igns are pre sent with a 
ve ry seve re o r  profound de gree of symp tomatology . 
Patient is  typ ically comatose . This is  a se rious or 
grave neuroLogical s ta te re quiring hospi talizat ion ; 
patie n t  is  ne arly or c omple te ly dependen t .  
C .  Symptom Li s t . (Local tumor e ffec t s  and/or incre ase d intra­
c rani al pre s sure e ffe c ts) . 
a .  hemipare s is . 
b .  le thargy or  c oma . 
c .  d i s orientation ; inte lle c tual impairme n t . 
d .  sensory de fic its . 
e .  he adache s . 
f .  nausea  and/or eme s is . 
g .  s lurre d  speech or aphasia . 
h .  se izure s . 
i .  ataxia ; gai t  d is turbance s .  
J .  othe r ce rebe l lar s igns or involvement . 
k .  pare s the sias ; numbne s s  and tingling . 
1 .  othe r (nystagmus , v isual fie l d  de fe c ts , cranial ne rve ) . 
D .  Tre atme n t . 
a .  c ort icos te roids . 
b .  i rr adiation . 
c .  surgical proce dure s . 
d .  chemothe rapy . 
e .  hormonal the rapy (othe r) . 
f .  comb ination of  two or more o f  the above . 
Group V I I  - Pe r iphe ral Ne rvous Sys tem Involvement . 
A .  Brachial Ple xus Involveme nt from sc alene and hilar or 
supraclavicular lymph node me tas tase s .  
B .  Othe r Pe r iphe ral Ne rve Involvement . 
*C . Symp tomatology , Se ve r i ty of Invo lveme n t . 
o asymp tomatic . 
1 mild or minimal pain ; minimal motor or sensory loss . 
2 mode rate pain , or  motor or sensory los s . 
3 seve re de gree o f  pain , and/or motor or sensory los s . 
4 e x t reme symptomatology . Se ve re pain and/or comple te 
motor or  sensory los s . 
D .  Tre atme n t . 
a .  i rradiation . 
b .  chemothe rapy . 
c .  hormonal the rapy . 
d .  comb ination o f  two or more o f  the above . 
Group VI I I  - Intraspinal Me tas tase s - Spinal Cord Compre s s ion . 
A .  Le ve l . 
a .  ce rvical sp ine . 
b .  thoracic  sp ine . 
c .  lumbar or sacral spine . 
*B . De gree  o f  Seve rity of Symptoms . 
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o no discernible motor , sensory , or  bowe l func tion impair­
men t . 
1 mild or  minimal dys func tion or s ymp tomatology . 
2 mode rate de gree of  dysfunc t ion or symptomatology se condary 
to cord compre s s ion . Patient can ambulate with cons ide r­
able ass is tance . 
3 marke d , seve re de gree of dys func tion (mo tor , sensory , or 
bowe l) , secondary to cord compre s s ion . Patie n t  i s  non­
ambulatory but s ome motor func t ion is pre sent . 
4 comp le te sensory and motor loss  be low the le ve l of  com­
p re s s ion . 
C .  Symptom Lis t . 
a .  sensory de fic i t s  or losse s . Pain and tempe rature , 
pos it ion sense , vibratory se nse , fine touch , deep  touch . 
b .  motor paralys i s . Varying de gre e s  of  motor loss dis tal 
to the le ve l of  compre s s ion . May be unilate ral , 
b ilate ral , and e ffe c t  s ingle or groups of muscle s . 
c .  los s of  sphinc te r control - bowe l incontinence . 
D .  Tre atme nt . 
a .  irradiation . 
b .  predn is one or othe r corticoste roid . 
c .  surgical lamine ctomy and de compre s s ion . 
d .  comb inat ion of the above , inc lud ing che mothe rapy . 
Group IX - Dis tant Lymph Node s . 
A .  S i te of Involvement . 
a .  contralate ral ax illary lymph node s . 
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b .  suprac lavicular or scalene lymph node s on e i the r s ide . 
c .  cervical lymph node s on e ithe r s ide . 
d .  abdominal  (me se nte ric ) lymph node s . 
e .  me d ias t inal and parae sophage al lymph node s . 
1 .  e sophage al s te nos is , mildly symptomatic . 
2 .  e sophage al obs truc tion , partial or comple te , wi th 
dysphagia .  
f .  pe lvic or inguinal lymph node s . 
g .  othe r d is tant node s . 
*B . Exte n t  of Involvement . 
o no d i s tant  lymphatic  invo lvement . 
l one re gional s i te of  lymphatic invo lve me nt from the list  
above . 
2 two isola te d  s i te s  o f  involvement  o f  the lymphatic s . 
3 three or more s ite s o f  involvement from the l i s t  above . 
4 seve re and e x tens ive involve me n t  of the d is tant  lymph 
node s , e spe c ially pe ritone al and abdominal .  
*c . Seve rity  o f  Symptomatology . 
o asymptomatic . 
1 min imal or ve ry mild symp toms from the lymph node spre ad .  
2 mode rate symptomatology in spe c i fic organs due to 
p re s sure or obs truc tion . 
3 seve re de gree o f  s ymptomatology ; spe c ific organ symptoms 
pre sent  w i th cons ide rable patient distre ss . Seve ral 
s ite s are typ ic ally involve d . 
4 ve ry seve re organ spe c i fic symptoms or  syndrome s due to 
pre s sure , obs t ruc tion , or e x tension of  the tumor mas se s  
in the lymphatics . 
D .  Tre atme n t . 
a .  chemothe rapy . 
b .  i rradiat ion . 
c .  surgE ry .  
d .  hormonal the rapy . 
e .  combination of  two or more o f  the above . 
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Group X - Skin and Soft Tissue . 
A .  Include s single or multiple subcutane ous nodule s ,  ulce ra­
tions , and infil t rations into soft tis sue or s truc ture s . 
*B . Exte n t  of  Dise ase . 
o no s kin or  s oft t i s sue involvement . 
l one or  two isolated , small (one - two centime te rs )  nodule s 
or ulce rat ions , or soft tis sue infiltrations . Minimal 
invo lvement . 
2 two or  three med ium s ize (two - three centime te rs) nodule s ,  
ulce rations , o r  s o ft tissue infiltrat ions . Mode rate 
involveme n t . 
3 se ve ral large (gre ate r than three centime te rs)  nodule s ,  
ulce rations , or s oft t i ssue infi ltrations . Se ve re 
involveme nt . 
4 wide spre ad ,  ve ry seve re involvement with skin nodule s ,  
ulce rations , o r  soft tis sue infiltration s . 
*c . Ove rall  Seve r i ty of Involvement o f  Symptoms . 
o none , as ymptoma t ic . 
1 min imal . 
2 mode rate . 
3 seve re . 
4 e x te n s ive , ve ry se ve re . 
D .  Tre atme n t . 
a .  chemothe rapy . 
b .  irradiation . 
c .  surge ry 
d .  hormonal the rapy . 
e . comb ination of  two or  more o f  the above . 
Group XI - Hype rcalcemia . 
*A . Seve r i ty of  Symptoms . 
o normal se rum c alc ium , no symptomatology . 
1 minor or  mild . Slightly e levated se rum calc ium , 
usually asymptomatic , minimal s igns may be p re sent . 
2 mode rate . The re is  a mode rate de gree of  e levation of  
se rum c alc ium with de fini te but mode rate clinical symp ­
toms that a re fai rly e as ily controlle d .  
3 se ve re . Ve ry high leve ls  o f  se rum calc ium with seve re 
cons ti tutional symptoms . Imme diate and intensive 
the rapy is imperative . 
4 profound . Extreme se rum calc ium le ve ls  with coma . 
B .  Symptom Li st . 
a .  nause a and eme s is . 
b .  c oma or  le thargy . 
b .  d ryne s s  of  the mouth . 
d .  confusion . 
e .  kidne y failu re . 
f .  othe r symptoms . 
C .  Tre atme n t . 
a .  mithramyc in . 
b .  phosphate s .  
c .  s te ro ids . 
d .  forced fluid  intake and low calc ium die t .  
e .  comb ination the rapy . 
Group XI I - Othe r Organ S i te s . 
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A .  Hematoge nous d i ssemination and actual organ involvement with 
me tas tatic c arc inoma from a bre ast  primary . 
Locations : 
a .  adre nals . 
b .  ovarie s . 
c .  s tomach . 
d .  pancre as . 
e .  re tina of  the e ye . 
f .  thyroid . 
g .  othe r . 
*B . The organ spe c ific s ymptoms or  syndrome s for each s i te are : 
o none . me tas tase s are no t pre sent . 
1 minor organ involvement and/or symp tomato logy . 
2 mode rate organ involvement and/or symp tomatology . 
3 seve re involvement and/or symp tomatology . 
4 profound de gree  of  involvement , with organ fai lure . 
C .  Tre atment . 
a .  chemothe rapy . 
b .  i rradiation . 
c .  surgical p rocedure 
d .  hormonal the rapy . 
e .  comb inat ion of  two 
or pre ce dure s . 
or more of the above . 
Group XI I I  - Cache x i a  and Sys temic Symptomatology . 
*A . Seve ri ty of the Syndrome . 
o no e vidence of  cachexia  or  systemic s ymptoms . 
1 mild o r  minor . Le s s  than ten pound we ight loss  with 
minor anore x ia , feve r ,  or fat i gue . 
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2 mode rate . Be tween  ten and 20  pound we ight los s , mode r­
a te anorexia , feve r ,  or fatigue , and distre ss , and 
mode rate pro te in or nitrogen imbalance . 
3 seve re . Be tween  2 0  and 35  pound we ight loss , muscular 
atrophy , p allor , trouble some anore xia , feve r ,  or fatigue , 
and seve re pro te in imbalance . 
4 e nd s tage c ache xia , profound sys temic symp toms . 
Group XIV - Vincrist ine Neurotoxic ity . 
*A . Extent o f  Involvement . 
o no toxic e ffe cts  due to the rapy ; patien t no t re ce iving 
vincris tine . 
1 minimal . cons tipation , minor p are s the s ias , insomnia , 
numbne ss  and t ingling , depre s s ion of deep tendon re fle xe s . 
2 mild- to -mode rate . cons t ipat ion , some loss  of bowe l  
mot il ity , mode rate pare s the s ias and numbne s s  and t ingl ing , 
loss  o f  dee p  te ndon re fle xe s , mild gene ral pain , mild 
gene ral we akne s s  (d is tal) , e as y  fatigab i l ity , insomnia . 
3 conside rable tox ic ity,  mild confus ion , incoord ination , 
gene ralized pain , e x traocular palsy , paralyt ic ileus , 
d i s t re s sing pare s the s i as and numbne s s  and tingl ing , 
wri s t  or  foot  drop , mode rate dis tal we akne ss . 
4 seve re . paralys i s , halluc inations , disorientat ion , 
psychos is , de lus ions , i le us , pe rmane nt wri s t  or foot 
drop , inab i l i ty to ambulate or seve re gait  abnormalitie s , 
ge ne ralize d mus cular we aknes s  and atrophy , but eve n  in 
seve re case s is usually dis tal . 
Group XV - Othe r Complications due to Tre atment ; those due to 
surge ry , che mothe rapy , hormonal the rapy , radiat ion the rapy , or 
othe r tre atment  admin i s te re d  for the ne oplastic proce s s . Con­
sult Addendum I I  - Complications Due to Tre atment  - Ge ne ral 
De script ion , for spe c i fic de tail . 
*A . Seve r i ty of  Symptoms 
o no complications or adve rse e ffects . 
1 min imal seve ri ty . 
2 mild to mode rate seve ri ty . 
3 seve re complicat ions or  symptoms . 
4 e xtreme ly seve re to profound complications or symp toms . 
B .  Tre a tment . 
a .  none . 
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h .  modi fication of  dosage of  d rug or  withdrawal of  drug . 
c .  alte rnate the rapy adminis te re d . 
d .  support ive the rapy and other tre atment me thods . 
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DATA COLLECTION FORM FOR MODEL A 
D ISSEMINATED BREAST CARC INOMA 
EXTENT OF METASTASES OPERATIONAL MODEL 
Group I - Pulmonary Me tastase s 
*A . Exte n t  o f  D ise ase 
*B . Symptomatology 
C .  Symptom Lis t  
D .  Tre atment 
Group I I  - Pleural Me tas tase s ;  Pleural e ffus ion . 
*A . Extent of  Involveme n t  
*B . Symp tomatology 
C .  Symp tom Li s t  
D .  Tre atment 
Group I I I  - Othe r E ffus ions (Pe ricardial , Asc ite s)  
*A . Exte n t  of  Involvement 
*B . De gree of Symp tomatology ____ __ 
C .  Tre atme n t  
Group IV - Bone Me tas tase s .  
*A . Ribs 
*B . Skull 
*C . Pe lv i s  - wing o f  i lium __ __ 
*D . Pe lvis  - ace tabulum 
*E . Pe lvi s  - ischium 
*F . Pe lvi s  - pubic  bone 
*G . S acrum 
*H . Femur - he ad and neck 
* 1 . Femur - inte rtrochante ric 
*Type of  Invo lvement  
*Symp tomatology De gree 
*J . Femur - subtro-
chante ric 
*K. Ve rtebrae lumbar 
*L . Ve rtabrae - thorac ic 
*M . Ve rtebrae - ce rvical 
*N . Shoulde r girdle (clavicle , 
hume rus , scapula) 
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Tre atment 
Group V - Live r Me tastase s .  
*A . Ex te nt o f  D i se ase  
*B . Se ve ri ty of Symptomatology 
C .  Symptom Lis t  -------------------------------------------------
D .  Tre a tme n t  
Group V I  - Brain Me tas tase s .  
*A . Extent  o f  Me tas tase s 
*B . Comb ination Seve rity of  Symptomatology and Func tional 
Leve l ---
C .  Symptom Lis t  
D .  Tre a tment  ----------------------------------------------------
Group VI I - Pe riphe ral Ne rve Involvement (Brachial Plexus Involve ­
men t) . 
A .  Are a o f  Involvement 
B .  Symptom List  
*C . Symptomatology , De gree of Se ve rity 
Group VI I I  - Intraspinal Me tas tase s .  Sp inal Cord Compre s s ion . 
A . Leve l 
*B . De gree o f  Seve ri ty of Symptoms 
C .  Symp t om Lis t  
D .  Tre atment  
Group IX  - D i stant  Lymph Node s 
A .  Node s Involve d ____________________________________________ ___ 
*B . Exte n t  o f  Involvement 
*C . Seve rity  of Symp tomatology 
D .  Tre atment 
Group X - Skin and Soft Tissue 
A .  Spe c i fie d Are a of  Involvement  
*B . Extent  of  Dise ase 
*C . Seve r i ty of  S ymp tomatology 
D .  Tre atme nt 
Group XI - Hype rcalcemia . 
*A . Seve r i ty of Symptoms 
B .  Symp tom Lis t  
C .  Tre atme n t  
Group XI I - Othe r Organ S i te s . 
A .  Loc a t ion 
*B . Organ Spe c i fi c  Symptoms or Syndrome s for each s i te : 
C .  Tre atment  
Group XI I I  - C ache xia  and Sys temic Symptomatology . 
*Seve r i ty o f  the s yndrome 
Group XIV - Vinc r i s t ine Ne urotoxicity . 
*A . Le ve l  o f  Neurotox icity 
B .  Tre atme n t  
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Group XV - Complications Due to Tre atme nt . 
*A . Seve rity  of Symptoms 
B .  Tre atme n t  
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ADDENDUM I TO APPEND IX A 
SEVERITY OF EXTENT OF METASTASES AND THE IR SYMPTOMS _ 
GENERAL DESCRI PTION 
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Introduc t ion : Symptomatology from organ involveme nt in me tas tatic 
b re as t  c arcinoma c an be change d app re c iab ly by various tre a tme nt  
re gime s . The re fore , the c las s i fication o f  any one patie n t  in 
re gard to exte nt of s ymptoms should be v iewed  as a dynamic and 
fluid  p roce s s  - and re ally only appl icable to the pe riod of evalua­
t ion ; i t  may change radically wi thin re lative ly short pe riods of  
t ime . In  o the r words , the cond i tion o f  the patient may vary con­
s ide rabl y  wi th tre a tme n t , gene ral phys ical condition , natural his­
tory  of the s i te and charac te ristics  of  the me tas tatic de po s i t  in 
que s t ion , and a hos t o f  othe r fac tors . Ex tent  of me tas tase s and 
s ymptomatology nee d  no t always agree for all s i te s . For e xample , 
seve re lung involveme nt may not cause seve re s ymptomatology . 
o Me tas tatic d i sease is  not pre sent . The re is  no evidence of 
me tas tase s in the organ , group , tissue , or system  in que s tion . 
1 The re i s  minimal involvement  of me tas tase s in the organ , t i s sue , 
group , or s ys tem  in que s t ion . The involvement  is ve ry apt to be 
asymptomatic i . e . bone or  live r  me tas tase s de te c ted  via radio­
nucl ide scanning but  not  c l inically e v ident . I f  symptoms are 
pre sent ,  they are minimal and inconse quent ial , and are usually 
tole rated we ll  by the patie nt . 
2 Mild-Mode rate . A mode rate de gree of symptomatology is  pre sent , 
which i s  to le rated only fa irly by the patient . Example s  are 
pain , lo s s  o f  range o f  mo tion , loss  o f  sensat ion , G I  d i s tur­
bance s ,  and mode rate spe c i fic organ s ymptoms . The symptoms 
cause d by  e xten t  o f  d i se ase in this category are usually we ll  
con trolled on  an  outpatien t basis . 
3 Se ve re . A s igni ficant and d i s tre s s ing de gree of  involvement of  
an  organ , t i ssue , group , or  sys tem is  p re se nt , usually produc ing 
seve re symptomatology , which will re quire intensive tre atment  
and , typically , hospi talization . Examp le s  include marked pain 
re qui ring powe rful analge s ic manage ment , dyspne a pre c lud ing 
unre s traine d  ac tivity , collapse of a ve rtebrae , seve re bone pain , 
cons ide rable cache x i a , and othe r seve re spe c i fic organ symp toms . 
4 Extre me - Pro found . Extreme (and in some ins tance s ,  end s tage ) 
de gree o f  s ymptomatology requiring ins titutionalization or othe r 
spe c ial care , and cons tant nurs ing or attent ion to mee t  the needs  
o f  incre as ing total dependency . Various targe t organ e ffects , 
including total failure of  that  organ to fulfill  i ts spe c i fie d 
func t ion , may occur s i ngly or conc omitantly ; for example , seve re 
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l ive r failure ; seve re dyspne a from pulmonary me tas tase s ;  pro­
found neurological s igns from ce rebral me tas tase s ;  pathologi­
c al fracture s of pe lvi s  or  long bone s ; or progre s s ive spinal 
c o rd compre s s ion . 
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ADDENDUM I I  TO  APPENDIX A 
COMPLICATIONS DUE TO TREATMENT - GENERAL DESCRI PTION 
I ntroduction : Comp lications due to tre atme nt may be hematologic , 
gas trointe s t inal , neurologic , hepatic , ge nitourinary , or  de rma­
tolo gic . Als o , infe c t ions and fe ve r may occur , as we ll as  othe r 
ge neral and misce llane ous symptoms . The cause o f  the se complica­
tions  c an be d i re c tly or indire c tly re late d  to concomitan t  the rapy 
such as e ndocr ine surge ry or hormonal the"rapy , radiation therapy 
including radioisotope s ,  s ys temic or  local chemothe rapy for me ta­
s tatic  dise ase , o the r surgical procedure s , and othe r forms  o f  
the rapy . Symptoms may vary from mild to profound . 
o The re are no adve rse e ffec t s  or symptoms due to chemothe rapy , 
radi o the rapy , hormonal the rapy , or othe r tre atment . A clas s i ­
ficat ion o f  T T O T T  i s  als o  given i f  patient i s  not re ce iving the 
the rapy in que s t ion . 
1 Minimal seve r i ty . Complications due to tre atment  are produc ing 
condi t ions and/or symptomatology that are minimal in nature , 
are tole rate d fai rly  we ll by the patient , and do  not re qui re 
dosage or o the r mod ification in tre atment . 
2 Mild seve rity . Comp l ications  and symptoms produced by the tre at­
ment  in que s t ion are mode rate or mild  in de gree , and are tole ­
rate d with some d i s tre ss on the part of the patient . Compli­
cations will  usually require dosage or othe r modification of  
tre atment  re gime . 
3 Seve re . Comp l ications and symptomatology produced by the tre at­
me nt  are s e ve re in nature , and are poorly tole rated w ith con­
s ide rab le d is t re s s  on the part of the p at ient . This c lass ifi­
c ation usually will demand that the tre atment or  the rapy be 
withdrawn or inte rrup ted . 
4 Extreme ly seve re or p rofound comp l ic at ions have ensue d  which 
unde r ce rtain circums tance s may be irre ve rs ible . Patient is  
profoundly ill  or is  in  se rious medical condi tion . 
199  
APPEND IX B 
MODEL B 
LEVEL OF FUNCTIONAL DISABILITY OPERATIONAL MODEL 
Maj or Obj e c t ive : to asse s s  the func tional d isabilitie s  of the 
me tas tatic bre a s t  cance r pat ie nt . The mode l is  divide d into twe lve 
maj or group s , e ach de scrib ing an e sse ntial daily ac tiv ity . Pe r­
formance on e ach of the se func tional ac tivi tie s will be score d 
according to the scale and de finitions given be low . S ince thi s 
mode l de fine s the cate gorie s more pre c ise ly , the re should be lit tle 
d i s agreeme nt re garding the le ve l of  disabi lity  for e ach cate gory 
for a particular patien t .  
LEVELS OF FUNCTIONAL D ISAB ILITY 
o Independent : safe in an unstruc ture d env ironme nt with or with­
out unive rsal equ ipment . 
1 Func tional : independent  within a struc ture d environme nt and/or 
with non unive rsal equipment . 
2 Minimal Ass i s t ive : require s safe ty guarding and/or ve rbal cue s . 
3 Mode rate Ass is tive : patient re quire s  contac t guarding . 
4 Max ima l As s is t ive ; Depe ndence : patie nt attempts  to he lp ; is  com­
p le te ly depe nde nt in the ac tivity . 
DEFINIT ION OF TERMINOLOGY 
a .  uns truc ture d env ironme nt ; community . 
b .  s truc ture d e nvironme nt : contained  or mod i fie d and/or supe rvised . 
c .  unive rs a l  equipment : portable , i . e .  whee lchai r ,  brace s ,  pro s ­
the t ics , splints , s l ings , ambulatory a ids  . (walke r ,  cane , 
crutche s , e tc . ) , o the r .  
d .  non-unive rsal equ ipment : not easily portab le , such as paralle l 
bars or hosp i tal be d ,  l i fts , e tc . 
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e .  ve rbal cue s : ve rbal commands or instruc tions . 
f .  safe ty guarding : s t and by supe rvision . 
g .  contact guarding : physical  as s istdnce . 
Group I - Fee d ing 
o Pat ient is  comple te ly indepe nde nt in all fee d ing a c t ivitie s . 
1 Func t ional . Patient can e at if  the me a l  is  on a table or 
tray be fore he r ,  and c an handle all e ating utens i ls satis ­
fac torily . 
2 Minimal as s i s tive . Pat ient typically needs  assis tance in 
cutting up food , use of some ute ns ils , or spre ading butte r . 
3 Mode rate as s is tive . Patie nt re quire s cons ide rable contac t 
guarding in fee d ing ac tiv i t ie s . 
4 Patient  c annot fee d  he rse l f ,  max imum assis tance or total 
dependence . 
Group I I  - Trans fe r  whee lchair to be d and back , or re gular chair 
to be d and bac k .  
o Pa tient is  to tally independent o r  ac tivity doe s not apply . 
1 Functional . Trans fe rs to and from a whee lchair or chair  
from a s t andard he ight be d .  Struc tured environment . 
2 Minimal ass i s t ive with various aspects  of the transfe r .  
3 Mode rate a s s i s tive . 
4 Max imal as s is tive to total dependence . Pat ient can attempt 
to he lp , but canno t pe rform transfe r  without max imal a s s i s ­
tance of  one or more pe rsons . 
Group I I I  - Pe rsonal toile t and hygiene ac tivi tie s (e xc luding 
bowe l and bladde r) . 
o Comp le te independence in this ac tiv ity . 
1 Func t ional . Pat ie n t  is  ab le to wash hands and face , take 
care of  hair , shaving nee ds , e tc . Female s can handle makeup 
and othe r appropriate pe rsonal to ile t needs . 
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2 Min imal assis tive . 
3 Mode rate assis tive : approx ima te ly one half of the ac t ivity 
or one half of the e ffor t behind the ac tivity is  pe rformed  
by the patient . 
4 Max imal ass is tive - ne ar total dependence re gard ing tasks . 
Group IV - Trans fe r  to and from and use of the toile t . 
o Comple te independe nce , or ac tivi ty · doe s not apply . 
1 Func tional . Patie nt ge ts on and off the toile t , adjus ts 
clothing , c le anse s se lf , and prevents soiling of se lf or 
c lothing . If  be dpan is  use d , the patient is  able to ge t on 
and off , use , cle an , and put away the be dpan within the 
s truc tured e nv ironment . 
2 Minima l ass i s tance require d ln use of the toile t  or bedp an . 
3 Mode rate a s s i s t ive . 
4 Max imal a s s is tance is  re quire d , e ithe r to ge t to the to ile t 
or use the be dpan ; patient is  comple te ly or ne arly comp le te ly 
de pende nt in the ac t ivity . 
Group V - Ba the s Se lf . 
o Inde pe ndent in ac t ivity . 
1 Func tional . 
sponge bath . 
be require d . 
Patient use s bathtub , showe r ,  or take s comple te 
Dire c t ion and modificat ion of the ac tivity may 
2 Minimal as s is t ive . 
3 Mode rate to cons ide rable assis tive - up to one half of activ­
ity or e ffort is  pe rformed by the patient he rse l f . 
4 Max imal assis tive to comp le te depende nce on othe rs for bath­
ing ac tivitie s .  
Group VI - Ambulat ion on le ve l surface s .  
o Indepe ndent ; unive rsal e quipment  may be used . 
1 Func tional ambulation . Patie nt can ambulate within a 
s truc ture d environment with or without unive rsal or non-
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unive rsal e quipment . 
2 Minimal ass i s t ive . Patie nt freque ntly needs safe ty guarding! 
ambulat ion tole rance fa ir to good . 
3 Mode rate assistive . Pa tient require s  phys ical assistance to 
ambulate/ambulation tole rance poor to fair . 
4 Patien t  can ambulate with ve ry max imal as s i s tance for only a 
few s teps/pat ient  is  non- ambulatory . 
Group V I I  - Ambulation on S tairs . 
o Independent . 
1 Func tional in asce nd ing or de scending stairs . 
2 Minimal as s i s tive , re quiring safe ty guard ing . Patient is  
typ ically  prone to  e arly or eas y  fat igue . 
3 Mode rate ass istive . Patient typically can , wi th assis tance , 
ascend and de scend s tairs once a day max imum . 
4 Max imal as s i s t ive or dependent . Ve ry max ima l assis tance 
nee de d  to asce nd one or two s teps/pat ient no t able to pe r­
form ac t iv i ty . 
Group VI I I  - Whee lchair  Ac tivitie s . 
ambulatory) . 
(Doe s not app ly i f  patie n t  is 
o Indepe ndent in all whee lchair ac tivitie s . 
1 Func tional . Mane uve rs  whee lchair on leve ls with occas ional 
supe rvi s ion or mod ification of ac tivity . 
2 Minimal ass is t ive . 
3 Mode rate assis tive . Cons ide rable assis tance l S  needed  for 
the patient to mobil ize the whee lchair .  
4 Max imal ass is t ive . For all  prac tical ity , patient i s  not 
able to maneuve r the whee lchair . 
Group IX - S i t t ing tole rance and ac t ivitie s . 
o Independent . Patient s it s  inde fini te ly ; can mobil ize se lf  
from the s itting posit ion . 
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1 Func tional . Patie nt tole rate s s i tting up mos t o f  waking 
hours , and pe rforms most  ac tivi tie s  from the s itting pos ition 
satis factor ily . 
2 Minimal a s s i s t ive . Patie nt tole rate s s itting up for approx i­
mate ly one half of the day . Needs minimal ass i s tance as 
de fine d  for ac tivitie s  in the s i tting pos i tion . 
3 Mode rate as s is tive . Patient tole rate s s itting up for short 
pe riods , an hour or so once or twice a day . Needs  mode rate 
ass i s tance as de fine d for activitie s  in the si tting pos i tion . 
4 Pat ie n t  canno t tole rate s it t ing up ; i s  con fine d to bed . 
Group X - Be d Act ivi t ie s . 
o Independent  in all be d ac tivitie s . 
1 Func tional . Wi thin the struc ture d environment , pat ient is  
able to s i t  up , turn from prone to  supine , and from supine 
to prone ; can turn se lf at night , and is  ab le to pos i t ion 
se l f  to c omfort . 
2 Min imal as s istive . Safe ty guarding and/or ve rbal cue s needed 
for be d mobility  activ i t ie s . 
3 Mode rate as s i s t ive . Pa tient will typ ically pe rform up to one 
hal f of  be d mobility  ac tivitie s he rse lf ; in addition to 
phys ical assis tance an ove rhe ad trape ze bar is fre quently 
ne e de d . 
4 Max imum a s s i s t ive to comple te dependence . 
Group XI  - Dre s s ing Ac tivitie s . 
A .  Uppe r Body Garments . 
ments) . 
o Indepe ndent . 
(Shirt , blouse , j acke t , pullove r gar-
1 Func tional . Needs  occas ional guidance and supe rvis ion 
within the struc ture d e nvironment . 
2 Minimal assis tance re quired . 
3 Mode rate ass i s tance ne eded . 
4 Max ima l as s i stance ; patient c anno t pe rform ac t ivity ; 
c omp le te ly depende n t . 
B .  Lowe r Body Garme nts (trouse rs , pants , shorts , ski rts) . 
Score d from ze ro to four as above . 
C .  Hose and Shoe s (Tie shoe s , loafers , s l ippe rs) . 
Score d  from ze ro to four as above . 
D .  Unde rclothing and/or be dclothing (Paj amas , nightgowns , 
s imple be dj acke ts ) . 
Score d  from ze ro to four as  above . 
G roup XI I - Bowe l and Bladde r Management . 
o Patient always con tinent  of  bladde r and bowe l . 
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1 Patie nt is  func t ional i n  bowe l and bladde r con trol . I s  able 
to take an e nema or supposi tory wi th supe rvis ion ; controls 
bowe l and b ladde r day and night . 
2 Minimal ass i s t ive . Patie nt has acc idents on occas ion ; is  too 
we ak to control func t ions fully . 
3 Mode rate assis tance as de fined in us ing any aids , such as 
e nemas or suppos i torie s or othe r de vice s , to control bowe l 
and bladde r func t ion . Acc ide nts are fre quent , e spe c ially 
at night . 
4 Patient is  incont inent of  e ithe r bowe l or bladde r func tion 
or both . 
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DATA COLLECTION FORM FOR MODEL B 
LEVEL OF FUNCTIONAL DISAB ILITY OPERATIONAL MODEL 
Group I - Fee d ing . 
G roup I I  - Transfe r  to whee lchai r or  regular chair to and from 
bed . 
Group I I I  - Pe rsonal To ile t and Hygie ne Activitie s . 
Group IV - Trans fe r  to and from and Use of  the To ile t . 
G roup V - Bathe s Se lf . 
Group VI - Ambulation on Leve l  Surface . 
Group V I I  - Ambulation on Stairs . 
Group V I I I - Whee lchair Ac tivitie s . 
G roup IX - S i t t ing Tole rance and Ac tivitie s . 
G roup X - Be d Ac t ivitie s . 
G roup XI  - Dre s s ing Ac tivi tie s . 
A .  Uppe r Body Garme nts . 
B .  Lowe r Body Garme nts . 
C .  Hose and Shoe s . 
D .  Be dc lothing . 
G roup XI I - Bowe l  and Bladde r Cont inence . 
VALIDATI ON PANEL - MODEL B 
Jim Youda s ,  RPT 
Carolyn Gile , RPT 
Debbie Lawre nce , RPT 
Lawre nce Ho , RPT 
Sus an Satte rwhite , RPT 
Lani Trykowski , RPT 
Nancy Bookste in , RPT 
Kare n Crabb , RPT 
Mary Mille r ,  RPT 
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APPENDIX C 
PRELIMINARY PATIENT INFORMATION PREPARATORY TO DATA COLLECTION 
SHORT DATA BASE 
Name : 
----------------------------
Hosp ital  Chart Numbe r :  ________ __ 
Date : 
--------------------------
Age : ____________________________ 
__ 
Add re ss : 
-----------------------------------------------------------
Date o f  B re as t  Cance r Diagno sis : __________________________________ __ 
Date o f  Radical Mas te ctomy or othe r Bre as t  Surge ry :  ______________ __ 
Known Me tastase s  (furthe r bre akdown will be outl ine d on the Extent 
of  Me tas tase s Ope rational Mode l) : 
S i te : __________________________ __ Date : __________________________ ___ 
Othe r Surgical Procedure s Use d : 
Date : __________________________ ___ 
Radiat ion Proce dure s Use d :  
Date : __________________________ ___ 
Chemothe rapy Tre atme nt : 
Agent : __________________ __ Date : __________________________ ___ 
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Hormonal Tre atment  
Additive (Es troge ns or Androge ns) : 
Agent : 
------------------------ Date : --------------------------
Abl at ive : 
Oophore ctomy : 
---------------- Date : --------------------------
Adre nale c tomy : 
--------------- Date : ------------------------
Hypophyse ctomy : 
------------
Date : 
--------------------------
Pre l iminary Func tional C lass ific ation (Pe rformance Status) 
1 
2 
3 
4 
5 
6 
Tentative Rehabili tat ion Goals (See Rehab ilitation Goa ls and The ir 
Cri te ria) 
A 
B 
C 
Type of  Primary C ancer 
1 .  Infi ltrating Ductal Carc inoma 
2 .  Lobular Carc inoma in Situ 
3 .  Medul lary (Circumscribe d) Carc inoma 
4 .  Inflammatory Carc inoma 
5 .  Pap i llary Carc inoma 
6 .  Mucoid (Colloid) Carc inoma 
7 .  Page t T s  Dise ase , Carc inomatous change 
8 .  Othe r 
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APPEND IX D 
PERFORMANCE STATUS - FUNCTIONAL CLASSIFICATION 
1 .  Pa tient i s  able to care for pe rsonal needs and to carry on 
normal daily ac t ivi t ie s  and to re turn to prev ious employment 
or  p revious household dutie s and func t ions , or  previous age 
app ropria te tasks (i . e . e lde rly ve rsus children) ; patient  has 
re turne d to pre morbid s tatus . 
2 .  Patien t  i s  able to care for personal ne eds and carry on normal 
daily ac tivi tie s  and to re turn to alte rnative employment  or 
alte rnative household dutie s or func tions or pre vious age 
appropriate tasks wi thin the limi ts o f  disabil ity . 
3 .  Pat ie nt i s  able to care for pe rsonal nee ds and c arry on norma l 
daily ac tivi tie s  and re turn to part time (le ss  than half time ) 
employment o r  part t ime household dutie s and func tions , or part 
t ime age appropriate tasks . 
4 .  Patient is  able to l ive at home and care for most  personal 
nee ds , and to carry on some no rmal daily ac tivit ie s , and 
engage in a l imi ted and min imal amount of  employment (le s s  
than p art  t ime ) , household dut ie s and func tions , o r  ve ry mini­
mal age appropriate tasks unde r prote c t ive condi tions . Some 
a s s i s tance will be require d  and the re is  a loss  of  independe nce 
to some de gree . 
5 .  Patie nt i s  able to pe rfo rm ve ry l imi ted  se lf  care but re qui re s 
c ons ide rable ass is tance in all daily ac tivitie s . Cons ide rable 
care will  probably be neede d . Patient i s  unable to be employed , 
pe rform household dut ie s and func tions , or  pe rform age appro­
priate tasks . The re is  a serious loss of  indepe ndence in all 
are as . 
6 .  Pat ie nt has virtually lost  all independence in her dispos i tion , 
is  unable to care for he rse l f ,  and re quire s the equivalent of 
ins t i tutional or hospi tal care . Cons tant me dical and nurs ing 
care are re quire d  as the patie nt approache s the te rminal s tage 
of he r dise ase . 
De finitions : 
Care for pe rsonal nee ds : Patient  is  able to take the re sponsi­
b i l ity for he r own se lf  care re garding bod ily func tions , pe r­
sonal hygiene , and re late d rout ine tasks . 
Normal daily ac tiv itie s : Those ac tivities  re garding ordinary 
daily funct ions that the patient routine ly pe rforms as a matte r 
of  hab i t , cus tom , or de s i re . 
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Employment dut ie s pe rtain to emp loye d  persons , working daily 
for a salary or wage . 
Household dutie s and func t ions pe rtain to pe rsons managing a 
household as the ac tiv i ty that  take s  the greate r  part of the 
day . 
Age appropriate tasks are those ac t ivi tie s not inc lude d under 
employme n t  or household dutie s and funct ions , such as the 
p lay ac t ivit ie s  of  children or the normal daily ac tivitie s  o f  
the aged . 
211 
APPENDIX E 
REHAB ILITATION GOALS AND THEIR CRITERIA 
A .  Re s torat ive Goal 
C r i te ria : - the total tumor has bee n  remove d or  e radicated  by 
surge ry , irradiation , chemothe rapy , or hormonal 
me thods . 
- the re is  no evidence of  re s idual or re current 
d i se ase . 
- the re is suffic ient re ason to be l ieve that the 
prognos is i s  good . 
- the re is  pos s ib le re s idual disab i l ity from the 
primary tumor or i ts tre atment (i . e . pos t mas te c ­
tomy lymphede ma ; loss  o f  an e x tremity due to surg­
ical amputation) . 
Rehab i l i ta tion Me aning : The patie nt in all like lihood can be 
re s to re d  to premorbid or  ve ry near premorbid pe rformance leve ls .  
Spe c ial  the rapie s  with p lanne d and graded rehabilitat ion goal s 
for the patie n t  can do much to as s i s t  him or he r in re alization 
of  full fun c t ional potent i a l . 
B .  Support ive Goal 
Crite ria : the re is  re s idual tumor rema ining afte r surge ry or 
othe r tre atment me thods . 
the re is  e v idence of re gional or dis tant spread . 
- al though the prognos is is unce rtain , the patient 
is  s t i l l  potentially controllable fo r a varying 
pe riod of time . 
Rehabi l i tation Me aning : The patient can be re s tored  to a pre ­
morb id o r  ne ar premorbid leve l of pe rformance for a varying 
pe riod of t ime . Modi fication of pe rformance le ve ls wil l  be 
ne ce s s ary in l ight of re alis tic  rehab i l itation goals . Distant 
me tas tatic spre ad of  the d ise ase doe s not ne ce ssarily or auto ­
matically  guarantee a s te ady downhill  c ourse or even s igni fi­
c ant d isabil i ty . Howe ve r ,  by prope r and ade quate train ing and 
tre atme n t , the re will  be e limination of as much di sabil ity as 
poss ible , and inte ns ive rehab il itat ion should be offe re d to 
the patie nt . 
C .  Pal l iative Goal 
Crite ria : - there is  wide spread me tas ta t ic dise ase pre sent . 
Rehabi l i tation Me aning : Inc reasing di sabil ity may occur from 
pro gre s s ing d ise ase with assoc iate d  de c re ase in pe rformance 
capac i t y ,  but appropriate prov i s ion of the rape utic treatment 
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will  e liminate some of  the comp l ications that might othe r­
wise e nsue . The e xpe rie nce d and compe te nt oncologis t who can 
d i scove r and tre at disseminate d d isease with alacrity may make 
a l l  the d iffe rence be tween  controlle d  versus uncontrolle d  
dise ase . The patient  nee ds support through the pre - te rminal 
and te rminal pe riod and aid in reaching the highe st le ve l  of 
func t ioning that is  poss ib le in l ight of the d isability that 
is pre se n t . 
DEPARTMENT OF PHYS ICAL THERAPY 
SCHOOL OF ALLIED HEALTH PROFESSIONS 
VIRGINIA COMMONWEALTH UNIVERS ITY 
CONSENT FORM 
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I he reby grant pe rmiss ion t o  Stephen A .  Gudas , RPT to 
e valuate my pe rformance in daily routine chore s , abil ity to e at 
and dre s s , and pe rformance in walking , mob ility , and othe r  se lf 
care ac tiv i t ie s . The purpose and proce dure s use d have been 
ade quate ly and fully explaine d to my sati s fac tion . The re will be 
no d i s c omfort or pain involve d in thi s  evaluation , howeve r ,  I 
unde rs tand that I may free ly and voluntarily wi thdraw my partici ­
pation i n  the evaluat ion proce ss  at  any time . I also give the 
s tude nt pe rmi s s ion to use the re sults of the func tional ab ility 
e valuation for use in writing his re se arch the s is . I also unde r­
s t and that  at  no t ime will my name be used to identify me in the 
course of  this re se arch . 
pe rson authoriz ing consent 
WITNESS 
DATE : _____ __ __ __ __ __ __ __ __ __  
